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9General introduction
Ageing of the population and higher survival rates of people with chronic diseases 
result in an increasing number of patients in need for palliative care1, 2. At the end 
of their lives, people with chronic diseases often suffer from symptoms such as 
pain, dyspnea, depressed mood, or existential problems3, 4. Symptoms that not 
only threaten a patients’ life but also the quality of their remaining lifetime. In 
daily clinical practice, however, care is often not centered around the patient but 
around the disease of the patient5. Many physicians, for example, often continue a 
curative treatment until late in the disease trajectory5. Yet, we know that following 
a palliative care approach alongside usual oncological care is more effective to 
improve the patient’s quality of life than just oncological care, without shortening 
it6. However, many patients still receive sub-optimal palliative care. Not all patients 
in need of palliative care, for example, have access to palliative care services7. 
But as Berwick already stated: “an adequate organisation of care is a prerequisite 
to good clinical care”8. To further improve the provision of palliative care, it is 
important to strengthen the organisation of palliative care. Yet, as the provision of 
palliative care is different per country, region and setting, an approach is needed 
that can identify areas for improvement in order to improve the organisation of 
palliative care at a local level. For that reason, the EU-funded 7th Framework 
IMPACT project (IMplementation of quality indicators for PAlliative Care sTudy) 
started in 2011 with the aim to develop quality indicators to assess and improve 
the organisation of palliative care by implementing improvement strategies in 
settings that provide palliative care. Researchers from ten countries participated 
in the IMPACT project to define, develop and implement strategies to improve the 
organisation of palliative care in different settings across Europe. The scientific 
work presented in this thesis presents (part of) the results of this IMPACT project.
Palliative care
Palliative care began in the hospice movement and originates back to the Roman 
era, where a hospice was a place of rest for travellers9. Travellers, but later also 
(terminally) ill persons were offered special hospitality as they were often far from 
home. The term ‘hospice’ disappeared for a while, but re-emerged in the 19th 
century as a sanctuary for the dying. In 1967, the modern hospice movement 
was founded by Dame Cicely Saunders10. In 1973, the Canadian physician Balfour 
Mount did not want to call his unit for terminally ill -dying- patients a ‘hospice’, 
since this term was already in use for the poor and destitute in French-speaking 
Canada. Instead, he called his unit ‘palliative care’11. Palliative care was by that 
time primarily known as ‘care of the dying’9, but later also incorporated terms as 
‘terminal care’, ‘end-of-life care’, ‘hospice care’ and ‘supportive care’9. In 1986, 
the World Health Organisation (WHO) defined palliative care as the “active total 
care of patients whose disease is not responsive to curative treatment [...]”12. 
This definition was later considered to be too focused at incurable diseases13. 
Therefore, in 2002, the WHO updated its definition on palliative care to “an 
approach that improves the quality of life of patients and their families facing 
the problems associated with life-threatening illness, through the prevention and 
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relief of suffering by means of early identification and impeccable assessment and 
treatment of pain and other problems, physical, psychosocial and spiritual”13.
Palliative care for patients with different incurable diseases
The 2002 WHO definition implies that palliative care is applicable to patients 
suffering from any life-threatening illness, such as cancer, chronic obstructive 
pulmonary disease (COPD), coronary heart failure (CHF), kidney failure, dementia, 
aids or ebola. The WHO estimated that over 20 million people are continuously in 
need of palliative care worldwide7; 69% adults (19 million), of which 13.1 million 
persons (69%) aged 60 years or older and 4.1 million persons (22%) in Europe7. 
They suffer: cardiovascular diseases (38.47%), cancer (34.01%), COPD (10.26%), 
HIV/AIDS (5.71%), diabetes mellitus (4.59%), kidney disease (2.02%), cirrhosis of 
the liver (1.70%), Alzheimer’s and other dementias (1.65%) and other chronic 
illnesses (1.59%)7. However, these figures are based on mortality data. We know 
that for some chronic diseases, such as dementia, often another (acute) cause of 
death is mentioned. The actual number of persons in need of palliative care will 
therefore double or even triple compared to what is stated above7.
The European perspective
In Europe, cancer is responsible for a large proportion of patients in need of 
palliative care. In 2008, there were about 3.2 million new cases of cancer and 
1.7 million deaths from cancer14. It is expected that the incidence of cancer will 
rise with about 20% in the next decade and the prevalence will rise due to longer 
survival14. 
Besides, as people are getting older, there will be a rising number of persons with 
dementia. In 2006, about 7.7 million persons were diagnosed with dementia15. This 
number is expected to double in the next 20 years15. Traditionally, older people 
have received less palliative care than younger people and services focused more 
on cancer than on dementia care. However, most deaths in Europe concern people 
aged over 6516. These figures underline the need for well-organised services that 
provide optimal palliative care, not only for patients with cancer but also for those 
with dementia.
Palliative care for patients with cancer
Cancer is characterised by a predictable decline in physical health over a period 
of weeks, months, or years (figure 1)17. Many patients with cancer suffer from 
pain as well as from fatigue, depressed mood, and non-medical problems 
that threaten the quality of life such as reduced autonomy4,18. Thereby, many 
patients with cancer are in need of more professional attention for coping with 
the unpredictability of the future and a fear of physical suffering18. Most weight 
loss, reduction in performance status, and impaired ability for self care occurs in 
patients’ last few months17. But in general there is time to anticipate on palliative 
care needs and plans for end-of-life care17. 
11
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The advantage of palliative care for patients with cancer
It has been shown that early palliative care improves the quality of life in patients 
with metastatic non-small-cell lung cancer. Temel et al, assigned patients to 
receive early palliative care integrated with standard oncologic care. After 12 
weeks, patients assigned to early palliative care had significantly higher quality 
of life scores, significantly lower percentage of depressed mood, improved 
documentation about resuscitation preferences, less aggressive care at the end 
of life and increased survival in comparison to those assigned to standard care19. 
Thereby, various cost-effectiveness studies showed that palliative care reduced 
healthcare expenditure20-23.
Palliative care for patients with dementia
Dementia is a clinical syndrome characterised by a decline in cognitive functioning 
resulting in impairments in daily living and that eventually will lead to death24-25. 
Dementia is characterised by a slow, progressive deterioration of the condition 
of the person affected (figure 2)17. The period between diagnosis of dementia 
and death can be two to 20 years24. During their illness trajectory, many people 
with dementia suffer from pain, agitation, dyspnoea, neuropsychiatric symptoms 
and depression and have reduced cognitive and communicative skills26. The 
disease trajectory is often associated with weight loss17, an increasing number of 
infections, disability and impairment25. Birch described that people with dementia 
may die at any stage during their illness: they may die from another acute or 
incurable illness, or a combination of dementia and another comorbidity or of 
dementia itself24. Although it is evident that a palliative care approach is also 
Figure 1: Short period of decline
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applicable to persons with dementia it is, because of the unpredictability of the 
disease trajectory, difficult to determine when to start palliative care. 
The advantage of palliative care for people with dementia
Understanding and responding to the needs of people with dementia improves 
their quality of life27. People with dementia often experience end-of-life 
related symptoms for a longer period than patients with cancer24. Cognitive, 
communication, functional and behavioural problems can make palliative care 
problematic as symptoms are difficult to detect26. Initiating a palliative care 
approach earlier in the disease trajectory allows to anticipate on future needs 
and wishes of a person with dementia and facilitates person-centred care24. But, 
unlike the benefits of early palliative care for patients with metastatic non-small-
cell lung cancer, there are few studies that describe the efficacy of palliative care 
for people with dementia. Sampson et al. conducted a review in which only two 
out of 885 studies were eligible for inclusion in the final review28: In the study of 
Ahronheim et al., people with dementia who were hospitalised with acute illness 
were randomised to receive advice from the palliative care team or to usual 
care. The intervention had no influence on length of hospital stay or reduction 
in painful interventions29. In a study of Volicer et al., a traditional long-term care 
unit was compared with a dementia special care unit. There was higher mortality 
but lower observed discomfort, costs of medication, radiology and laboratory 
procedures were significantly less and there were fewer patient transfers to acute 
medical settings in the dementia special care unit30. Sampson et al. identified 
another study with a weaker methodology that showed better symptom control 
Figure 2: Prolonged decline
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and improved analgesia usage28,31. In addition, Shega et al. described that early 
stage support for people with dementia was helpful for complying with patients’ 
wishes and choice of place of death32.
Provision of palliative care
Palliative care can be provided wherever the patient resides. Depending on the 
healthcare organisation per country, different services where palliative care 
can be provided exist33. The spectrum of services is supposed to cover all the 
different levels of care needed by the patients, including acute care (hospital), 
long-term care (nursing home and hospice) and home care (general practitioner 
and community nurses)34,35. Patients with cancer usually receive palliative care at 
home and in the hospital; non-cancer patients at home, in the hospital and nursing 
home; and patients with dementia primarily at home and in nursing homes36. 
Another distinction can be made between generalist and specialist palliative care. 
Generalist services offer a standard of palliative care that can be provided by all 
healthcare professionals in all services. Specialist services offer a higher standard 
of palliative care, provided at the expert level, by a trained multi-professional 
team34,35. Specialist palliative care is in the Netherlands, for example, provided at 
a palliative care unit, hospice, by a home based palliative care team34,35, or by a 
telephone support team37.
Many healthcare professionals do not have the adequate knowledge, experience 
and skills to provide optimal palliative care38. In many countries, the integration 
of palliative care into the core curricula of medical and nursing education is still 
lacking39. Consequently, too many patients receive suboptimal or delayed care, 
leaving many patients suffer from severe physical, psychosocial and spiritual 
symptoms40. 
Improving the quality of palliative care  
Evidence-based and best practices are often not implemented in daily clinical 
practice. Healthcare professionals, for example, just don’t have enough time to 
keep up-to-date with all new evidence41. Thereby, professionals often have a lack 
of knowledge regarding how to implement scientific evidence. Implementation of 
scientific evidence can therefore best be guided by a step-by-step approach such 
as the Plan-Do-Study-Act Model42, Framework for complex interventions43, and 
Grol’s Implementation of Change Model (figure 3)44. Consequently, using such an 
approach facilitates the identification of potential barriers and facilitators, allowing 
to tailor the implementation process to the specific situation. An essential step to 
ensure the effectiveness of the implementation process.
Analysis of actual performance
One of the first steps in the implementation process is to measure the current 
level of quality of care45. A description of the current level of care can be used 
to objectively compare the results before and after an intervention study. Such 
a systematic and transparent data collection can be achieved by using quality 
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indicators45. A quality indicator is “a measurable element of practice performance 
for which there is evidence or consensus that it can be used to assess quality and 
hence changes in the quality of care provided”46. Donabedian distinguished three 
types of quality indicators: structure (type and amount of resources), process 
(activities and tasks) or outcome (effects of healthcare)47. 
Quality indicators 
The structure and process quality indicators proposed by Donabedian can be used 
to identify potential areas for improvement regarding the organisation of care. 
Figure 3: Implementation of Change Model (Grol et al., 2005)
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If a quality indicator is used for such a purpose, they are called ‘internal quality 
indicators’. Quality indicators designed to improve the organisation of care cannot 
be used for external purposes, as this will make them unfit for their task48,49. 
Berwick et al. summarised this as “measuring for improvement is not measuring 
for judgement”50. Engels et al.51, for example, applied a set of quality indicators to 
assess the organisation of general practices. One of their quality indicators was 
about the availability of essential medicines in the doctor’s bag. The result of the 
assessment was used to initiate a stepwise improvement plan to improve the 
availability of emergency medicines52. 
In the past few years, several sets of quality indicators for palliative care have 
been developed53-57. The aim of these studies were mainly to improve clinical care 
and not the organisation of care. Pasman et al. developed a set of 142 quality 
indicators, but this set did not focus on the organisation of care, was often 
restricted to a specific setting like the intensive care unit, was not developed 
within an international context and was not widely implemented53.
In the EU funded ‘Europall’ project (2007-2010), Woitha et al. developed an 
international set of quality indicators for the organisation of proactive palliative 
care55,56. However, Woitha et al. focused on palliative care in general, and did not 
consider specific patient groups such as those with dementia55,56. 
Including palliative care for dementia might stimulate the development of 
collaborative care in these two clinical domains. Knowledge, experience and best 
practices from both domains can then be shared in order to improve both.
Implementing change
Evidence based interventions do not implement themselves, even if new 
knowledge has been made ready for use by the development of quality indicators. 
This is particularly the case in the complex organisation of palliative care. However, 
it is still unclear which implementation strategies are effective to change the 
organisation of palliative care58. Subsequently, it is also unclear which factors 
influence these strategies. This hampers the actual translation of clinical evidence 
into daily clinical practice. This is especially true for the different countries in 
Europe, where differences in the national healthcare system can prevent transfer 
of successful strategies from one service to another and from one country to 
another. However, as the European population is ageing1,2, there is much to 
gain. Palliative care has evolved from care for patients with incurable cancer, to 
care for patients with all kind of life-limiting chronic diseases. But irrespective of 
the disease, patients in need of palliative care have a lot in common. They have 
changing (and often increasing) needs for treatment and support, have multiple 
(and comparable) problems and symptoms4,18, receive care from a variety of 
professionals33, and often move between services. However, disease features, 
trajectories over time and dying scenarios differ due to the characteristics of the 
underlying disease2. To further improve palliative care, it is therefore inevitable to 
increase the transition of evidence based and best practices beyond the borders 
16
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of one medical specialty. For that reason, it is important to develop a tool that can 
be used by all healthcare professionals across all levels of care to assess whether 
their service meets a basic quality level of palliative care and that can identify 
potential areas for improvement. 
Objective of this thesis
Starting from Grol’s Implementation of Change Model44, we aim to assess whether 
the first steps of the model are applicable for the organisation of palliative 
care. Thereby, we aim to add knowledge about the implementation of quality 
improvement initiatives specifically for the field of palliative care. Secondly, we 
aim to improve the identification of persons with dementia that are in need of 
palliative care.
The objective of the present thesis therefore is to develop a generic set of quality 
indicators that 1) make it feasible to assess the organisation of palliative cancer 
and dementia care; 2) can be implemented in daily practice; and 3) can initiate 
quality improvements for the organisation of palliative cancer and dementia care. 
And secondly, to improve the identification of persons with dementia that are 
in need of palliative care. Consequently, the following research questions were 
formulated:
1. Which quality indicators are useful to assess the organisation of palliative 
cancer and dementia care in different settings and countries?
2. What are the most optimal strategies to implement evidence-based and 
best practices regarding the organisation of palliative care into daily clinical 
practice?
3. What are barriers and facilitators regarding strategies aiming to improve the 
organisation of palliative care as perceived by professionals in five European 
countries?
4. When do professionals working in long-term care facilities consider a person 
with dementia in need of palliative care?
Outline of this thesis
Chapter 2 provides an overview of the entire IMPACT project. Chapter 3 describes 
the results of a modified RAND Delphi-procedure used to compose a set of quality 
indicators specifically for the organisation of palliative care. Chapter 4 describes 
an integrative review of strategies aimed to improve the organisation of palliative 
care. Chapter 5 describes the results of a qualitative study to explore barriers and 
facilitators perceived by professionals when implementing strategies to improve 
the organisation of palliative care of services in five European countries. Chapter 
6 describes the results of a qualitative study in which an international group of 
experts considered the most optimal strategies to implement evidence-based 
medicine into daily clinical practice. Chapter 7 describes the results of a qualitative 
study to explore the opinions of professionals working in long-term care facilities 
when they considered a person with dementia in need of palliative care. Finally, 
17
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chapter 8 summarises and discusses the main findings of this thesis, considers 
its strengths and limitations, as well as the implications of the findings for the 
organisation of palliative care in Europe.
18
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Abstract
Background: There is a wide gap between knowledge about palliative care and 
its application in everyday clinical practice, affecting many patients in our ageing 
population. However, changing healthcare practice is a complex and challenging 
process. Therefore the EU funded IMPACT (IMplementation of quality indicators in 
PAlliative Care sTudy) project aims to develop optimal implementation strategies 
to improve the organisation of palliative care for people with cancer or with 
dementia in Europe.
Methods and design: The organisation of palliative care in Europe will be mapped 
to develop and prepare strategies to improve it, and an overview of barriers and 
incentives regarding successful organisational changes in palliative care will be 
undertaken. A pre-test with a set of quality indicators (QIs), developed within 
the project, will be used to identify aspects of the organisation of palliative 
care requiring change in hospitals, nursing homes, hospices and primary care in 
five European countries. Based on the results of the pre-test, each setting will 
be invited to prioritise and improve aspects of their organisation that appeared 
weak. The improvement objective they choose will be tailored to national and 
setting-specific barriers. Finally, a post-test with the same QIs will determine 
the effectiveness of the strategies used. An extensive process analysis will be 
conducted throughout the entire study. 
Discussion: It is expected that the IMPACT project will provide professionals and 
policy makers useful tools to facilitate effective implementation of high quality 
palliative cancer and dementia care in different settings in Europe.
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Background
Continuous development of health services is required to maintain the highest 
quality of care1. However, ‘gaps’ exist between readily available evidence of best 
practice and its use in everyday care. This is particularly the case for palliative 
care, which aims to “improve the quality of life of patients and families who 
face life-threatening illness, by providing pain and symptom relief, spiritual and 
psychosocial support from diagnosis to the end of life and bereavement”2.
Ageing of the population and higher survival rates of people with life-threatening 
diseases result in a larger number of patients with multiple and complex health-
threatening problems3,4. Within the next decade, for example, the incidence and 
prevalence of cancer will increase by about 20%; the prevalence of dementia will 
double before 20505-7. To prevent problems and to provide adequate symptom 
relief, it is necessary to identify and assess symptoms as early as possible in 
order to initiate and develop a pro-active palliative care plan. To optimally 
promote the quality of life of a person affected with a complex, incurable and life-
threatening health problem the care pathway should address physical, emotional, 
psychosocial and spiritual aspects of the patient’s health, as stated in the World 
Health Organisations (WHO) definition of palliative care8. 
 
Although the organisation of palliative care has been described9-11, knowledge 
about how best to improve it has hardly been studied12. Quality indicators (QIs) can 
be used to assess where care can be improved. QIs are evidence-based, explicitly 
defined and measurable items that evaluate and describe the structure, processes 
and outcomes of healthcare, and that can indicate either potential problems in 
or achievement of good quality care13. They can be used to assess and feed back 
to professionals their actual performance compared to benchmarks, as a starting 
point for quality improvement14. QIs have been used effectively to assess and 
improve hospital care15, primary care16, and dementia care17. Several international 
studies have also developed QIs to improve the structures and process needed 
for the delivery of good quality palliative care18-20. However, these large sets, with 
QIs ranging between 56 to 142, are more a tool for research than actually useful 
in daily practice. These indicator sets have, therefore, not yet been widely applied 
in everyday clinical practice. This study proposes to implement QIs and strategies 
into daily practice to improve the organisation of palliative care in Europe. Unlike 
other studies21, this study will not only focuss at the organisation of palliative care 
for patients with cancer, but also at the organisation of palliative care for patients 
with dementia.  
 
Methods and design
Objective
The  IMPACT project (IMplementation of quality indicators in PAlliative Care sTudy) 
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aims to develop optimal strategies to improve the organisation of palliative cancer 
and dementia care in Europe  with the use of QIs. This study will be conducted in 
five European countries (England, Germany, Italy, Norway, and the Netherlands) 
and is supported by researchers in another five European countries and Australia.
Time frame
This study runs from 2011 to 2015. At the time of publication, the project is in its 
third year: the mapping exercise has finished and a set of QIs has been developed. 
These QIs are currently being tested in the pilot study.
Study design
The stepwise implementation model of this study is built on the framework for the 
development and evaluation of complex interventions to improve health of the 
UK Medical Research Council (MRC)14,22. The main tasks in this study correspond 
with the developmental steps of the MRC framework in that theoretical and 
modelling activities will be undertaken before the intervention study will be 
designed and implemented. Table 1 provides a detailed overview of the tasks that 
will be conducted in the IMPACT project. 
Theory and modelling 
Semi-structured interviews with professional healthcare providers and policy 
makers will be used to map the different palliative care models in Europe. This 
mapping exercise will facilitate the development of QIs and strategies to improve 
the organisation of palliative care. QIs will be selected from existing sets. Only 
QIs that are related to the organisation of palliative cancer care or palliative 
dementia care (e.g. process and structure QIs) will enter a modified RAND Delphi-
procedure23. A purposefully selected panel of about 40 international experts will 
participate in the modified RAND Delphi-procedure. These panellists have to 
be either an expert in palliative care, cancer care, or dementia care, and have 
knowledge about QIs. Panellists will be asked to rate each individual QI on a 
9-point Likert scale for clarity and usefulness  in two written rounds and one 
consensus round. QIs with a median rating on the usefulness scale of 7, 8 or 9 
without disagreement will be considered face valid. This Delphi exercise will result 
in one set of QIs that is applicable for the organisation of both palliative cancer 
and dementia care and can be used in different types of settings. This final set will 
be structured according to the recommendations for the organisation of palliative 
care of the Council of Europe24.
Strategies to improve the organisation of palliative care will be identified with the 
use of an integrative review, in order to allow the inclusion of both empirical and 
theoretical literature on implementation strategies25. Subsequently, interviews 
and focus group interviews with healthcare professionals will be used to adjust 
the strategies in response to national and setting-specific barriers and facilitators, 
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in order to develop a toolkit of country and setting-specific strategies to improve 
the organisation of palliative care.
Pilot
Setting and participants
Palliative care is provided by a range of professionals in different settings: including, 
but not limited to specialised palliative care teams in hospitals, palliative home 
care provided by the general practitioner and community nurses, palliative care 
wards/teams in nursing homes, and hospice care11,26. The IMPACT project aims 
to incorporate all of these services. Therefore, QIs and improvement strategies 
will be implemented in four types of settings (hospitals, nursing homes, hospices 
and primary care). In each country, a minimum of two services per setting will 
participate in order to compare the usefulness of QIs in palliative cancer and 
palliative dementia care services. 
The multidisciplinarity of the research team will help recruitment of the study 
settings. The team includes experts of the pan-European research group on 
detection and timely INTERvention in DEMentia (Interdem) and the European 
Association for Palliative Care (EAPC), all of whom are stakeholders in their 
country in palliative cancer and/or dementia care. The research team will be 
invited to use their networks to purposefully select settings to take part in the 
intervention. Services will be excluded from participation in the study if they 
Table 1: Tasks of the IMPACT project
Year 1 Theory
Mapping the organisation of palliative care in Europe
Year 2 Modelling
Identifying barriers and facilitators to successful interventions in focus groups and 
individual interviews
Identifying quality improvement strategies to improve the organisation of 
palliative care
Development of QIs to assess the organisation of palliative care
Year 3 Pilot
Pre-test: assessment of the organisation of palliative care, using QIs
Implementation of strategies to improve the organisation of palliative care, 
tailored to national and setting-specific barriers and facilitators
Post-test: assessment of the organisation of palliative care, using QIs
Year 4 Evaluation and dissemination
Process evaluation of the pilot
Development of toolkit and manual about how to implement changes in the 
organisation of palliative care
Other scientific output (papers, presentations, etc.)
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do not treat palliative patients aged 18 years or above, or when they have not 
provided palliative care for the last three years. Within these services, healthcare 
professionals will be selected to participate in the pre-test – intervention - post-
test study.
Implementation
Professionals from the participating settings will be asked to answer qualitative 
and quantitative questions derived from the QIs, to identify aspects in the 
organisation that require change (pre-test). An online survey will facilitate easy 
use of the QIs, allow early comparison of data between settings and/or countries 
and provide rapid feedback to participants. Following the feedback, professionals 
will be stimulated to use the stepwise implementation model to set improvement 
objectives formulated in a SMART way (Specific, Measurable, Acceptable, Realistic 
and Timely)14. These improvement objectives will help professionals to choose 
specific strategies, adjusted to their situation, to improve the organisation of 
palliative cancer and dementia care (intervention). During the entire intervention, 
each service will be regularly visited by a trained consultant to guide them 
through the stepwise implementation model. After the intervention period, the 
organisation of palliative care will again be assessed (post-test) with the use of the 
same QIs as used in the pre-test. 
Evaluation and dissemination
During the intervention period, a process evaluation will be performed to study 
actual barriers and facilitators of the implementation process27. Therefore, the 
implementation process will be monitored by using an activity report (including 
but not limited to questions related to the progress, barriers and facilitators, and 
personal experiences of the improvement strategies). Each time the consultant 
visits a service, they will fill in an activity report. To get a better understanding of 
the aspects mentioned in the activity reports, semi-structured individual and focus 
group interviews will be conducted with professionals from each participating 
service. Professionals will be purposefully selected based on their participation in 
and knowledge of the conducted improvement strategies. These interviews will 
be continued until data saturation is reached. Results of the evaluation will be 
used to guide professionals introducing changes to improve their daily practice.
Data analysis
Quantitative data of the pre- and post-test will be transferred from the web-based 
data system into a computer program for statistical analysis (SPSS) for descriptive 
analysis. The degree to which professionals are intending to act according to 
the recommendations expressed in the QIs will be compared between pre- and 
post-test. Comparing the results within and between countries and settings will 
also allow the identification of optimal strategies to improve the organisation of 
palliative care.
Qualitative data, resulting from the individual and focus group interviews, will 
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be analysed28 using computer software such as Atlas.ti for content analysis29, and 
(if applicable) grounded theory development30. QIs with low adherence will be 
omitted from the study, unless individual and focus group interviews identified 
strong reasons to keep the QI. 
Discussion
The aim of the IMPACT project is to assess and improve the organisation of 
palliative cancer and dementia care in Europe. With the use of quality indicators, 
the current organisation of palliative care will be assessed in order to identify 
aspects of the organisation that require change. Results from this assessment will 
be fed back to professionals working in the settings. Next, a consultant will help 
each setting to start and finish structured improvement projects31.
We know that using feedback alone results in small to moderate effects on service 
performance32. In addition to the feedback, this study will also use other strategies 
tailored to national and setting-specific barriers and facilitators, to improve the 
implementation of change. Many of these strategies have been tested before1,33, 
but not yet in the complex multidimensional field of palliative care. In conjunction 
with the WHO definition on palliative care2, this study will not only focus on 
palliative care for patients with cancer but will compare the organisation of 
palliative cancer care and palliative dementia care. This comparison allows for the 
identification of common strategies (and their barriers) that are suited to improve 
the organisation of palliative care as well as identify those that are disease specific. 
These results can be used as a template for further research in other healthcare 
settings that provide care for chronically ill patients. 
Results from the IMPACT project will be provided to stakeholders and decision 
makers in order to facilitate effective implementation of high quality palliative 
cancer and dementia care in a variety of settings in Europe.  
Strengths and Limitations
First, the IMPACT consortium consists of a multidisciplinary research team, 
including researchers experienced in quantitative and qualitative research and 
well-known experts in the field of palliative and dementia care. In each country, 
the research team consists of at least a PhD student for the day-to-day work and 
one or more senior researchers responsible for the scientific output. Regular face-
to-face meetings (at least twice a year with the research team and once a year 
with the entire consortium) and telephone conferences (at least every two months 
with the research team) will ensure that the project is conducted simultaneously 
in the five countries.
Second, a financial incentive will be rewarded for participating services upon 
meeting specific milestones (e.g. completion of the pre-test), stimulating their 
motivation to implement strategies to improve their organisation of palliative 
care. 
Third, the stepwise implementation model that will be used in this study allows us 
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to tailor the intervention at a setting and country level, in other words to translate 
the intervention to everyday clinical practice14. This will require the use of 
research methods that are able to cope with the factors that shape palliative care 
in general and its organisational processes in particular. Controlling these aspects 
in an international study with strict deadlines would have made a randomised 
controlled trial impractical34-36. Thereby, randomised controlled trials are usually 
focused on one setting and often in one country, while this study explores and 
initiates quality improvements in several settings in different European countries. 
Before the start of the project, two potential limitations have been identified. 
First, time management is a major risk throughout the course of the project. All 
of the phases of the project depend on each other. Failure in one phase will result 
in problems in the next. In conjunction with the European Union’s 7th Framework 
Programme, deliverables (table 2) have been formulated. Each of the work 
package leaders involved in the IMPACT consortium has to produce deliverables, 
stimulating them to deliver their results on time. In consequence, strict time 
management is required by the project coordinator who will actively monitor and 
stimulate all the researchers involved.
Second, IMPACT is a European project conducted in five different countries, with 
different cultures, languages, healthcare systems and organisation of palliative 
care, making it difficult to compare services between countries. These differences 
have to be taken into account during the entire project. The IMPACT project 
explicitly tries to overcome this challenge by providing detailed information of 
each participating service (e.g. number of staff, level of trained staff, etc.). This 
critical reflection of the differences in service delivery in each country will help to 
compare the results of the project on an international level.
Table 2: Scientific deliverables
Deliverable name Month
Analytic framework to characterise palliative care across Europe 12
Model of the organisation of palliative care related to the national context 
(macro-level), the available workforce (meso-level) and the settings and 
professionals level (micro-level)
14
Concept set of implementation strategies 24
Table of strategies used in five countries 36
Description of factors influencing implementation 36
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Abstract 
Background: Large numbers of vulnerable patients are in need of palliative cancer 
and dementia care. However, a wide gap exists between the knowledge of best 
practices in palliative care and their use in everyday clinical practice. As part 
of a European policy improvement program, quality indicators (QIs) have been 
developed to monitor and improve the organisation of palliative care for patients 
with cancer and those with dementia in various settings in different European 
countries.
Method: A multidisciplinary, international panel of professionals participated in a 
modified RAND Delphi-procedure to compose a set of palliative care QIs based on 
existing sets of QIs on the organisation of palliative care. Panellists participated in 
three written rounds, one feedback round and one meeting. The panel’s median 
votes were used to identify the final set of QIs.
Results: The Delphi-procedure resulted in 23 useful QIs. These QIs represent key 
elements of the organisation of good clinical practice, such as the availability of 
palliative care teams, the availability of special facilities to provide palliative care 
for patients and their relatives, and the presence of educational interventions 
for professionals. The final set also includes QIs that are related to the process 
of palliative care, such as documentation of pain and other symptoms, 
communication with patients in need of palliative care and their relatives, and 
end-of-life decisions.
Conclusion: International experts selected a set of 23 QIs for the organisation of 
palliative care. Although we particularly focused on the organisation of cancer and 
dementia palliative care, most QIs are generic and are applicable for other types 
of diseases as well. 
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Background
Europe faces a huge challenge with a population that is rapidly aging in the 
coming decades. It is estimated that the incidence and prevalence of cancer will 
increase by about 20% and the prevalence of dementia will double before 20501-4. 
Although it concerns two totally different diseases with different care needs and 
disease trajectories, they do have a lot in common: they are often unnecessarily 
hospitalised5, have a high need for a multidisciplinary approach6 and many suffer 
from symptoms which are partly the same, like pain7,8. Higher survival rates of 
people with life-threatening and progressive chronic diseases will result in a larger 
number of patients that have multiple and complex health-threatening problems. 
Therefore, a growing number of patients will be in need of palliative care. However, 
a wide gap exists between the knowledge of best practice in palliative cancer and 
dementia care and its application in every day clinical practice9. 
As a first step in bridging this gap, it is important to assess current performance 
of palliative care in relation to its desired performance. Such an assessment of 
healthcare can be achieved by using quality indicators (QIs). QIs are evidence based, 
explicitly defined and measurable items that evaluate and describe structures, 
processes and outcomes of healthcare10. As such, they reflect the core elements 
of good clinical care. In day-to-day terms QIs can, for example, show whether 
pain is regularly being assessed using a validated tool; or whether a general 
practitioner is timely informed about a patient’s situation before or directly after 
discharge from hospital11,12. QIs can help trace potential problems or confirm good 
quality of care and can be used to guide quality improvement processes10. They 
have been used effectively to assess and improve hospital care13, primary care14, 
and dementia care15,16. Several studies have also developed QIs to improve the 
structures and process needed for the delivery of good quality palliative cancer or 
dementia care11,12,17,18. However, these studies were performed five or more years 
ago, developed large sets of QIs, ranging from 56 to 142 QIs. Furthermore, none 
of these sets were widely implemented in everyday clinical practice. 
The objective of this study was to integrate existing sets of QIs into one generic 
set that can be used to assess and improve the organisation of palliative care in 
different services and countries. The study was conducted within the framework of 
the European IMPACT project (IMplementation of quality indicators for PAlliative 
Care sTudy)19.
Methods
A modified RAND Delphi-procedure was used to develop a set of QIs20, which is 
considered an accepted methodology to develop QIs10. Typically, a RAND Delphi-
procedure consists of a written and a face-to-face round20. In this study, four 
written rounds and one face-to-face round were performed to reach consensus 
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about the essential aspects regarding the organisation of palliative care.
Panellists
The IMPACT consortium consists of experts of the pan-European research group 
on detection and timely INTERvention in DEMentia (Interdem) and the European 
Association for Palliative Care (EAPC), all of whom are stakeholders in their country 
in palliative cancer and/or dementia care. The research team was invited to use 
their networks to purposefully select panellists for the modified RAND Delphi-
procedure. A key selection criteria was that the expert had to have extensive 
knowledge about palliative care, cancer care or dementia care. Additionally, 
experts had to be able to communicate in English (both verbally and non-verbally) 
and were planning to attend the 2012 Congress of the European Association of 
Palliative Care (EAPC) in Trondheim, Norway. Project partners nominated national 
and international experts in palliative cancer and dementia care. All nominated 
experts were approached via email (n=50), forty experts from twelve countries 
agreed to participate in the modified RAND Delphi-procedure (table 1). All 
participants provided written informed consent. About half of them were experts 
in palliative cancer care and the other half in dementia care. Twenty-two panellists 
were active clinicians in this field (e.g. physician, nurse, psychologist, etc. currently 
involved in direct-patient care), the others were researchers. 
Selecting a preliminary set of QIs
A search for existing sets of QIs was conducted in PubMed. The search strategy was 
limited to English literature and consisted of various search terms that referred to 
subject-specific keywords describing palliative care (combined using “or”), as well 
as (“and”) the assessment of care using QIs (combined using “or”). Synonyms and 
medical subheading terms were used to fully include relevant literature (see table 
2). 
Table 1: Panellists per country
Country Researcher Clinician
Australia 1
Belgium 1 2
Canada 1
Germany 2 3
Italy 1
Netherlands 8 3
Norway 3
Poland 1
Switzerland 2
Spain 1 1
United Kingdom 2 7
United States 1
Total 18 22
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Subsequently, references of key papers describing sets of QIs were hand searched. 
Additionally, consortium members of the IMPACT project were asked to nominate 
national and international sets of QIs on palliative cancer and dementia care they 
considered important. Two researchers (YE & JvRP) subsequently reviewed all of 
the identified QIs independently to determine if the QIs assessed the structure 
and process of palliative care and to structure them according to the domains of 
the recommended framework for the organisation of palliative care of the Council 
of Europe21. 
First written Delphi-round
For the first written Delphi-round (April 2012), panellists received a personal 
invitation for an online questionnaire. To reduce the large number of identified 
QIs, panellists were asked to nominate one QI per domain of palliative care22. 
Those QIs that were nominated by the panellists were included in the second 
round of the modified RAND Delphi-procedure.
Second written Delphi-round
In the second round (May 2012), also via an online questionnaire, panellists were 
asked to rate QIs on a 9-point Likert scale for clarity (1= not clear at all; 9 =very 
clear), usefulness (1= not useful at all; 9= very useful), to rephrase unclear and 
to add missing QIs. They were instructed to rate a QI high on usefulness if it: 1) 
corresponded with a basic quality level; 2) referred to a higher quality level that 
would be met only in very good practices; or 3) was associated with an innovative 
quality level which is exceptional at the moment, but could become the optimal 
quality level in the near future23. They were asked to give a low rating on usefulness 
if a proposed QI: 1) was too ambiguous or represented an unrealistically high 
quality level; 2) did not correspond with the material, social or cultural conditions 
of the situation in their country; or 3) was not in accordance with the regulations 
of palliative cancer and dementia care in their country23. 
Third interactive Delphi-round 
A consensus meeting was organised during the EAPC Congress June 7, 2012 in 
Trondheim, Norway. The meeting was chaired by an independent researcher with 
the aim to reach consensus on the QIs on which there was disagreement or where 
Table 2: Overview of search terms
Search term
Palliative care Quality indicators
Terminal care Quality assurance
Hospice care Quality measurement
Cancer care Quality assessment
Dementia care
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the median score was between 4 and 6 in the second Delphi round. Participants 
received a rating sheet on which the median ratings of the second Delphi-round 
of all experts were visible. Participants were given 30 minutes to rate the adapted 
QIs for usefulness. Next, per QI, participants were asked to raise their hand if 
they had rated usefulness 6 or less. If at least nine (30%) participants raised their 
hand20, the QI was discussed until consensus was reached.
Fourth written Delphi-round
After the consensus-round, the remaining indicators were fed back to the panellist 
with the purpose to validate the changes that were made (September 2012).
Fifth written Delphi-round
In the final step of the QI development process, QIs were operationalised by the 
research team into questions that could be used by healthcare professionals to 
assess their organisation of palliative care and identify areas for improvement. 
During this process, it appeared that some QIs were inappropriate or not 
measurable (e.g. too time consuming to answer them appropriately). All QIs 
were therefore rated for necessity by the IMPACT research team (October 2012), 
representing both clinicians and researchers that also took part in the modified 
RAND Delphi-procedure. QIs that were considered not necessary after this round, 
were omitted from the list.
Analysis
QIs with a median rating on the usefulness scale of 7, 8 or 9 without disagreement 
were considered to have face validity. Disagreement was defined as: 30% or more 
of the panellists  rated  a single QI in the 1-3 tertile and more than 30% in the 7-9 
tertile. QIs scored with a median of 1-3 without disagreement were not considered 
to have face validity. Because panellists had rated QIs high on usefulness, only QIs 
with median ratings of 8 or 9 were considered face valid for the second Delphi-
round. Only QIs that were rated valid by all panellists were included in the final 
set20.
Ethical considerations
The Medical Ethics Committee of the district Arnhem-Nijmegen has declared that 
this study doesn’t fall within the remit of the Medical Research Involving Human 
Subjects Act (WMO) (registration number 2012/075). This means that this study 
can be carried out without an approval by an accredited medical ethics committee.
Results
650 QIs were selected from literature11,16,18,22,24-54. After having assessed these QIs, 
554 were excluded because they were not about the organisation of palliative 
care or because of overlap; the remaining 96 QIs were included in a preliminary 
set of QIs (figure 1). Of the 40 experts invited as panellists, 25 (63%) participated. 
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In the first Delphi round, 65 of the 96 QIs were selected and 13 missing QIs were 
suggested in an open question in which panellists were asked if they missed any 
relevant QI. This resulted in an adapted list of 78 QIs, which were included in the 
second Delphi round.
In the second Delphi-round, 27 (67,5%) of the 40 invited panellists participated. 
Sixteen QIs were considered to have face validity, 28 were invalid, and six QIs were 
added to the list based on suggestions made by the panellists. The 40 QIs on which 
there was no agreement on, were included into the third Delphi round.
In the third Delphi-round, a consensus meeting, 29 (72,5%) of the 40 panellists 
participated. After having rated 40 QIs, one was excluded and 10 were discussed. Of 
the QIs that were discussed, six were accepted and four were excluded. Panellists 
also agreed to merge 11 QIs. Round three therefore resulted in 24 accepted QIs. 
The total list of QIs (QIs considered to have face validity in round two and three) 
comprised 40 QIs. 
In the fourth Delphi-round, panellist provided feedback to the remaining set of QIs. 
This resulted in minor linguistic changes and the exclusion of three QIs because 
they were considered inappropriate by the majority of panellists. The resulting set 
of QIs, therefore, consisted of 37 QIs. This list was critically assessed by members 
of the IMPACT consortium for their necessity (round five). Fourteen QIs were 
considered to be overlapping, inappropriate, or not measurable in palliative care. 
The final list of QIs, therefore, consisted of 23 QIs, covering seven domains (table 
3). Key findings can be summarised as follows:
Access to palliative care
The availability of a dedicated palliative care team was considered important by 
almost all panellists in the Delphi-procedure. They explicitly stated that palliative 
care services should not only be available during office hours, but at all times (day, 
evening, night and weekend). Furthermore, specific elements of palliative care 
were considered important, such as the availability of opioids and anticipatory 
medications for symptom control, as well as the availability of bereavement 
support.
Almost all panellists also rated important the accessibility of the medical record 
to healthcare professionals, timely transfer of information between settings 
(including when transferring or discharging patients). Panellists also considered 
an assigned contact person, who maintains regular contact with patients and their 
families, useful.
Infrastructure
The infrastructure of the place where palliative care is provided, such as a single 
bed hospital room, was rated important. Access to equipment (such as anti-
decubitus mattresses, suction equipment, etc.), required to provide palliative 
care, was considered important. Panellists also rated high consensus for facilities 
for relatives to visit, stay overnight, and a private area for saying goodbye to the 
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Round 1
Nomination 
of best QIs
Round 2
Rating of 
QIs
Round 3
Consensus
meeting
Round 4
Feedback
round
Round 5
Rating for
necessity
Literature study: 96
Nominated: 65
New: 13
Face-valid: 16 Equivocal
1: 34
New: 6
Invalid: 36
Invalid: 28
Merged2: 11
Invalid: 5
Face-valid: 24
Face-valid: 37 Invalid: 3
Face-valid: 23 Invalid: 14
Final set: 23
Figure 1: Modified RAND Delphi-procedure
QI: Quality indicator
1 Equivocal is defined as all QIs on which there was no agreement:  e.g. QIs with 30% or 
more of ratings in both the 1-3 tertile and the 7-9 tertile and all indicators with a median 
rating in the 4-6 tertile.
2 At the end of round three, panelists agreed that 11 QIs could be merged.
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deceased. There was no agreement on QIs that aimed to control waiting time or 
waiting list, i.e. these aspects were not considered to be unique for palliative care 
and therefore not important.
Assessment tools
Regular assessment of pain and other symptoms was rated as a valid quality 
criterion, though it was commented that a validated instrument might not always 
be available, particularly for specific patient groups (e.g. for persons with advanced 
dementia). 
Personnel
There was agreement on the need for a multidisciplinary team, which should 
consist of at least a physician and nurse, and have access to a range of supporting 
disciplines, such as: physiotherapist, psychologist, occupational therapist, social 
worker, dietician, and chaplain. Panellists also rated a regular multidisciplinary 
team meeting important.
Documentation of clinical data
Panellists recognised the importance of having a well-structured medical record. 
However, a QI about the structure of the medical record was not considered 
important by the panellists. Panellists only considered the inclusion of a medication 
regimen in the medical record important. They also considered a timely assessment 
(within 48 hours) of pain and other symptoms, psychosocial and spiritual needs, 
patient preferences, wishes and needs, and the patient’s capacity to be involved 
in the decision making process as important. 
Furthermore, almost all panellists rated the documentation of communication 
on the medical condition, goals of treatment, physical, psychosocial, and spiritual 
needs of the patient and their relatives, intention to return home, advanced 
directive, and end-of-life decisions as important.
Quality and safety
Panellists rated the QI about assessing the experiences of care givers with the 
palliative care service important. Secondly, a QI about the quality of care, assessing 
the use of an end-of-life care pathway within the last three days of life, was also 
considered useful.
Education
QIs about the staff’s learning objectives and a program for specialised and/
or continuing medical education about the physical, psychosocial, and spiritual 
needs of a patient in need for palliative care were not rated important. There was 
also no agreement on disease-specific education for staff members, but panellists 
considered palliative care training specified to the professional’s background 
important. 
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Table 3: Overview of quality indicators
1. Access to palliative care
1a. Access and availability
1. A specialist palliative care team* is available 24/7.
2. Specialist palliative care* advice is available 24/7 to professionals delivering palliative 
care.
3. Bereaved relatives and/or professionals involved in care of a person in need of 
palliative care are offered support during the bereavement process if they need or 
wish to have support.
1b. Out of hours care
4. Opioids are accessible and available for persons in need of palliative care 24/7.
5. Co-analgesics* for symptom control are available to treat persons in need of pallia-
tive care 24/7.
1c. Continuity of care
6. An (electronic) file of a person in need of palliative care is accessible to professionals 
in charge of the person 24/7.
7. At each transition between care settings, comprehensive information (including care 
goals and care plan) of a person in need of palliative care is transferred to the profes-
sional(s) in charge in the next setting.
8. The professional in charge of the person is informed before a person in need of 
palliative care is discharged home or sent to the next setting.
9. Persons in need of palliative care have an assigned contact person who maintains 
regular contact with the person and their families, and ensures coordinated delivery 
of health and social care.
2. Infrastructure
10. Specialised equipment (e.g. anti decubitus mattresses, suction equipment, stoma 
care, oxygen delivery, drug administration pumps, hospital beds, etc.) is available to 
persons in need of palliative care.
11. Single bedrooms are available for persons who are dying and who wish to have one.
12. Family members and friends are able to visit the dying person without restrictions of 
visiting hours.
13. There are facilities for relatives to stay overnight with their dying relative.
14. There is a private area for saying goodbye to the deceased, nearby or on the ward/
unit where the person died.
3. Assessment tools
15. There is a regular assessment of pain and other symptoms using a validated 
instrument*.
4. Personnel
4a. Team
16. The multidisciplinary team* that delivers palliative care services consists of at least: 
a physician and nurse; and has access to one or more of the following profession-
als: physiotherapist, psychologist, occupational therapist, social worker, chaplain, 
dietician.
17. There is a weekly multidisciplinary meeting with at least the physician and nurse in 
charge of the person in need of palliative care to review treatment and care plans.
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4b. Sharing information
18. The file of the person in need of palliative care contains documentation of a 
discussion with the person or representative (if the person lacks capacity e.g. is 
unable to communicate) about:
• medical condition;
• goals for treatment;
• the physical*, psychosocial and spiritual needs of the person and family caregiver;
• an advance directive or advance care plan;
• end-of-life decisions*;
• the intention to return home or to another facility from the place where the 
person is currently staying.
5. Documentation of clinical data
5a. Clinical records
19. The file of the person in need of palliative care contains a medication list that is 
accessible to the professionals caring for the person.
5b. Timely documentation
20. Within 48 hours of admission to the service, the file of the person in need of 
palliative care contains documentation of the initial assessment of:
• pain and other symptoms, using a validated instrument*;
• psychosocial and spiritual needs;
• persons preferences, wishes and needs;
• capacity to be involved in the decision making process.
6. Quality
21. Family and caregiver experiences of the palliative care service are assessed / 
evaluated / recorded.
22. An end-of-life care pathway (such as the Liverpool Care Pathway) was used for the 
last 3 days of life of a person in need of palliative care.
7. Education
23. All professionals that deliver palliative care services receive accredited training in 
palliative care, appropriate to their discipline.
NB Where person is stated, one can also read patient.
*Glossary
Palliative care team
A home palliative care team provides specialised palliative care to patients who need it at 
home (or home replacing institute) and support to their families and carers at the patient’s 
home. They also provide specialist advice to general practitioners, family doctors and nurs-
es caring for the patient at home. The core team of a home palliative care team consists 
of four to five full-time professionals and comprises physicians and nurses with specialist 
training, a social worker and administrative staff. The home palliative care team works in 
close collaboration with other professionals so that the full range of multi-professional 
team work can be realised in the home-care setting. (Source: Radbruch L, Payne S: White 
paper on standards and norms for hospice and palliative care in Europe: part 2. European 
Journal for Palliative Care 2010, 17:22-33)
Table 3: Continued
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A hospital palliative care support team provide specialist palliative care* advice and 
support to other clinical staff, patients and their families and carers in the hospital environ-
ment. They offer formal and informal education, and liaise with other services in and out 
of the hospital. A hospital palliative care support team is composed of a multiprofessional 
team with at least one physician and one nurse with specialist palliative care training. The 
team should have ready access to other professionals working in liaison with it, including 
bereavement specialists, chaplains, dietitians, therapists, oncologists, pharmacists, physio-
therapists, psychiatrists, psychologists, social workers and speech and language therapists. 
(Source: Radbruch L, Payne S: White paper on standards and norms for hospice and pallia-
tive care in Europe: part 2. European Journal for Palliative Care 2010, 17:22-33).
Team
A team is hereby defined as a group of people organised to work together, which consists 
of at least a nurse and a physician.
Specialist palliative care
Specialist palliative care is provided by specialised services for patients with complex 
problems not adequately covered by other treatment options. Specialist palliative services 
require a team approach, combining a multiprofessional team with an interdisciplinary 
mode of work. Team members must be highly qualified and should have their main focus 
of work in palliative care. (Source: Radbruch L, Payne S: White paper on standards and 
norms for hospice and palliative care in Europe: part 2. European Journal for Palliative 
Care 2010, 17:22-33).
Co-analgesics
An adjuvant (or co-analgesic) is a drug that in its pharmacological characteristic is not 
necessarily primarily identified as an analgesic in nature, but that has been found in 
clinical practice to have either an independent analgesic effect or the additive analgesic 
properties when used with opioids. (Source: Khan MIA, Walsh D, Brito-Dellan N. Opioid 
and Adjuvant Analgesics: Compared and Contrasted. Am J Hosp Palliat Care 2011, 28(5) 
378-383)
Validated instrument 
Instruments such as the Visual Analogue Scale (VAS) or the Numeric Rating Scale (NRS) 
that can be used to indicate the severity of the patient’s pain or other symptom. (Source: 
Ahmedzai S, Gómez-Batiste X, Engels Y, Hasselaar J, Jaspers B, Leppert W, Menten J, Mol-
lard JM, Vissers K: Assessing Organisations to Improve Palliative Care in Europe. Nijmegen: 
Vantilt Publishers; 2010).
End-of-life decisions
End-of-life care may be used synonymously with palliative care or hospice care, with end 
of life understood as an extended period of one to two years during which the patient/
family and health professionals become aware of the life-limiting nature of their illness. 
End-of-life care may also be understood more specifically as comprehensive care for dying 
patients in the last few hours or days of life. Either way, the patient preserves his/her 
self-determination regarding the power of decision on place of care, treatment options 
and access to specialist (palliative) care. End-of-life decisions are all the decisions made 
by the patient/family and health professionals regarding this last phase of a patient’s life, 
e.g. decisions that may influence the time of death, either prolonging life (or prolonging 
dying) or shortening life (or let patients die). (Source: Radbruch L, Payne S: White paper on 
standards and norms for hospice and palliative care in Europe: part 1. European Journal 
for Palliative Care 2010, 16(6):278-289).
Physical needs
For example if the patients physical symptoms require certain needs, such as special bed
Table 3: Continued
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Discussion
With the help of a modified five-round RAND Delphi-procedure, we were able to 
develop an internationally validated set of QIs for the organisation of palliative 
care with high face validity as judged by experts in the field of cancer and dementia 
care. The final set provides 23 quality aspects regarding the accessibility of the 
service, its infrastructure, the use of symptom assessment tools, management of 
personnel, documentation of clinical data, quality of care, and education. Of these 
23 QIs, one was identical to the original one (Family members and friends are 
able to visit the dying person without restrictions of visiting hours)12, two were 
new (Family and caregiver experiences of the palliative care service are assessed / 
evaluated / recorded and An end-of-life care pathway (such as the Liverpool Care 
Pathway) was used for the last 3 days of life of a person in need of palliative care) 
and 20 were rephrased QIs. Panellist agreed not to formulate disease-specific QIs 
for the organisation of palliative care, since our set of QIs provide information 
about the organisation of services and not about the care provision itself. This 
might explain why so many QIs were rated face-valid for as well the organisation 
of cancer as dementia palliative care: regarding aspects as access to and 24h 
availability of specialist palliative care or transferring information between 
settings, the specific condition of the patient (advanced cancer, dementia, or even 
COPD or heart failure) is not relevant, making our set of QIs much more broadly 
applicable. Therefore, these QIs are generically applicable and can be used in 
different settings. Thereby, they can also be used for (cross-)national comparisons 
and to identify best practices regarding the organisation of palliative care in other 
services and countries.
In the recent literature several sets of QIs for palliative care have been 
identified11,12,17,38,55. For example, Pastrana et al. used a nominal group technique 
to identify indicators for the assessment and evaluation of palliative care38. 
However, they primarily focused on the German healthcare system, which makes 
this set difficult to apply in an international context38. Pasman et al. conducted 
a literature review, and identified 142 QIs in 16 studies11. However, this set also 
has not been developed within an international context and it does not focus 
on the organisation of palliative care11. An update of this review, published in 
2013, included a further 187 QIs, bringing the total to 326 QIs, with still few QIs 
about the organisation of palliative care55. Around the same time, Woitha et al. 
developed a set of 56 QIs12,17. Woitha et al. conducted two written Delphi rounds, 
leaving little room for discussion, while we conducted a consensus round with 
extensive opportunity to discuss the QIs. Secondly, they included professionals 
from different European countries only, while we also included professionals from 
countries such as Canada, Australia and the USA, making the set of QIs presented 
here globally applicable. Thirdly, they focused on the organisation of palliative 
care in general and did not specifically consider the organisation of palliative care 
for patients with dementia, like was done in the present study. 
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A recently published White paper defining optimal palliative care in older people 
with dementia56, described several recommendations on palliative care treatment 
for persons with dementia. All of their recommendations that can be translated 
to the organisation of care, like the use of assessment tools, multidisciplinary 
meetings, bereavement support and about specialist palliative care teams, are 
represented in our QI set. 
Another quality indicator, suggested by the World Health Organisation as part of 
the framework programme on non-communicable diseases has been the focus 
of attention recently. This QI is being proposed to describe access to palliative 
care by assessing morphine equivalent consumption per death from cancer57,58. 
However, this QI has been criticised as it might have provided flawed information 
due to inaccuracies in the underlying data base and the unavailability of national 
cancer registries59. Instead of assessing palliative care on a global level, we aim to 
assess whether palliative care services meet a basic quality level or higher quality 
level that would be met only in very good practices. Our set of QIs can therefore 
be used as internal QIs by healthcare providers (professionals and managers) to 
monitor and improve their service. They can also be used to describe and rank 
services according to performance, but this should not lead to a quality rating, as 
there may be good reasons for the differences in performance with the QI (e.g. 
different organisational structure). 
Using our QIs as an external quality assessment tool will therefore make them unfit 
for their task60. Berwick et al. summarised this as ‘measuring for improvement 
is not measuring for judgement’61. An ongoing intervention in 40 palliative care 
services in Europe, including hospitals, hospices, nursing homes and primary 
care settings, performed as part of the IMPACT project, in which this set of QIs 
is used as starting point to assess the organisation of palliative care, will evaluate 
the feasibility and discriminatory power of the QIs in relation to improving the 
organisation of palliative care in the participating services.
Strengths and limitations
Strengths of this study were that we used a large international group of panellists 
for our Delphi-procedure, who were actively involved in palliative care (such as 
members of the European Association for Palliative Care). Secondly, by organising 
our consensus meeting during the EAPC Congress in Trondheim, Norway, key 
persons active in this fields of palliative care and dementia care were able to 
contribute extensively to the discussion for the Delphi-procedure. Thirdly, the 
multidisciplinary character of palliative care was represented by the panellists (e.g. 
physicians, nurses, psychologists) involved in the Delphi-procedure. Furthermore, 
half of them were professionals active in dementia care. Fourth, combining QIs 
for the organisation of services that provide care to palliative patients with cancer 
and those that provide such care to patients with dementia is unique. Our QIs can 
therefore be used in different settings. 
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A limitation of this study is that this set of QIs might not be comprehensive. Because 
an international, generic set of QIs was developed, some QIs that were important in 
only one or a few countries were excluded from the list. For that reason, important 
national or setting-specific QIs must be added when the set is used in a specific 
country. Secondly, this set of QIs is only related to the organisation of palliative 
care. Outcome and patient-related outcome measures were not included because 
they address a distinct purpose in measuring quality of palliative care. Thirdly, 
participants of the modified RAND Delphi-procedure were selected because of 
their knowledge about palliative care, cancer care or dementia care. Because 
some experts of two large European networks (EAPC and InterDem) are part of 
the IMPACT consortium, they were also selected as participant for the modified 
RAND Delphi-procedure (n=18). Although not all countries were represented 
(like France) and others were overrepresented (like the Netherlands), the experts 
covered 12 countries from three continents, covering different healthcare systems 
and types of organisation of palliative care. Pilot testing the set of QIs in those 
countries and continents that were not represented in this study will reveal 
whether they are applicable in these countries too. Fourthly, unfortunately, there 
were no patient representatives involved as panellist. Testing the final set of QIs 
will therefore also have to incorporate their views on the basic quality level or 
higher quality level that would be met only in very good services.
Conclusion
International experts selected a set of 23 QIs for the organisation of palliative 
care that can be implemented in daily practice in order to demonstrate that 
organisations are providing high quality and effective palliative care or to identify 
areas for improvement.
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Abstract
Background: The European population is ageing, and as a consequence, an 
increasing number of patients are in need of palliative care, including those 
with dementia. Although a growing number of new insights and best practices 
in palliative care have been published, they are often not implemented in 
daily practice. The aim of this integrative review is to provide an overview of 
implementation strategies that have been used to improve the organisation of 
palliative care.
Methods: Using an integrative literature review, we evaluated publications with 
strategies to improve the organisation of palliative care. Qualitative analysis of 
the included studies involved categorisation of the implementation strategies into 
subgroups, according to the type of implementation strategy.
Results: From the 2379 publications identified, 68 studies with an experimental or 
quasi-experimental design were included. These studies described improvements 
using educational strategies (n = 14), process mapping (n = 1), feedback (n = 1), 
multidisciplinary meetings (n = 1) and multi-faceted implementation strategies 
(n = 51). Fifty-three studies reported positive outcomes, 11 studies reported 
mixed effects and four studies showed a limited effect (two educational and two 
multi-faceted strategies).
Conclusions: This review is one of the first to provide an overview of the available 
literature in relation to strategies used to improve the organisation of palliative 
care. Since most studies reported positive results, further research is needed to 
identify and improve the effects of strategies aiming to improve the organisation 
of palliative care.
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Background
The European population is ageing, and as a consequence, an increasing number 
of patients are in need of palliative care, including those with dementia. The 
World Health Organisation has defined palliative care as an ‘approach to improve 
the quality of life of patients and families who face life-threatening illness, by 
providing pain and symptom relief, spiritual and psychosocial support from 
diagnosis to the end of life and bereavement’1-3. Although a growing number of 
new insights and best practices in palliative care are being published, knowledge 
translation into daily practice is lacking4. Study results in both the USA and the 
Netherlands suggest that up to 40% of patients in need of palliative care do not 
receive evidence-based care5. Apparently, there is a wide ‘gap’ between the 
available scientific evidence and its use in daily practice5.
The implementation of new evidence into daily practice is particularly challenging 
when complex changes are needed, cooperation between disciplines is required, 
or behaviour needs to be changed6. The use of traditional implementation 
strategies to convince professional care providers to use new evidence (such 
as identifying, synthesising and disseminating evidence in journals, guidelines, 
continuing medical education and conferences) is apparently not sufficient to 
engineer changes in the complex systems of palliative care5.
Yet, many studies that aim to improve palliative care have been performed. 
Often, these studies require much time investment and money from both 
the professional workforce as well as patients, which raises cost-effectiveness 
questions. It is therefore of utmost importance to synthesise and disseminate 
state-of-the-art scientific knowledge5,7. The aim of this integrative review is to 
provide an overview of effective implementation strategies that have been used 
to improve the organisation of palliative care. As such, results of this review have 
been used in the EU-funded Seventh Framework IMPACT project (IMplementation 
of quality indicators for PAlliative Care sTudy) which aims to develop and tailor 
national and setting-specific strategies to improve the organisation of palliative 
care in Europe8.
Methods
A review of available research literature was considered important to identify 
current knowledge about this topic.
The integrative review methodology summarises past empirical and theoretical 
literature that uses diverse methodologies and study designs from a variety 
of sources in order to provide a comprehensive understanding of a complex 
healthcare problem9. Therefore, an iterative comparison and analysis of relevant 
publications about the implementation of strategies to improve the organisation 
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of palliative care was conducted.
Search strategy
A comprehensive literature review was conducted, including Medline, CINAHL, 
British Nursing Index, PsycINFO, and by searching for grey literature10 (e.g. literature 
that has not been published in peer-reviewed literature). The search strategy was 
limited to English literature only, to publications that concerned palliative care 
for adults (aged 18 or above) and to publications that were published between 
2000 and August 2011. Various search terms were used that referred to subject-
specific keywords describing palliative care, as well as the type of implementation 
strategy and outcomes of the implementation, including synonyms and Medical 
SubHeadings (MeSH) to include all relevant literature. Table 1 provides an 
overview of the search terms (the search string is available in appendix 1). Disease-
specific search terms, such as cancer or dementia, were not included because the 
organisation of palliative care goes beyond a specific disease11.
Inclusion and exclusion criteria
Publications were included when they described (1) improvements to the 
organisation of palliative care, (2) which implementation strategies were used, 
(3) how these strategies were implemented and (4) the effectiveness of these 
strategies. Publications were excluded when (1) no abstract was available, (2) 
the implementation strategies were not directed at healthcare professionals 
or volunteers, (3) they were not directed at adult healthcare services or (4) 
educational curricula were developed.
Table 1: Overview of search terms
Search terms
palliative care implementation strategy outcomes of 
implementation
terminal care health plan implementation quality of health care
hospices program development program evaluation
hospice care quality indicators quality
end of life care implementation strategy improvement
comfort care program evaluation change
supportive care information dissemination
cancer care facilities information distribution
oncology service, hospital organisation change
diffusion of innovation
educational models
organisational models
quality improvement
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Data extraction and analysis
Two of the authors (JvRP and RS, one with a background in nursing and health 
sciences and the other in sociology) independently screened title and abstract and 
reviewed the full-text articles of the included studies to identify implementation 
strategies to improve the organisation of palliative care. A data collection form 
was used to extract information about the country and year in which the study 
was published, study design, setting, type of disease, healthcare professionals 
involved, and type, description and impact of the implementation strategies 
used. Subsequently, implementation strategies were categorised into subgroups, 
according to the type of implementation strategy, similar to the approach of Grol 
and Grimshaw5. Data from the subgroup classification was coded and compiled 
into a matrix, whereby the effect of each implementation strategy was summarised 
as a significant improvement (++), improvement (+), mixed or limited effect (+/−) 
or no effect (−). To ensure the trustworthiness and rigour of the analysis, peer 
debriefing took place with the other authors throughout the entire process of 
data analysis.
Results
Study selection
Of the 2379 initially identified publications, 241 were selected for full-text 
assessment (figure 1). A first assessment of the full-text of these publications 
revealed that 156 publications could be excluded, as they did not meet the inclusion 
criteria (for example, because there were no details given about the improvement 
strategy used). Reference lists of all publications eligible for inclusion as well as a 
hand search in grey literature databases revealed an additional 27 publications 
eligible for inclusion. The remaining publications represented a wide variety of 
research methods and designs: interviews, focus groups, strategy development 
designs, case descriptions, surveys, process evaluations, RCTs, pre-post-test 
interventions, review papers as well as theoretical papers. Because of the large 
number of identified studies, of which many were of low scientific quality and 
with incomparable outcome measures, only studies with an experimental (n = 12) 
or quasi-experimental (n = 56) study design were selected for further analysis.
Characteristics of included studies
A total of 17 single intervention studies and 51 multi-faceted intervention studies 
were identified. Most studies were conducted in the USA (n = 29), UK (n = 19) and 
Australia (n = 8), but studies were also included from countries such as Japan, 
Taiwan, Italy and the Netherlands. Studies were conducted within the entire range 
of palliative care services, from home care services to advanced palliative care 
units in hospitals. Fifty-one studies were conducted in one setting (primary care: 
n = 2, hospital: n = 38, nursing home: n = 9, hospice: n = 1 and other: n = 1) and 
11 were conducted in multiple settings. For six studies, the type of setting could 
not be identified. Within the included studies, a large variety of professionals 
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2877 potentially relevant publications
498 duplicate publications
2379 relavant publications
20 not about the organisation of palliative care
25 not directed at healthcare professionals
42 not directed at adults
114 educational curriculum development
1366 no improvement strategies described
350 other (i.e. not available in English)
462 publications included
2 not directed at adults
10 not about the organisation of palliative care
13 not directed at healthcare professionals
15 educational curriculum development
67 no abstract available
104 no improvement strategies described
10 other (i.e. not available in English)
241 publications included
156 no improvement strategies described
85 publications included
27 publications
included
12 experimen-
tal studies
56 quasi-ex-
perimental 
studies
29 non-experi-
mental studies
7 case-report 
studies
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participated. Thirty-five studies were directed at a single type of professionals 
(e.g. nurses only), 29 at two or more different groups of professionals (e.g. nurses 
and physicians), and four studies did not report the target group of professionals.
Strategies and its impact
Appendix 2 provides a summarised description of the methodology, setting and 
country, number and type of participants, the implementation strategy and the 
impact of the strategy of each individual study. Table 2 provides an overview of 
the results of studies with an experimental or quasi-experimental study design.
Educational strategies
Two experimental and 12 quasi-experimental studies used different types of 
educational strategies to improve palliative care, including lectures12-14, study 
days15,16, role play sessions17,18, interactive education19,20, educational outreach 
visits21 and computer-facilitated education22-25. Eight studies were targeted at a 
single profession, while six were targeted at multiple professionals. Four studies 
reported significant improvements, eight reported improvement, and two studies 
had limited or no effect.
Process mapping
One study used process mapping to improve the organisation of palliative care 
in a nursing home26. Before implementing the Liverpool Care Pathway, nursing 
home staff organised interdisciplinary team discussions where they answered 
the question, ‘If your patient is diagnosed as dying at 10 am on Monday morning 
and they are in pain, what happens?’ or in other words, ‘What is the process?’ in 
order to identify bottlenecks to be expected26. A repeated process measure post-
implementation reduced the numbers of expected bottlenecks.
Feedback
One study addressed feedback to improve the organisation of palliative care27. 
In an RCT, patients completed a health-related quality of life questionnaire. In 
the intervention group, hospital physicians received automated feedback upon 
completion of this questionnaire. The RCT showed improved health-related 
quality of life in the intervention group compared to the control group.
Multidisciplinary meetings
One quasi-experimental study performed by Lilly et al. described family and 
multidisciplinary meetings to improve the communication and shared-decision 
making at the intensive care unit (ICU) in a hospital28,29. Pre- and post-intervention 
measurements showed that the use of such meetings reduced length of ICU stay.
Mixed interventions
Fifty-one studies used a combination of strategies. Half of these studies used a 
combination of solely educational strategies (for example, lecture combined with 
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role play sessions)30-58, while the other half combined a variety of strategies (for 
example, education combined with feedback and reminders)59-86. Nine studies 
had an experimental design. Based on the conclusions of the authors, there were 
13 studies that had no or a limited effect on the specified outcomes, 21 studies 
that had a positive effect, and the remaining 17 studies reported a significant 
improvement.
Discussion
We made a comprehensive overview of the available literature in relation to 
strategies used to improve the organisation of palliative care. In total, 68 studies, 
representing an experimental or quasi-experimental study design, were discussed. 
These studies included educational strategies, process mapping, feedback, 
multidisciplinary meetings as well as mixed interventions.
For this review, all reported outcome measures in the identified studies were 
extracted. These measures included several patient outcome data items (e.g. 
assessment of the percentage of patients in pain following an educational session 
about pain treatment) as well as data concerning the process of care (e.g. the 
frequency of patient referral to specialist care following the introduction of a 
new referral form), making comparisons of outcomes impossible. However, the 
aim of all included studies was to improve the organisation of palliative care. We 
therefore generalised the outcomes to the degree in which they aimed to improve 
the organisation of palliative care.
Fifty-three studies, covering all strategies identified, reported that their study 
resulted in improving the organisation of palliative care. Eleven studies showed 
improvements for some of the characteristics targeted (four multi-educational 
and seven multi-faceted strategies), and four studies reported limited or no 
improvements (one using interactive education, one using computer-facilitated 
education and two multi-faceted strategies). The studies with a mixed or limited 
result on improving the organisation of palliative care were primarily conducted 
in one setting (hospital) and directed at one professional group. This stipulates the 
challenges that are encountered when implementing new evidence in complex 
environments such as a hospital as well as the importance of the multidisciplinary 
and interdisciplinary character of palliative care.
The different strategies identified in this review have been described in other fields 
in healthcare. In a review by Grol and Grimshaw, for example, large conferences 
and courses showed mixed effects, small group interactive education showed 
positive effects, educational outreach showed positive effects, feedback showed 
mixed effects and the use of mixed interventions often resulted in better results 
compared to single intervention studies5. Reviews that focused on one strategy 
type, for example, on audit and feedback87, printed educational materials88 or 
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educational outreach visits89, all had similar findings. One reason for the primarily 
positive findings of the studies identified in this review might be the fact that 
participants in a quality improvement project perform better as a result of knowing 
they are a study object (Hawthorne effect)90. Another reason might be that effects 
were often measured immediately after the intervention, so we do not know if 
the effects were sustained. Finally, only a few studies (n = 12) used a randomised 
controlled design, which is often considered to be the gold standard in research 
91, compared to other designs. RCTs require significant time and funding and 
expert research guidance, and particularly, in palliative care populations, they are 
scarce because of recruitment restrictions, high attrition, (selection) bias, lack of 
blinding, confounding and small sample sizes91,92. Many of these aspects, however, 
are also relevant in studies with a quasi-experimental, non-experimental or case-
study design. The studies that were included in this review might, therefore, not 
represent the strongest designs to test improvement strategies.
The included studies were conducted in a variety of settings (e.g. hospitals, nursing 
homes, hospices and primary care facilities). The provision of palliative care within 
these settings may vary depending on the patient group. Patients with cancer, for 
example, have a different disease trajectory, and other symptoms and needs than 
persons with dementia93,94. Despite these differences, there are many similarities 
regarding the organisation and multidisciplinary character of palliative care. For 
all chronic, life-threatening conditions, palliative care entails a patient-centred 
approach in which multidimensional interventions related to actual and future 
problems, needs and preferences are made.
The WHO definition of palliative care is therefore applicable for all patient groups 
3. The European Association of Palliative Care illustrates this by recommending 
a common approach for palliative care across settings95,96. In addition, 40 
international experts agreed that there is no need to formulate disease-specific 
quality criteria for the organisation of palliative care97. However, this does not 
mean that there is ample evidence regarding effective strategies to improve (the 
organisation of) palliative care in the different settings. Hall et al., for example, 
described that there is limited evidence for palliative care service delivery for 
residents of care homes for older people98. This illustrates the necessity to further 
improve the field of implementation science, in particular, in underdeveloped 
areas such as palliative care for persons with dementia.
Quality improvement projects often require investments of time and money from 
both the professional workforce and patients. It is important that the evidence of 
effective strategies is used to improve daily clinical practice. However, researchers 
and professionals often have different cultures, values, timelines, goals and 
rewards99. Even when the intervention is well-designed, real-world contextual 
factors may prevent the intervention from being realised. Implementation of 
evidence-based and best practices should therefore always be guided by a step-by-
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step model in order to identify the problem, barriers and facilitators and tailored 
strategies to solve the problem100. Integrated knowledge translation can then be 
used as a bridge in closing the gap between what we know and what we do101.
The results of this review were used in the EU-funded Seventh Framework IMPACT 
project. An intervention study investigating improvement projects with pre- and 
post-test evaluations was performed in 40 services providing palliative care across 
Europe (including hospitals, nursing homes, hospices and primary care facilities). 
In this study, quality indicators were used to identify potential areas to improve 
the organisation of palliative care. Subsequently, Grol’s Implementation of Change 
model100 was used to guide the services in their quality improvements. The 
strategies described in this review were used as an example and if possible also 
as actual strategies regarding how to change the organisation of palliative care.
Strengths and limitations
This is one of the first reviews that provides an overview of implementation 
strategies used to improve the organisation of palliative care. The results of 
this review can be used as a starting point for further research. However, some 
limitations should be taken into account. Firstly, this review used the integrative 
review methodology. Although this approach allows for the combination of 
diverse methodologies (including non-experimental research), only studies with 
an experimental and quasi-experimental design were included because of the 
unexpected high number of publications on the highest evidence level. Since a 
variety of methods was used in these studies, a quantitative comparison of effect 
size was considered impossible. Secondly, because it was the aim of this review 
to provide an overview of strategies used to improve the organisation of palliative 
care rather than the effectiveness, we did not assess each individual study for risk 
of bias or effect estimates. The effects of the strategies presented in this paper 
should therefore be interpreted with caution. Thirdly, we have limited the search 
strategy to English literature only. Although publications have been included from 
non-English speaking countries such as Japan and Italy, it is likely that we have 
missed potentially interesting publications from countries that often publish in 
their own language. Fourthly, there is no generic set of search terms to identify 
literature about improvement strategies, despite the fact that improvements 
are now being recognised as a science102,103. Although we have captured a broad 
selection of literature with our search strategy, it is possible that it did not identify 
all available publications on this topic.
Conclusion
This review provides an overview of the available literature in relation to strategies 
used to improve the organisation of palliative care. The identified studies described 
educational strategies, process mapping, feedback, multidisciplinary meetings 
and multi-faceted interventions. Future research, with more rigid designs, proper 
duration, control and blinding are necessary to identify and improve scientific 
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evidence regarding the optimal strategies to improve the organisation of palliative 
care.
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Appendix 1
Search string
BNI
palliat*.ti,ab. or exp Terminal care/ or terminal care.ti,ab. or Terminal Care 
: Hospices/ or Terminal care : nursing/ or Terminal care : services/ or Cancer : 
services/ or hospic*.ti,ab. or end of life care.ti,ab. or comfort care.ti,ab. or 
supportive care.ti,ab.
AND
implement*.ti,ab. or program development.ti,ab. or “Standards and guidelines”/ 
or Audit/ or “Care plans and planning”/ or Health service planning/ or Management 
information systems/ or quality indicator*.ti,ab. or program evaluat*.ti,ab. or 
information disseminat*.ti,ab. or information distribut*.ti,ab. or organi?ational 
innovat*.ti,ab. or organi?ational chang*.ti,ab. or “Models and theories”/ or 
Quality assurance/
AND
Exp Quality assurance/ or quality*.ti,ab. or Management information systems/ 
or  program evaluat*.ti,ab. or improv*.ti,ab. or chang*.ti,ab. or Evidence based 
practice/
Limitation
not (child* OR neonat* OR infant* OR pediatr* OR paediatr*).ti.
yr=”2000 to current”
CINAHL
MH “Palliative Care” or TI palliat* OR AB palliat* OR MH “Terminal Care” or TI 
“terminal care” OR AB “terminal care” or MH “Hospice and Palliative Nursing” or 
MH “Hospices” or MH “Hospice Care” or MH “Hospice patients” or TI hospic* or 
AB hospic* or TI “end of life care” or AB “end of life care” or TI “comfort care” or 
AB “comfort care” or TI “supportive care” or AB “supportive care” or MH “Cancer 
Care Facilities”
AND
MH “Program development+” or MH “Patient care plans+” or TI “health plan 
implement*” or AB “health plan implement*” or TI “program implement*” 
or AB “program implement*” or TI “program development” or AB “program 
development” or MH “Clinical indicators” or TI “quality indicator*” or AB “quality 
indicator*” or TI “clinical indicator*” or AB “clinical indicator*” or MH “Quality 
improvement” or TI “quality improvement*” or AB “quality improvement*” or 
TI “implementation strateg*” or AB “implementation strateg*” or TI “program 
evaluat*” or AB “program evaluat*” or TI “information disseminat*” or AB 
“information disseminat*” or TI “information distribut*” or AB “information 
distribut*” or MH “Organizational change” or TI “organi?ational innovat*” or AB 
“organi?ational innovat*” or TI “organi?ational chang*” or AB “organi?ational 
chang*” or MH “Diffusion of innovation” or MH “Models, educational” or MH 
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“Quality of care research”
AND
MH “Quality of Health Care+” or TI quality* or AB quality* or MH “Program 
Evaluation” or TI “program evaluat*” or AB “program evaluat*” or TI improv* or 
AB improv* or TI chang* or AB chang*
Limitation
not (MH child+ not MH adult+)
Published Date from: 20000101-20111231
MEDLINE
exp palliative care/ or palliat*.ti,ab. or terminal care/ or terminal care.ti,ab. or exp 
hospices/ or exp hospice care/ or hospic*.ti,ab. or end of life care.ti,ab. or comfort 
care.ti,ab. or supportive care.ti,ab. or exp cancer care facilities/ or exp oncology 
service, hospital/
AND
exp health plan implementation/ or health plan implement*.ti,ab. or exp program 
development/ or program development.ti,ab. or exp quality indicators, health 
care/ or quality indicator*.ti,ab. or implementation strateg*.ti,ab. or exp program 
evaluation/ or program evaluat*.ti,ab. or exp information dissemination/ or 
information disseminat*.ti,ab. or information distribut*.ti,ab. or exp organizational 
innovation/ or organi?ational innovat*.ti,ab. or organi?ational chang*.ti,ab. or exp 
diffusion of innovation/ or exp models, educational/ or exp models, organizational/ 
or Quality improvement/
AND
Exp Quality of health care/ or quality*.ti,ab. or program evaluat*.ti,ab. or improv*.
ti,ab. or chang*.ti,ab.
Limitation
not ((exp child/ or exp adolescent/) not exp adult/)
yr=”2000 -Current”
PsycINFO  
Exp Palliative care/ or palliat*.ti,ab. or terminal care.ti,ab. or Exp hospice/ or 
hospic*.ti,ab. or end of life care.ti,ab. or comfort care.ti,ab. or supportive care.
ti,ab.
AND
health plan implement*.ti,ab. or exp Program development/ or program 
development.ti,ab. or exp Program evaluation/ or program evaluat*.ti,ab. or quality 
indicator*.ti,ab. or implementation strateg*.ti,ab. or Information dissemination/ 
or information disseminat*.ti,ab. or information distribut*.ti,ab. or organi?ational 
innovat*.ti,ab. or exp Organizational change/ or organi?ational chang*.ti,ab. or 
diffusion of innovation.ti,ab. or Organizational development/ or organi?ational 
develop*.ti,ab. or Organizational learning/ or organi?ational learning.ti,ab.
AND
Exp Quality of services/ or quality*.ti,ab. or exp Program evaluation/ or program 
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evaluat*.ti,ab. or improv*.ti,ab. or chang*.ti,ab. or Evaluation/ or evaluat*.ti,ab. 
or Professional standards/ or professional standards.ti,ab. or Best practices/ or 
best practices.ti,ab.
Limitation
Yr=”2000-current”
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rs
 
(n
=u
nk
no
w
n)
1-
ho
ur
, r
ot
at
in
g,
 m
on
th
ly
 p
ro
gr
am
 o
f c
as
e 
pr
es
en
ta
ti
on
s 
an
d 
an
al
ys
is
 t
o 
as
si
st
 c
lin
ic
al
 
nu
rs
es
 in
 t
ra
ns
la
ti
ng
 r
es
ea
rc
h 
an
d 
on
go
-
in
g 
kn
ow
le
dg
e 
in
to
 p
ra
ct
ic
e:
 fa
ci
lit
at
or
 
in
tr
od
uc
ed
 p
ur
po
se
 o
f p
re
se
nt
at
io
n,
 st
af
f 
nu
rs
e 
pr
es
en
te
d 
th
e 
ca
se
 s
tu
dy
. 5
-m
in
ut
e 
pr
es
en
ta
tio
n 
ab
ou
t e
vi
de
nc
e 
ba
se
d 
pr
ac
tic
e 
w
as
 g
iv
en
, 3
 t
ea
m
 m
em
be
rs
 p
re
se
nt
ed
 fo
r 
10
 m
in
ut
es
 o
n 
re
le
va
nt
 n
ur
si
ng
 is
su
es
 u
si
ng
 
EB
P 
fr
om
 t
he
 li
te
ra
tu
re
, a
 2
0-
30
 m
in
ut
e 
di
sc
us
si
on
 fo
llo
w
ed
.
Pr
e-
po
st
 in
te
rv
en
ti
on
 e
va
lu
at
io
n 
re
ve
al
ed
 t
ha
t 
co
n-
fid
en
ce
 in
 k
no
w
le
dg
e 
in
cr
ea
se
d 
by
 a
lm
os
t 
on
e 
po
in
t 
on
 a
 fi
ve
-p
oi
nt
 s
ca
le
. 
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So
ur
ce
St
ud
y 
m
et
ho
d-
ol
og
y
Se
tt
in
g 
/ 
co
un
tr
y
Pa
rt
ici
pa
nt
s i
n 
in
te
rv
en
tio
n 
(n
)
De
sc
rip
tio
n 
of
 st
ra
te
gy
Re
su
lts
O
ut
re
ac
h 
vi
si
t
N
ew
to
n,
 
20
09
Q
ua
si
-e
x-
pe
rim
en
-
ta
l s
tu
dy
Co
m
m
u-
ni
ty
 ca
re
, 
H
os
pi
ta
l, 
H
os
pi
ce
 
&
 N
ur
si
ng
 
ho
m
e 
/ 
U
K
N
ur
se
s 
(n
=3
3)
Im
pl
em
en
ta
ti
on
 o
f t
he
 p
re
fe
rr
ed
 p
la
ce
 o
f 
ca
re
 d
oc
um
en
t,
 in
cl
ud
in
g 
a 
1-
3 
ho
ur
 fa
ce
-
to
-f
ac
e 
ed
uc
at
io
na
l c
on
ta
ct
 w
it
h 
ea
ch
 s
tu
dy
 
sit
e,
 p
rio
r t
o 
th
e 
co
m
m
en
ce
m
en
t o
f t
he
 
pr
ef
er
re
d 
pl
ac
e 
of
 c
ar
e 
do
cu
m
en
t.
A
ss
es
sm
en
t 
of
 p
re
fe
rr
ed
 p
la
ce
 o
f c
ar
e 
do
cu
m
en
t 
an
d 
pe
ri
od
ic
 q
ue
st
io
nn
ai
re
 s
ho
w
ed
 t
ha
t 
85
%
 o
f t
he
 
nu
rs
es
 u
sin
g 
th
e 
do
cu
m
en
t s
ta
te
d 
th
at
 it
 h
ad
 a
ffe
ct
-
ed
 t
he
ir
 p
ra
ct
ic
e,
 b
ec
au
se
 it
 h
el
pe
d 
ra
is
e 
aw
ar
en
es
s.
 
Th
e 
do
cu
m
en
t 
w
as
 in
it
ia
te
d 
la
te
r 
in
 t
he
 p
at
ie
nt
 
tr
aj
ec
to
ry
 t
ha
n 
re
co
m
m
en
de
d.
 7
1%
 o
f t
he
 p
at
ie
nt
s 
du
ri
ng
 t
he
 s
tu
dy
 p
er
io
d 
di
ed
 a
t 
th
ei
r 
PP
C.
 
Co
m
pu
te
r 
fa
ci
lit
at
ed
 e
du
ca
ti
on
Er
se
k,
 
20
08
Q
ua
si
-e
x-
pe
rim
en
-
ta
l s
tu
dy
H
om
e 
ca
re
, 
N
ur
si
ng
 
ho
m
e,
 
ho
sp
ic
e 
&
 
ho
sp
it
al
 /
 
U
SA
N
ur
si
ng
 a
ss
is
-
ta
nt
s 
(n
=6
5)
Si
x 
ho
ur
s 
of
 n
ur
si
ng
 a
ss
is
ta
nt
 c
om
pu
te
ri
se
d 
ed
uc
at
io
n 
pr
og
ra
m
m
e 
w
as
 u
se
d 
ov
er
 a
 
six
 w
ee
k 
pe
rio
d,
 w
hi
ch
 w
as
 b
as
ed
 o
n 
th
e 
pa
lli
at
iv
e 
ca
re
 e
du
ca
ti
on
al
 r
es
ou
rc
e 
te
am
 
pr
og
ra
m
m
e 
an
d 
th
e 
co
re
 c
ur
ri
cu
lu
m
 fo
r 
th
e 
ho
sp
ic
e 
an
d 
pa
lli
at
iv
e 
nu
rs
in
g 
as
si
st
an
t.
Ev
al
ua
ti
on
 q
ue
st
io
nn
ai
re
, a
nd
 p
re
te
st
-p
os
tt
es
t 
en
d-
of
-li
fe
 c
ar
e 
kn
ow
le
dg
e 
ex
am
 a
nd
 s
el
f-
ev
al
ua
ti
on
s 
sh
ow
ed
 a
 s
ig
ni
fic
an
tl
y 
in
cr
ea
se
d 
kn
ow
le
dg
e 
an
d 
im
pr
ov
ed
 p
er
ce
iv
ed
 s
ki
lls
 in
 c
ar
in
g 
fo
r 
pa
ti
en
ts
 a
t 
th
e 
en
d 
of
 li
fe
.
H
ul
sm
an
, 
20
02
Q
ua
si 
ex
pe
ri-
m
en
ta
l 
st
ud
y
H
os
pi
ta
l /
 
th
e 
N
et
h-
er
la
nd
s
Ph
ys
ic
ia
ns
 
(n
=2
1)
A
 4
 h
ou
r 
co
m
pu
te
r 
as
si
st
ed
 c
om
m
un
ic
at
io
n 
sk
ill
s 
tr
ai
ni
ng
, c
on
si
st
ed
 o
f 4
 m
od
ul
es
. M
od
-
ul
e 
1:
 fo
cu
se
d 
on
 b
as
ic
 c
om
m
un
ic
at
io
n 
sk
ill
s 
re
ga
rd
in
g 
ve
rb
al
 a
nd
 n
on
-v
er
ba
l b
eh
av
io
ur
 
of
 p
hy
si
ci
an
 a
nd
 p
at
ie
nt
. M
od
ul
e 
2:
 b
re
ak
in
g 
ba
d 
ne
w
s.
 M
od
ul
e 
3:
 p
ro
vi
di
ng
 in
fo
rm
at
io
n 
ef
fe
ct
iv
el
y,
 b
as
ed
 o
n 
tw
o-
w
ay
 in
te
ra
ct
io
n.
 
M
od
ul
e 
4:
 d
ea
lin
g 
w
it
h 
pa
ti
en
ts
’ e
m
ot
io
ns
. 
In
 e
ac
h 
m
od
ul
e,
 v
id
eo
 e
xa
m
pl
es
 w
er
e 
us
ed
 
to
 p
re
se
nt
 p
oo
r a
nd
 a
de
qu
at
e 
co
m
m
un
ica
-
tio
n.
 
Pr
e 
an
d 
po
st
 in
te
rv
en
ti
on
 v
id
eo
ta
pe
d 
pa
ti
en
t 
in
te
rv
ie
w
s a
nd
 p
at
ie
nt
 sa
tis
fa
ct
io
n 
ra
tin
gs
 sh
ow
ed
 a
 
po
si
ti
ve
 c
ou
rs
e 
ef
fe
ct
 o
n 
ra
ti
ng
 o
f t
he
 q
ua
lit
y 
of
 p
hy
-
si
ci
an
s’
 p
er
fo
rm
an
ce
. N
o 
co
ur
se
 e
ff
ec
t 
w
er
e 
fo
un
d 
on
 th
e 
fre
qu
en
cie
s o
f p
hy
sic
ia
ns
’ c
om
m
un
ica
tio
n 
be
ha
vi
ou
rs
 a
nd
 o
n 
th
e 
pa
tie
nt
 sa
tis
fa
ct
io
n 
ra
tin
g.
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l s
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U
SA
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te
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al
 m
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ca
l h
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 s
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(n
=1
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)
Im
pl
em
en
ta
ti
on
 o
f p
al
lia
ti
ve
 c
ar
e 
or
de
r 
se
t:
 A
n 
ed
uc
at
io
na
l e
-m
ai
l w
as
 s
en
t 
w
hi
ch
 
ou
tl
in
ed
 e
ac
h 
se
ct
io
n 
w
it
hi
n 
th
e 
or
de
r 
se
t 
w
it
h 
lin
ks
 t
o 
in
te
rn
al
 a
nd
 e
xt
er
na
l w
eb
 s
it
es
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fe
re
nc
in
g 
pa
lli
at
iv
e 
m
an
ag
em
en
t 
of
 p
ai
n,
 
se
da
ti
on
, d
el
ir
iu
m
, s
ec
re
ti
on
s,
 d
ys
pn
oe
a,
 
co
de
 s
ta
tu
s,
 n
ut
ri
ti
on
 a
nd
 fl
ui
ds
. T
he
 e
-m
ai
l 
w
as
 o
nl
y 
se
nt
 o
nc
e,
 w
he
n 
th
e 
or
de
r 
se
t 
w
as
 
in
tr
od
uc
ed
.
Pr
e-
in
te
rv
en
ti
on
 (n
=9
7)
 a
nd
 p
os
t-
in
te
rv
en
ti
on
 
(n
=7
6)
 e
va
lu
at
io
n 
sh
ow
ed
 a
 s
ig
ni
fic
an
t 
in
cr
ea
se
 in
 
th
e 
pe
rc
en
ta
ge
 o
f r
es
id
en
ts
 c
om
fo
rt
ab
le
 w
it
h 
re
ga
rd
 
to
 th
e 
fo
ur
 a
sp
ec
ts
 o
f s
ym
pt
om
 m
an
ag
em
en
t.
Sm
it
h,
 
20
10
Q
ua
si
-e
x-
pe
rim
en
-
ta
l s
tu
dy
Va
ri
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s 
/ 
U
K
N
ur
se
s 
(n
=3
0)
Si
x 
w
ee
k,
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nl
in
e 
co
m
m
un
ic
at
io
n 
an
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en
d-
of
-
lif
e 
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ss
m
en
t 
sk
ill
s 
tr
ai
ni
ng
.
Pr
e 
an
d 
po
st
-t
es
t 
se
lf-
as
se
ss
m
en
t 
qu
es
ti
on
na
ir
e,
 
po
st
-in
te
rv
en
ti
on
 c
an
di
da
te
 e
va
lu
at
io
n,
 a
nd
 p
os
t-
in
-
te
rv
en
ti
on
 m
od
er
at
or
 e
va
lu
at
io
n 
sh
ow
ed
 im
pr
ov
e-
m
en
ts
 in
 p
ar
tic
ip
an
ts
’ c
on
fid
en
ce
.
N
on
 e
du
ca
ti
on
 in
te
rv
en
ti
on
s
Pr
oc
es
s 
m
ap
pi
ng
Ta
yl
or
, 
20
07
Q
ua
si
-e
x-
pe
rim
en
-
ta
l s
tu
dy
N
ur
si
ng
 
ho
m
e 
/ 
N
ew
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al
an
d
M
an
ag
er
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ca
re
 m
an
ag
er
, 
se
ni
or
 n
ur
se
, 
ph
ar
m
ac
ist
, 
LC
P 
fa
ci
lit
at
or
, 
LC
P 
co
ns
ul
ta
nt
 
ph
ar
m
ac
ist
 
(n
=u
nk
no
w
n)
A 
m
ee
tin
g 
w
as
 a
rr
an
ge
d 
w
ith
 m
em
be
rs
 o
f 
th
e 
in
te
rd
is
ci
pl
in
ar
y 
te
am
 t
o 
m
ap
 t
he
 p
ro
-
ce
ss
 o
f c
ar
e 
in
 o
rd
er
 t
o 
im
pl
em
en
t 
th
e 
Li
ve
r-
po
ol
 C
ar
e 
Pa
th
w
ay
. T
he
 s
ec
on
d 
pa
rt
 o
f t
he
 
m
ee
ti
ng
 in
vo
lv
ed
 lo
ok
in
g 
at
 t
he
 b
ot
tl
en
ec
ks
.
Af
te
r s
ix 
m
on
th
s, 
th
e 
pr
oc
es
s w
as
 re
m
ap
pe
d,
 
de
m
on
st
ra
ti
ng
 a
 d
is
ti
nc
t 
re
du
ct
io
n 
in
 b
ot
tl
en
ec
ks
 
an
d 
im
pr
ov
ed
 p
re
-e
m
pt
iv
e 
pr
es
cr
ib
in
g.
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 w
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te
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ro
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(c
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pl
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 t
ou
ch
-s
cr
ee
n 
he
al
th
 r
el
at
ed
 
qu
al
it
y 
of
 li
fe
 q
ue
st
io
nn
ai
re
 a
nd
 fe
ed
ba
ck
 
of
 r
es
ul
ts
 t
o 
ph
ys
ic
ia
n)
, a
tt
en
ti
on
-c
on
tr
ol
 
gr
ou
p 
(c
om
pl
et
io
n 
of
 t
ou
ch
-s
cr
ee
n 
he
al
th
 
re
la
te
d 
qu
al
it
y 
of
 li
fe
 q
ue
st
io
nn
ai
re
, w
it
ho
ut
 
fe
ed
ba
ck
 t
o 
ph
ys
ic
ia
n)
, a
nd
 c
on
tr
ol
 g
ro
up
 (n
o 
to
uc
h-
sc
re
en
 m
ea
su
re
m
en
t 
of
 h
ea
lt
h 
re
la
te
d 
qu
al
it
y 
of
 li
fe
).
Ph
ys
ic
ia
ns
 r
ef
er
re
d 
ex
pl
ic
it
ly
 t
o 
th
e 
he
al
th
 r
el
at
ed
 
qu
al
it
y 
of
 li
fe
 d
at
a 
in
 o
nl
y 
64
%
 o
f t
he
 e
nc
ou
nt
er
s.
 
H
ow
ev
er
, a
 la
rg
er
 p
ro
po
rt
io
n 
of
 p
at
ie
nt
s 
in
 t
he
 
in
te
rv
en
ti
on
 g
ro
up
 s
ho
w
ed
 c
lin
ic
al
ly
 m
ea
ni
ng
fu
l 
im
pr
ov
em
en
t 
in
 H
RQ
L 
co
m
pa
re
d 
w
it
h 
pa
ti
en
ts
 in
 
at
te
nt
io
n-
co
nt
ro
l a
nd
 c
on
tr
ol
 g
ro
up
s.
 R
ou
ti
ne
 u
se
 
of
 H
RQ
L 
in
fo
rm
at
io
n 
du
ri
ng
 t
he
 e
nc
ou
nt
er
s 
ha
d 
an
 
im
pa
ct
 o
n 
ph
ys
ic
ia
n-
pa
ti
en
t 
co
m
m
un
ic
at
io
n 
w
it
ho
ut
 
pr
ol
on
gi
ng
 t
he
 in
te
rv
ie
w
s.
 C
hr
on
ic
 n
on
sp
ec
ifi
c 
sy
m
pt
om
s 
w
er
e 
di
sc
us
se
d 
m
or
e 
fr
eq
ue
nt
ly
.
M
ul
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di
sc
ip
lin
ar
y 
m
ee
ti
ng
s
Li
lly
, 2
00
0 
&
 L
ill
y 
20
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Q
ua
si 
ex
pe
ri-
m
en
ta
l 
st
ud
y
H
os
pi
ta
l /
 
U
SA
Ph
ys
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ia
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nu
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 (n
=5
4)
In
 t
he
 p
re
in
te
rv
en
ti
on
 p
er
io
d,
 fo
rm
al
 
fa
m
ily
 m
ee
ti
ng
s 
w
er
e 
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ua
lly
 h
el
d 
af
te
r 
th
e 
pr
ov
id
er
 te
am
 h
ad
 re
ac
he
d 
co
ns
en
su
s 
th
at
 r
es
to
ra
ti
on
 o
f f
un
ct
io
n 
or
 s
ur
vi
va
l w
as
 
un
lik
el
y.
 In
 t
he
 in
te
rv
en
ti
on
 p
er
io
d,
 a
n 
in
it
ia
l 
fo
rm
al
 m
ul
ti
di
sc
ip
lin
ar
y 
m
ee
ti
ng
 w
it
h 
th
e 
pa
ti
en
t,
 fa
m
ily
 o
r 
bo
th
 w
as
 h
el
d 
w
it
hi
n 
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ho
ur
s 
af
te
r 
ad
m
is
si
on
 t
o 
th
e 
IC
U
. P
ur
po
se
 o
f 
th
e 
m
ee
ti
ng
 w
as
: 1
) r
ev
ie
w
 m
ed
ic
al
 fa
ct
s 
an
d 
op
ti
on
s 
fo
r 
tr
ea
tm
en
t;
 2
) d
is
cu
ss
 p
at
ie
nt
s’
 
pe
rs
pe
ct
iv
es
; 3
) t
o 
ag
re
e 
on
 c
ar
e 
pl
an
; a
nd
 
4)
 t
o 
ag
re
e 
on
 c
ri
te
ri
a 
by
 w
hi
ch
 t
he
 s
uc
ce
ss
 
or
 fa
ilu
re
 o
f t
hi
s 
ca
re
 p
la
n 
w
ou
ld
 b
e 
ju
dg
ed
. 
W
ee
kl
y 
m
ul
ti
di
sc
ip
lin
ar
y 
ca
se
 r
ev
ie
w
s 
w
er
e 
he
ld
 t
o 
en
su
re
 t
ha
t 
al
l r
el
ev
an
t 
pa
ti
en
ts
 h
ad
 
se
ss
io
ns
.
Pr
ei
nt
er
ve
nt
io
n 
(n
=1
34
) c
om
pa
re
d 
to
 in
te
rv
en
ti
on
 
(n
=3
96
) d
em
on
st
ra
te
d 
a 
si
gn
ifi
ca
nt
 in
cr
ea
se
 in
 
ph
ys
ic
ia
n-
le
d 
m
ee
ti
ng
s,
 le
ng
th
 o
f s
ta
y 
in
 t
he
 IC
U
 
w
as
 r
ed
uc
ed
 fr
om
 4
 d
ay
s 
to
 3
 d
ay
s 
(a
ft
er
 4
 y
ea
rs
, 
th
is
 w
as
 s
ti
ll 
3 
da
ys
) a
nd
 t
he
re
 w
as
 a
 d
ec
re
as
e 
in
 
un
ad
ju
st
ed
 o
ve
ra
ll 
m
or
ta
lit
y 
(p
=0
.0
2)
 a
nd
 a
 t
re
nd
 
to
w
ar
d 
re
du
ce
d 
m
or
ta
lit
y 
du
ri
ng
 t
he
 IC
U
 s
ta
y.
 T
he
 
ra
te
 o
f p
ro
vi
de
r 
no
n-
co
ns
en
su
s 
da
ys
 d
ec
re
as
ed
 fr
om
 
65
 d
ay
s 
pe
r 
1,
00
0 
pa
ti
en
t-
da
ys
 t
o 
4 
da
ys
 p
er
 1
,0
00
 
pa
ti
en
t-
da
ys
. T
he
 r
at
e 
of
 fa
m
ily
 n
on
-c
on
se
ns
us
 d
e-
cr
ea
se
d 
fr
om
 1
71
 d
ay
s 
10
00
 p
at
ie
nt
-d
ay
s 
to
 1
6 
da
ys
 
pe
r 
10
00
 p
at
ie
nt
-d
ay
s.
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nt
ro
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ro
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 t
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re
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In
te
rv
en
ti
on
 g
ro
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 1
 r
ec
ei
ve
d 
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3-
ho
ur
 
di
da
ct
ic
 p
re
se
nt
at
io
n,
 in
cl
ud
in
g 
ca
se
 s
tu
dy
, 
pr
es
en
ta
tio
n 
an
d 
di
sc
us
sio
n.
 In
te
rv
en
tio
n 
gr
ou
p 
2 
re
ce
iv
ed
 3
-h
ou
r 
di
da
ct
ic
 p
re
se
nt
a-
ti
on
 +
 4
-h
ou
r 
be
ds
id
e 
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in
ic
al
 e
xp
er
ie
nc
e 
at
 a
 
lo
ca
l h
os
pi
ce
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on
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si
gn
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ca
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 d
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en
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er
ce
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nd
-o
f-
lif
e 
ca
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er
e 
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un
d 
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ro
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te
rv
en
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rd
, 
20
06
 &
 
Lie
na
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pe
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ve
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co
m
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un
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at
io
ns
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 t
ra
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in
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ou
r 
le
ct
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e 
an
d 
17
-h
ou
r 
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al
l g
ro
up
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ol
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pl
ay
in
g 
se
ss
io
ns
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 S
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se
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qu
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y,
 p
hy
si
ci
an
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ra
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el
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te
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ec
ei
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ou
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w
or
ks
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am
e 
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o-
gr
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s 
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si
c 
tr
ai
ni
ng
) o
r 
w
er
e 
pl
ac
ed
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n 
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e 
w
ai
ti
ng
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on
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lid
at
io
n 
w
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ks
ho
p 
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te
d 
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m
on
th
s 
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te
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.
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ol
id
at
io
n 
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or
ks
ho
p 
im
pr
ov
ed
 c
om
m
un
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io
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te
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ie
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s 
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w
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: s
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ca
nt
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cr
ea
se
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 o
pe
n 
an
d 
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en
 d
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ct
iv
e 
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tio
ns
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d 
ut
te
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nc
es
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in
g 
pa
ti
en
ts
 t
o 
re
al
it
y.
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ig
ni
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ic
an
t 
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se
 in
 p
re
m
at
ur
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re
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su
ra
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e.
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ie
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te
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ie
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le
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en
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m
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at
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 s
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m
en
ts
, e
du
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ot
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si
gn
ifi
ca
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 c
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la
ti
on
s 
w
er
e 
ob
se
rv
ed
 a
t 
ba
se
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be
tw
ee
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 c
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on
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at
ie
nt
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 p
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en
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si
gn
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ou
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ge
s 
in
 p
at
ie
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 r
el
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iv
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ie
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w
-
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a 
th
re
e-
pe
rs
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 c
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at
io
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w
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er
ve
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si
gn
ifi
ca
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 c
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ng
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si
ci
an
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lit
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et
ec
t 
re
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ti
ve
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 d
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tr
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s 
. H
ow
ev
er
, t
he
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ff
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t 
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ia
ns
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te
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 p
at
ie
nt
s’ 
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n 
th
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re
 a
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pa
ni
ed
 
by
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 r
el
at
iv
e.
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at
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at
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 c
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 c
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 c
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 t
ra
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m
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m
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ra
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in
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. C
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ti
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 c
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tr
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l a
nd
 a
tt
it
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gn
ifi
ca
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Si
gn
ifi
ca
nt
 e
ff
ec
t 
w
as
 fo
un
d 
fo
r 
co
m
m
un
ic
at
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 b
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ow
ev
er
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 p
os
it
iv
e 
tr
ai
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ec
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 p
at
ie
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at
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io
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ve
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) c
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 o
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m
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at
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ni
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 d
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ra
ti
on
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m
m
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ra
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s,
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ed
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ol
e-
pl
ay
, c
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ru
ct
iv
e 
fe
ed
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, d
is
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ss
io
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 c
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so
lid
at
io
n 
m
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er
ia
ls
 (h
an
do
ut
s,
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ef
er
en
ce
s,
 e
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A
ud
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ap
ed
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ur
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en
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 (8
5 
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co
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ro
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rm
, a
nd
 8
2 
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te
rv
en
ti
on
 g
ro
up
) a
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 a
ft
er
 
(8
2 
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 c
on
tr
ol
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rm
, a
nd
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2 
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 in
te
rv
en
ti
on
 g
ro
up
) t
he
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in
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ra
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m
m
un
ic
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io
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ge
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 c
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en
ce
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ur
se
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at
ie
nt
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is
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ct
io
n 
w
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ls
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gr
ea
te
r 
in
 t
he
 
in
te
rv
en
tio
n 
gr
ou
p.
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 c
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at
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 p
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 c
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 c
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 c
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at
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 c
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ig
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fic
an
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de
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 r
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ci
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ig
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t 
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 o
f 
na
so
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 m
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 b
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w
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ul
at
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m
m
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at
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sk
ill
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ur
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e 
an
d 
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st
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es
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al
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te
d 
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ov
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 c
on
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en
ce
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 a
bi
lit
y 
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 p
or
tr
ay
 c
ar
in
g 
at
ti
tu
de
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nd
 h
el
pe
d 
to
 im
pr
ov
e 
co
m
m
un
ic
at
io
n 
sk
ill
s 
w
it
h 
pa
ti
en
ts
 a
nd
 t
he
ir
 fa
m
ili
es
.
Br
av
e-
m
en
, 
20
01
Q
ua
si
-e
x-
pe
rim
en
-
ta
l s
tu
dy
H
os
pi
ce
, 
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m
e 
ca
re
 /
 
U
SA
Un
kn
ow
n
1s
t  i
nt
er
ve
nt
io
n:
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du
ca
ti
on
 o
f s
ta
ff
 a
bo
ut
 p
ai
n 
m
an
ag
em
en
t 
vi
a 
tw
o 
1-
ho
ur
 in
-s
er
vi
ce
 t
ra
in
-
in
g 
se
ss
io
ns
 o
f p
hy
si
ca
l, 
ps
yc
ho
so
ci
al
, s
oc
ia
l 
an
d 
sp
ir
it
ua
l m
an
ife
st
at
io
ns
 o
f p
ai
n 
an
d 
pa
in
 in
te
rv
en
tio
ns
. T
hi
s e
du
ca
tio
n 
co
ns
ist
ed
 
of
 a
n 
in
tr
od
uc
to
ry
 le
ct
ur
e,
 d
is
cu
ss
io
ns
 a
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ro
le
-p
la
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ng
. A
 la
m
in
at
ed
 p
oc
ke
t-
ca
rd
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nd
 
ch
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is
ts
 w
er
e 
de
ve
lo
pe
d 
w
hi
ch
 in
cl
ud
ed
 
th
e 
m
os
t 
im
po
rt
an
t 
in
fo
rm
at
io
n,
 a
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 a
ll 
st
af
f 
w
er
e 
gi
ve
n 
a 
se
t 
of
 g
ui
de
lin
es
. A
 p
ai
n 
ex
pe
rt
 
w
as
 c
re
at
ed
 a
t 
ea
ch
 s
it
e.
 2
nd
 in
te
rv
en
ti
on
: 
w
ee
kl
y 
pa
in
 n
ew
sl
et
te
r
Pr
e 
an
d 
po
st
-t
es
t 
co
m
pe
te
nc
y 
as
se
ss
m
en
t 
an
d 
ch
ar
t 
au
di
ts
 in
di
ca
te
d 
fo
r 
th
e 
1s
t  i
nt
er
ve
nt
io
n:
 S
om
e 
im
-
pr
ov
em
en
ts
 in
 d
oc
um
en
ta
ti
on
. L
it
tl
e 
im
pr
ov
em
en
ts
 
in
 st
af
f c
om
pe
te
nc
y. 
A
nd
 fo
r 
th
e 
2n
d  i
nt
er
ve
nt
io
n:
 g
re
at
 im
pr
ov
em
en
t 
in
 
st
af
f c
om
pe
te
nc
y.
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at
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at
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ro
le
-p
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 t
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l d
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ur
e 
de
fe
nc
es
, s
ig
ni
fic
an
t d
ec
re
as
e 
in
 
bo
rd
er
lin
e 
de
fe
nc
e 
an
d,
 o
n 
th
e 
in
di
vi
du
al
 le
ve
l, 
th
e 
ov
er
al
l d
ef
en
si
ve
 fu
nc
ti
on
in
g 
im
pr
ov
ed
 fo
r 
8 
ou
t 
of
 
10
 c
lin
ic
ia
ns
.
Fa
llo
w
-
fie
ld
, 
20
01
Q
ua
si 
ex
pe
ri-
m
en
ta
l 
st
ud
y
H
os
pi
ta
l 
/ 
U
K
N
ur
se
s 
(n
=1
29
)
A
 t
w
o-
da
y 
co
m
m
un
ic
at
io
n 
sk
ill
s 
tr
ai
ni
ng
 
w
as
 g
iv
en
 t
o 
sm
al
l g
ro
up
s 
(1
2 
pe
rs
on
s 
pe
r 
se
ss
io
n)
. P
ar
ti
ci
pa
nt
s 
w
or
ke
d 
on
 s
pe
ci
fic
 
sk
ill
s 
in
 s
m
al
l g
ro
up
s 
of
 fo
ur
 o
r 
le
ss
, u
si
ng
 
vi
de
o 
re
vi
ew
 o
f r
ol
e-
pl
ay
 w
it
h 
st
an
da
rd
is
ed
 
pa
tie
nt
s. 
In
te
ra
ct
iv
e 
gr
ou
p 
de
m
on
st
ra
tio
ns
, 
sm
al
l g
ro
up
 d
is
cu
ss
io
n 
of
 p
re
pa
re
d 
vi
de
o 
m
at
er
ia
ls
 a
nd
 a
 r
es
ou
rc
e 
fil
e 
of
 s
el
ec
te
d 
ke
y 
re
ad
in
g 
pr
ov
id
ed
 a
 c
on
ce
pt
ua
l f
ra
m
ew
or
k 
an
d 
ex
pa
ns
io
n 
of
 p
ar
ti
ci
pa
nt
s’
 k
no
w
le
dg
e 
of
 
th
e 
lit
er
at
ur
e.
Be
fo
re
 a
nd
 3
-m
on
th
s 
af
te
r 
th
e 
co
ur
se
 (n
=9
2)
, n
ur
se
s 
fil
le
d 
in
 a
 q
ue
st
io
nn
ai
re
. P
os
tt
es
t 
da
ta
 s
ho
w
ed
 t
ha
t 
nu
rs
es
 r
ep
or
te
d 
si
gn
ifi
ca
nt
ly
 g
re
at
er
 c
on
fid
en
ce
 in
 
ha
nd
lin
g 
14
 c
om
m
on
 c
om
m
un
ic
at
io
n 
pr
ob
le
m
 a
re
as
 
in
 c
an
ce
r 
an
d 
in
 8
 d
iff
er
en
t 
ar
ea
s 
of
 t
ea
ch
in
g.
 T
hr
ee
 
m
on
th
s 
po
st
-c
ou
rs
e 
91
%
 r
ep
or
te
d 
ch
an
gi
ng
 t
he
ir
 
ow
n 
te
ac
hi
ng
 p
ra
ct
ic
e 
an
d 
85
%
 h
ad
 in
it
ia
te
d 
ne
w
 
co
m
m
un
ic
at
io
n 
sk
ill
s 
te
ac
hi
ng
.
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Overview of improvement strategies
So
ur
ce
St
ud
y 
m
et
ho
d-
ol
og
y
Se
tt
in
g 
/ 
co
un
tr
y
Pa
rt
ici
pa
nt
s i
n 
in
te
rv
en
tio
n 
(n
)
De
sc
rip
tio
n 
of
 st
ra
te
gy
Re
su
lts
Fi
ns
et
, 
20
03
Q
ua
si 
ex
pe
ri-
m
en
ta
l 
st
ud
y
Se
tt
in
g 
un
-
kn
ow
n 
/ 
De
nm
ar
k,
 
Fi
nl
an
d,
 
Ic
el
an
d,
 
N
or
w
ay
 
an
d 
Sw
e-
de
n
Ph
ys
ic
ia
ns
 
(n
=2
19
)
A
 c
om
m
un
ic
at
io
n 
sk
ill
s 
co
ur
se
, c
on
si
st
in
g 
of
 
th
re
e 
m
od
ul
es
. M
od
ul
e 
1:
 t
hr
ee
 s
em
in
ar
s 
of
 3
 h
ou
rs
 a
t 
tw
o 
w
ee
k 
in
te
rv
al
s 
ab
ou
t 
in
te
rv
ie
w
 t
ec
hn
iq
ue
s,
 p
sy
ch
ol
og
ic
al
 d
ef
en
ce
 
m
ec
ha
ni
sm
s a
nd
 cr
isi
s r
ea
ct
io
ns
, u
sin
g 
in
st
ru
ct
io
na
l v
id
eo
s 
an
d 
se
lf-
st
ud
y 
m
at
er
ia
ls
. 
M
od
ul
e 
2:
 a
 b
oa
rd
in
g 
co
ur
se
 la
st
in
g 
fo
r 
3 
da
ys
, i
nc
lu
di
ng
 e
xp
er
ie
nt
ia
l l
ea
rn
in
g 
in
 t
he
 
fo
rm
 o
f r
ol
e-
pl
ay
, w
hi
ch
 w
as
 v
id
eo
ta
pe
d 
to
 s
ti
m
ul
at
e 
di
sc
us
si
on
. M
od
ul
e 
3:
 t
hr
ee
 
se
m
in
ar
s 
of
 3
 h
ou
rs
 a
im
ed
 a
t 
ho
w
 d
oc
to
rs
 
ex
pe
rie
nc
ed
 th
ei
r w
or
k 
w
ith
 ca
nc
er
 p
at
ie
nt
 
an
d 
te
st
in
g 
ne
w
 s
ki
lls
.
Ph
ys
ic
ia
ns
 fi
lle
d 
in
 a
 q
ue
st
io
nn
ai
re
 b
ef
or
e,
 a
t 
th
e 
co
m
pl
et
io
n,
 a
nd
 2
 t
o 
6 
ye
ar
s 
af
te
r 
co
ur
se
 c
om
pl
e-
ti
on
 (n
= 
15
5)
. 9
4%
 o
f t
he
 p
hy
si
ci
an
s 
re
po
rt
ed
 h
ig
h 
de
gr
ee
 t
o 
fa
ir
ly
 la
rg
e 
ex
te
nt
 o
f s
at
is
fa
ct
io
n 
of
 t
he
 
co
ur
se
 c
on
te
nt
. T
he
 c
ou
rs
e 
im
pr
ov
ed
 a
ll 
co
m
m
un
i-
ca
ti
on
 le
ar
ni
ng
 n
ee
ds
, e
xc
ep
t 
ap
pl
yi
ng
 k
no
w
le
dg
e 
of
 d
ef
en
ce
 m
ec
ha
ni
sm
s, 
m
ee
tin
g 
de
pr
es
sio
n 
in
 
pa
ti
en
ts
, m
ee
ti
ng
 w
it
hd
ra
w
al
 in
 p
at
ie
nt
s,
 a
nd
 m
ee
t-
in
g 
su
ic
id
al
 p
at
ie
nt
s.
 P
ar
ti
ci
pa
nt
s 
de
sc
ri
be
d 
th
at
 
co
m
m
un
ic
at
io
n 
in
 c
ha
lle
ng
in
g 
si
tu
at
io
ns
 is
 e
as
ie
r 
th
an
 b
ef
or
e 
th
e 
co
ur
se
.
Fi
sc
he
r, 
20
07
Q
ua
si 
ex
pe
ri-
m
en
ta
l 
st
ud
y
H
os
pi
ta
l /
 
U
SA
In
te
rn
al
 m
ed
-
ici
ne
 in
te
rn
s 
(n
=5
1)
A
 3
-h
ou
r 
co
m
m
un
ic
at
io
n 
sk
ill
s 
w
or
ks
ho
p 
w
as
 
pr
ov
id
ed
. T
he
 w
or
ks
ho
p 
co
ns
ist
ed
 o
f g
ro
up
 
di
sc
us
si
on
s,
 a
 b
ri
ef
 le
ct
ur
e,
 v
id
eo
ta
pe
 r
ev
ie
w
, 
an
d 
ro
le
-p
la
yi
ng
.
Pr
et
es
t 
(n
=4
3)
 a
nd
 p
os
tt
es
t 
(n
=2
9)
 s
ur
ve
y 
sh
ow
ed
 a
n 
in
cr
ea
se
 in
 o
ve
ra
ll 
kn
ow
le
dg
e,
 b
ad
 n
ew
s 
su
bs
co
re
, 
an
d 
ad
va
nc
e 
ca
re
 p
la
nn
in
g 
su
bs
co
re
. T
he
re
 w
as
 
al
so
 a
n 
in
cr
ea
se
 in
 p
ar
ti
ci
pa
nt
s’
 c
on
fid
en
ce
 in
 a
bi
lit
y 
to
 d
is
cu
ss
 a
dv
an
ce
 c
ar
e 
pl
an
ni
ng
 a
nd
 li
m
it
at
io
ns
 
of
 t
re
at
m
en
t,
 d
el
iv
er
in
g 
ba
d 
ne
w
s 
an
d 
ha
nd
lin
g 
em
ot
io
na
l r
es
po
ns
es
 fr
om
 p
at
ie
nt
s.
 T
he
re
 w
as
 n
o 
sig
ni
fic
an
t d
iff
er
en
ce
s i
n 
at
tit
ud
e 
be
fo
re
 a
nd
 a
fte
r 
th
e 
w
or
ks
ho
p.
Fu
rm
an
, 
20
06
Q
ua
si 
ex
pe
ri-
m
en
ta
l 
st
ud
y
H
os
pi
ta
l /
 
U
SA
Ph
ys
ic
ia
ns
 
(n
=8
)
Pa
rt
ic
ip
an
ts
 a
tt
en
de
d 
a 
m
or
ni
ng
 r
ep
or
t 
co
ns
ist
in
g 
of
 b
ot
h 
di
da
ct
ic 
tr
ai
ni
ng
 a
nd
 
th
re
e-
pe
rs
on
 r
ol
e-
pl
ay
ed
 d
is
cu
ss
io
n 
in
 o
rd
er
 
to
 im
pr
ov
e 
di
sc
us
sio
n 
of
 a
dv
an
ce
 d
ire
ct
iv
es
.
Pr
e 
(n
=4
4)
 a
nd
 p
os
t 
(n
=3
5)
 in
te
rv
en
ti
on
 c
ha
rt
 a
ud
it
, 
sh
ow
ed
 t
ha
t 
32
%
 o
f t
he
 p
at
ie
nt
s 
ha
d 
a 
do
cu
m
en
te
d 
ad
va
nc
e 
di
re
ct
iv
e 
di
sc
us
sio
n 
be
fo
re
 in
te
rv
en
tio
n 
co
m
pa
re
d 
to
 3
4%
 a
ft
er
 t
he
 in
te
rv
en
ti
on
. R
es
ul
ts
 
w
er
e 
no
t 
st
at
is
ti
ca
lly
 s
ig
ni
fic
an
t.
Gu
eg
ue
n,
 
20
09
Q
ua
si
-e
x-
pe
rim
en
-
ta
l s
tu
dy
H
os
pi
ta
l /
  
U
SA
Ph
ys
ic
ia
ns
, 
nu
rs
es
, n
ur
se
 
pr
ac
tit
io
ne
rs
, 
ph
ys
ici
an
 a
ss
is-
ta
nt
s 
(n
=4
0)
D
id
ac
ti
c 
pr
es
en
ta
ti
on
, i
nc
lu
di
ng
 e
xe
m
pl
ar
y 
vi
de
o 
cl
ip
s,
 fo
llo
w
ed
 b
y 
ro
le
-p
la
y 
w
it
h 
di
s-
cu
ss
io
n 
an
d 
fe
ed
ba
ck
 to
 im
pr
ov
e 
co
m
m
un
i-
ca
ti
on
 s
ki
lls
. P
ar
ti
ci
pa
nt
s 
w
er
e 
al
so
 g
iv
en
 a
n 
ed
uc
at
io
na
l b
oo
kl
et
.
A
no
ny
m
ou
s,
 p
os
t-
te
st
 e
va
lu
at
io
n 
fo
rm
s 
sh
ow
ed
 
th
at
 t
he
 c
on
fid
en
ce
 in
 c
on
du
ct
in
g 
fa
m
ily
 m
ee
ti
ng
 
in
cr
ea
se
d 
si
gn
ifi
ca
nt
ly
 fr
om
 r
et
ro
sp
ec
ti
ve
 p
re
-t
es
t 
ev
al
ua
ti
on
.
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So
ur
ce
St
ud
y 
m
et
ho
d-
ol
og
y
Se
tt
in
g 
/ 
co
un
tr
y
Pa
rt
ici
pa
nt
s i
n 
in
te
rv
en
tio
n 
(n
)
De
sc
rip
tio
n 
of
 st
ra
te
gy
Re
su
lts
H
al
l, 
20
07
Q
ua
si
-e
x-
pe
rim
en
-
ta
l s
tu
dy
Pa
lli
at
iv
e 
ca
re
 u
ni
t 
/ 
Ca
na
da
Ph
ys
ic
ia
ns
, 
nu
rs
es
 (n
=1
7)
Fo
ur
-h
ou
r 
ed
uc
at
io
n 
se
ss
io
ns
 fo
r 
nu
rs
es
 a
nd
 
ca
se
 s
tu
dy
 a
nd
 r
ol
e-
pl
ay
 w
er
e 
us
ed
 b
y 
ph
y-
sic
ia
ns
 to
 re
vi
ew
 co
m
m
un
ica
tio
n 
st
ra
te
gi
es
, 
sh
ar
ed
 d
ec
is
io
n-
m
ak
in
g 
an
d 
ca
re
 p
la
nn
in
g 
co
nc
ep
ts
. A
n 
ad
va
nc
ed
 p
ra
ct
ice
 n
ur
se
 w
as
 
av
ai
la
bl
e 
on
 t
he
 u
ni
t 
ev
er
y 
da
y 
w
he
n 
th
e 
pi
lo
t 
be
ga
n 
to
 s
up
po
rt
 s
ta
ff
 w
it
h 
th
e 
ch
an
ge
 
pr
oc
es
s.
D
ai
ly
 lo
gs
 o
f a
ct
iv
it
ie
s 
an
d 
sa
ti
sf
ac
ti
on
, p
re
 a
nd
 
po
st
-t
es
t 
qu
es
ti
on
na
ir
es
, i
nt
er
vi
ew
s,
 a
nd
 fo
cu
s 
gr
ou
ps
 in
di
ca
te
d 
im
pr
ov
ed
 co
m
m
un
ica
tio
n 
be
tw
ee
n 
ph
ys
ici
an
s a
nd
 n
ur
se
s a
nd
 th
e 
in
cr
ea
se
d 
as
se
ss
m
en
t 
re
sp
on
si
bi
lit
y 
of
 n
ur
se
s 
re
du
ce
d 
ph
ys
ic
ia
n 
ti
m
e 
on
 
th
e 
w
ar
d.
 
Ki
nn
an
e,
 
20
09
Q
ua
si
-e
x-
pe
rim
en
-
ta
l s
tu
dy
H
os
pi
ta
l /
  
A
us
tr
al
ia
Vo
lu
nt
ee
rd
 
an
d 
vo
lu
nt
ee
r 
co
or
di
na
to
rs
 
(n
=8
)
3-
da
y 
tr
ai
ni
ng
, i
nc
lu
di
ng
 c
la
ss
ro
om
 a
nd
 
gr
ou
p 
ac
ti
vi
ti
es
 (e
.g
. r
ol
e-
pl
ay
) a
bo
ut
 t
he
 
se
rv
ic
e,
 c
om
m
un
ic
at
io
n 
sk
ill
s,
 s
up
po
rt
 a
nd
 
se
lf-
ca
re
.
Pr
e-
po
st
 in
te
rv
en
ti
on
 (n
=8
) s
ho
w
ed
 im
pr
ov
em
en
ts
 
in
: c
om
m
un
ic
at
io
n 
sk
ill
s,
 o
ff
er
in
g 
su
pp
or
t,
 k
no
w
l-
ed
ge
 o
f a
va
ila
bl
e 
se
rv
ic
e,
 c
on
fid
en
ce
. M
os
t 
va
lu
ed
 
as
pe
ct
 o
f t
ra
in
in
g:
 r
ol
e-
pl
ay
, l
ea
rn
in
g 
co
m
m
un
ic
at
io
n 
sk
ill
s,
 in
fo
rm
at
io
n 
of
 t
he
 s
er
vi
ce
s.
Q
ui
nn
, 
20
08
Q
ua
si
-e
x-
pe
rim
en
-
ta
l s
tu
dy
H
os
pi
ta
l, 
N
ur
si
ng
 
ho
m
e,
 
G
en
er
al
 
pr
ac
ti-
tio
ne
r, 
ho
sp
ic
e 
/ 
 
A
us
tr
al
ia
A
lli
ed
 h
ea
lt
h-
ca
re
 p
ro
fe
s-
si
on
al
s,
 p
hy
si
-
cia
ns
, n
ur
se
s, 
pe
rs
on
al
 c
ar
e 
at
te
nd
an
t 
(n
=4
95
)
N
in
e 
se
ss
io
ns
 p
re
se
nt
ed
 b
y 
sp
ec
ia
lis
t 
pa
lli
at
iv
e 
ca
re
 c
lin
ic
ia
ns
. S
es
si
on
s 
co
ns
is
te
d 
of
 d
id
ac
ti
c 
le
ct
ur
es
, q
ue
st
io
n 
an
d 
an
sw
er
 
se
ss
io
ns
, w
or
ks
ho
ps
 a
nd
 p
an
el
/ 
ca
se
 d
is
cu
s-
si
on
s.
 P
ar
ti
ci
pa
nt
s 
w
er
e 
al
so
 g
iv
en
 e
du
ca
-
ti
on
al
 m
at
er
ia
l.
Pr
e 
an
d 
po
st
-t
es
t 
qu
es
ti
on
na
ir
e,
 p
os
t-
te
st
 e
va
l-
ua
tio
n,
 a
nd
 a
 fo
cu
s g
ro
up
 sh
ow
ed
 a
 si
gn
ifi
ca
nt
 
im
pr
ov
em
en
t 
in
 a
bi
lit
y 
to
 id
en
ti
fy
 p
al
lia
ti
ve
 c
ar
e 
pa
ti
en
ts
, r
el
at
io
ns
hi
p 
an
d 
ro
le
s,
 p
ro
vi
di
ng
 s
up
po
rt
 
se
rv
ic
es
, c
om
m
un
ic
at
io
n 
sk
ill
s,
 s
ym
pt
om
 a
nd
 p
ai
n 
m
an
ag
em
en
t,
 le
ga
l a
nd
 e
th
ic
al
 is
su
es
, s
pi
ri
tu
al
 a
nd
 
cu
lt
ur
al
 a
sp
ec
ts
 a
nd
 g
ri
ef
 a
nd
 b
er
ea
ve
m
en
t.
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So
ur
ce
St
ud
y 
m
et
ho
d-
ol
og
y
Se
tt
in
g 
/ 
co
un
tr
y
Pa
rt
ici
pa
nt
s i
n 
in
te
rv
en
tio
n 
(n
)
De
sc
rip
tio
n 
of
 st
ra
te
gy
Re
su
lts
Re
ym
on
d,
 
20
05
Q
ua
si
-e
x-
pe
rim
en
-
ta
l s
tu
dy
Pr
im
ar
y 
ca
re
 /
 
A
us
tr
al
ia
G
P,
 n
ur
se
, 
nu
rs
e 
as
sis
-
ta
nt
, p
er
so
na
l 
ca
re
 w
or
ke
r, 
in
di
ge
no
us
 
he
al
th
 w
or
ke
r, 
re
sp
ite
 ca
re
 
w
or
ke
r, 
di
ve
rs
io
na
l 
th
er
ap
ist
, 
Ph
ys
io
th
er
-
ap
is
t,
 s
oc
ia
l 
w
or
ke
r, 
pa
s-
to
ra
l w
or
ke
r 
(n
=1
49
)
3-
ho
ur
 w
or
ks
ho
p 
co
ns
is
ti
ng
 o
f i
nt
ro
du
ct
or
y 
di
da
ct
ic 
te
ac
hi
ng
 o
n 
pa
rt
ici
pa
nt
 n
om
in
at
ed
 
to
pi
cs
, s
m
al
l g
ro
up
 c
as
e 
m
an
ag
em
en
t 
di
sc
us
-
si
on
, a
nd
 a
 s
es
si
on
 d
ev
ot
ed
 t
o 
ps
yc
ho
so
ci
al
 
an
d 
co
un
se
lin
g 
in
pu
ts
.
Pr
e 
an
d 
po
st
-w
or
ks
ho
p 
qu
es
ti
on
na
ir
es
 (n
=1
16
) 
sh
ow
ed
 t
ha
t 
G
Ps
’ c
on
fid
en
ce
 in
cr
ea
se
d 
si
gn
ifi
ca
nt
ly
 
in
 k
no
w
le
dg
e 
an
d 
sk
ill
 le
ve
ls
 in
 m
an
ag
in
g 
co
m
m
on
 
sy
m
pt
om
s 
(n
oc
ic
ep
ti
ve
 t
is
su
e 
pa
in
, n
eu
ro
pa
th
-
ic
 p
ai
n,
 d
ys
pn
oe
a,
 c
on
st
ip
at
io
n,
 a
nd
 d
el
ir
iu
m
).
 
O
th
er
 p
ri
m
ar
y 
he
al
th
ca
re
 w
or
ke
rs
 h
ad
 a
 s
ig
ni
fic
an
t 
im
pr
ov
em
en
t 
in
 r
at
ed
 k
no
w
le
dg
e 
of
 t
re
at
m
en
t 
of
 
pa
in
 a
nd
 d
ys
pn
ea
 (c
on
st
ip
at
io
n 
w
as
 n
ot
 s
ig
ni
fic
an
t)
, 
an
d 
ra
te
d 
sk
ill
 le
ve
l w
as
 s
ta
ti
st
ic
al
ly
 in
cr
ea
se
d 
fo
r 
pa
in
 m
an
ag
em
en
t i
n 
de
m
en
tia
. T
he
ir 
co
nf
id
en
ce
 in
 
de
ve
lo
pi
ng
 m
an
ag
em
en
t 
pl
an
s 
an
d 
co
m
m
un
ic
at
in
g 
w
it
h 
pa
ti
en
ts
 a
ls
o 
in
cr
ea
se
d 
si
gn
ifi
ca
nt
ly
.
Su
lli
va
n,
 
20
05
 
Q
ua
si 
ex
pe
ri-
m
en
ta
l 
st
ud
y
Se
tt
in
g 
un
kn
ow
n 
/ 
U
SA
Ph
ys
ic
ia
ns
, 
nu
rs
es
, 
so
ci
al
 w
or
ke
rs
, 
ph
ar
m
ac
ist
s, 
et
hi
cis
ts
, 
an
d 
ot
he
r 
he
al
th
ca
re
 
pr
of
es
si
on
al
s 
(n
=1
49
)
Pa
lli
at
iv
e 
Ca
re
 E
du
ca
ti
on
 a
nd
 P
ra
ct
ic
e 
w
as
 
de
liv
er
ed
 in
 t
w
o,
 o
ne
-w
ee
k,
 fu
ll-
ti
m
e,
 o
n-
si
te
 
se
ss
io
ns
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 b
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 d
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l c
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 c
ar
e.
 
Se
ss
io
n 
2 
in
cl
ud
ed
 e
xp
er
ie
nt
ia
l l
ea
rn
in
g 
in
 
cl
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l c
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 b
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ra
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ra
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at
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 p
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 p
ra
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 b
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at
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 p
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ra
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 c
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 p
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 c
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 d
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 c
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 p
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 p
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 d
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 p
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 p
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 d
iff
er
-
en
t 
le
ve
ls
 o
f 
m
an
ag
em
en
t 
(n
=u
nk
no
w
n)
Fo
ur
 e
du
ca
ti
on
al
 w
or
ks
ho
ps
, c
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 c
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 p
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 t
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 c
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 d
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 c
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 c
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 c
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 d
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 o
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at
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os
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at
io
n 
sk
ill
s 
tr
ai
ni
ng
, u
si
ng
 a
 
te
ac
hi
ng
 p
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 re
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 d
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 t
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-
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 c
on
fid
en
ce
 in
 c
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ra
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 c
on
si
st
ed
 o
f a
  1
0-
m
in
ut
e 
le
ct
ur
e,
 
fo
ur
 in
te
ra
ct
iv
e 
60
-m
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ra
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at
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 D
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l b
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-p
la
y 
pr
ac
ti
ce
s,
 fo
llo
w
ed
 b
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 p
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 c
ha
ng
es
 in
 le
ng
th
 o
f s
ta
y 
in
 IC
U
 b
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at
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m
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se
 (n
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w
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fic
an
t i
m
pr
ov
em
en
t i
n 
th
e 
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m
be
r o
f f
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us
ed
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op
en
 q
ue
st
io
ns
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re
ss
io
ns
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f e
m
pa
th
y, 
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d 
ap
pr
op
ri
at
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sp
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se
s 
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 p
at
ie
nt
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 c
ue
s 
fo
r 
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co
l-
og
ist
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ho
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 b
ee
n 
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co
ur
se
 co
m
pa
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d 
to
 
th
os
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w
ho
 h
ad
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tt
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 e
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de
nc
e 
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r 
th
e 
ef
fe
ct
iv
en
es
s o
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te
n 
fe
ed
ba
ck
.
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en
ta
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ud
y
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os
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K
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ia
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e 
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llo
w
fie
ld
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e 
an
d 
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st
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te
rv
en
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nn
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vi
de
ot
ap
ed
 p
at
ie
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te
rv
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ho
w
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fic
an
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ov
ed
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es
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 b
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ar
d 
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ci
al
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es
 c
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w
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os
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in
ic
ia
n 
sa
ti
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 m
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th
s 
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(n
=4
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 c
ou
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e 
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d 
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re
 (n
=4
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) a
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ft
er
 (n
=4
22
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he
 c
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e 
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r 
th
e 
co
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ro
l g
ro
up
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 t
he
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ea
su
re
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le
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ng
es
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 c
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ic
ia
ns
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io
ur
, t
he
 c
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m
un
ic
at
io
n 
sk
ill
s 
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g 
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gn
ifi
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 p
at
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at
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e 
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llo
w
fie
ld
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00
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is
 s
tu
dy
 d
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cr
ib
es
 a
 1
2 
m
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th
 fo
llo
w
-u
p.
12
 m
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th
 fo
llo
w
-u
p 
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se
ss
m
en
ts
 o
f v
id
eo
ta
pe
d 
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tie
nt
 in
te
rv
ie
w
s, 
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ow
ed
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at
 th
e 
ef
fe
ct
 re
co
rd
ed
 
af
te
r 
3 
m
on
th
s 
w
as
 s
ti
ll 
in
 e
ff
ec
t 
af
te
r 
12
 m
on
th
s.
 
Th
er
e 
w
er
e 
fe
w
er
 in
te
rr
up
tio
ns
 e
vi
de
nt
 a
nd
 
su
m
m
ar
isi
ng
 o
f i
nf
or
m
at
io
n 
in
cr
ea
se
d,
 re
sp
on
se
s 
to
 p
at
ie
nt
-le
d 
cu
es
 im
pr
ov
ed
 w
hi
le
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he
 n
um
be
r 
of
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ap
pr
op
ria
te
 re
sp
on
se
s d
ec
re
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ed
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ra
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pe
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f d
ev
el
op
-
m
en
t c
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 d
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ur
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 p
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sis
ta
nt
, 
ot
he
r n
ur
sin
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ho
m
e 
st
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no
w
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ne
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ay
 c
on
fe
re
nc
e 
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t 
ho
sp
ic
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en
-
ro
llm
en
t 
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se
rv
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ai
n 
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an
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em
en
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nc
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 c
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e 
pl
an
ni
ng
, c
om
m
un
ic
at
io
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d 
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al
it
y 
im
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ov
em
en
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 o
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 e
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ca
ti
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ov
em
en
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lit
at
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ng
 
an
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ni
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lli
at
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e 
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 p
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 d
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 c
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de
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 p
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an
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 d
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lin
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 a
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 m
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 p
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po
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ar
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re
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ca
te
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im
pr
ov
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e 
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en
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pr
ov
id
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ua
lit
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at
iv
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ca
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os
pi
ce
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nr
ol
lm
en
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m
be
r 
of
 p
ai
n 
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se
ss
m
en
ts
, n
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-p
ha
rm
ac
ol
og
ic
al
 
tr
ea
tm
en
t 
an
d 
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-d
ep
th
 d
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cu
ss
io
ns
 a
bo
ut
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nd
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lif
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it
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de
nt
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 p
re
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le
nc
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 p
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t c
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: D
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of
 g
ui
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fe
ed
ba
ck
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ou
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 D
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us
io
n 
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 g
ui
de
lin
e 
+ 
au
di
t 
an
d 
fe
ed
ba
ck
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 e
du
ca
ti
on
al
 o
ut
re
ac
h 
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si
t.
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it
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in
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 p
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ri
pt
io
n 
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ow
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im
pl
e 
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us
io
n 
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de
lin
e 
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ef
fe
ct
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e.
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im
pl
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us
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 g
ui
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lin
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t 
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d 
fe
ed
ba
ck
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lt
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 p
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lt
s.
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on
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 d
iff
us
io
n 
of
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ui
de
lin
e,
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ud
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nd
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ed
ba
ck
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ed
uc
at
io
n 
ou
tr
ea
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isi
t h
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 p
os
iti
ve
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pa
ct
 o
n 
an
tie
m
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pr
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ip
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 b
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fe
rio
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w
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se
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os
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l-w
id
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 c
om
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se
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cl
in
ic
al
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cu
m
en
ta
ti
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f p
ai
n 
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di
ng
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de
la
ye
d 
re
as
se
ss
m
en
t 
al
er
t 
in
te
rv
en
ti
on
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w
as
 im
pl
em
en
te
d 
us
in
g 
a 
de
ta
ile
d 
pr
in
te
d 
ex
pl
an
at
io
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 b
ri
ef
 g
ro
up
 t
ra
in
in
g 
se
ss
io
ns
 
an
d 
fe
ed
ba
ck
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po
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ev
ea
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 p
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se
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ut
io
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 p
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ra
te
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Re
su
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Bo
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00
Q
ua
si
-e
x-
pe
rim
en
-
ta
l s
tu
dy
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im
ar
y 
ca
re
 /
 
A
us
tr
al
ia
G
Ps
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=2
2)
G
Ps
 a
tt
en
de
d 
w
ee
kl
y 
pa
ti
en
t 
ca
se
 c
on
fe
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-
es
 to
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 th
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r o
w
n 
pr
ac
tic
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 th
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 w
er
e 
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ke
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ee
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ar
y 
of
 p
at
ie
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 r
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 p
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 p
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at
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m
pt
om
 c
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ol
og
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 p
sy
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et
hi
ca
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ss
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ti
ve
 c
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he
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ee
kl
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sc
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si
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m
en
to
r.
Pr
e 
an
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po
st
-in
te
rv
en
ti
on
 q
ue
st
io
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ai
re
s 
in
di
ca
t-
ed
 s
ta
ti
st
ic
al
 s
ig
ni
fic
an
t 
im
pr
ov
em
en
t 
in
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 G
Ps
 
pe
rc
ei
ve
d 
le
ve
l o
f k
no
w
le
dg
e,
 s
ki
lls
 a
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 c
on
fid
en
ce
 
in
 p
ro
vi
di
ng
 p
al
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ti
ve
 c
ar
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bi
nd
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00
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Q
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rim
en
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l s
tu
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os
pi
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SA
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se
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od
uc
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re
 p
at
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ay
, c
on
sis
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g 
of
 
in
te
rd
is
ci
pl
in
ar
y 
ca
re
 p
at
h,
 n
ur
se
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 d
ai
ly
 fl
ow
-
sh
ee
t, 
an
d 
a 
st
an
da
rd
ise
d 
ph
ys
ici
an
 o
rd
er
 
sh
ee
t,
 n
ur
se
s 
re
ce
iv
ed
 e
du
ca
ti
on
al
 s
es
si
on
 
ab
ou
t 
en
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fe
 c
ar
e 
an
d 
ho
us
e 
st
af
f a
nd
 
ph
ys
ic
ia
n 
as
si
st
an
ts
 r
ec
ei
ve
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ca
se
-b
as
ed
 
te
ac
hi
ng
 r
ou
nd
. O
n 
ea
ch
 s
tu
dy
 w
ar
d,
 a
 n
ur
se
 
le
ad
er
 a
ct
ed
 a
s 
lia
is
on
 t
o 
th
e 
pr
oj
ec
t.
 E
va
lu
a-
ti
on
 t
oo
ls
 w
er
e 
us
ed
 t
o 
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se
ss
 a
nd
 fe
ed
ba
ck
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pr
og
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ad
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e 
an
d 
po
st
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te
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en
ti
on
 c
ha
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tr
ac
ti
on
 
(n
=1
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;1
56
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 p
ro
ce
ss
 a
ud
it
, a
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 k
no
w
le
dg
e 
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es
-
ti
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na
ir
e 
(n
=1
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) i
nd
ic
at
ed
 t
ha
t 
th
e 
m
ea
n 
nu
m
be
r 
of
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pt
om
s 
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ss
m
en
t 
in
cr
ea
se
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si
gn
ifi
ca
nt
ly
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Si
gn
ifi
ca
nt
 d
ec
re
as
e 
in
 t
he
 n
um
be
r 
of
 p
ro
bl
em
at
ic
 
sy
m
pt
om
s 
id
en
ti
fie
d 
an
d 
in
te
rv
en
ti
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s 
em
pl
oy
ed
 
in
 t
he
 p
al
lia
ti
ve
 c
ar
e 
un
it
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ig
ni
fic
an
t 
in
cr
ea
se
 in
 t
he
 
nu
m
be
r 
of
 in
pa
ti
en
t 
co
ns
ul
ta
ti
on
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 In
cr
ea
se
d 
di
sc
us
-
si
on
 o
f p
at
ie
nt
’s
 g
oa
ls
 o
f c
ar
e 
an
d 
pa
ti
en
t 
pr
ef
er
en
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es
; I
nc
re
as
ed
 u
se
 o
f p
al
lia
ti
ve
 c
ar
e 
in
 v
oc
ab
ul
ar
y 
of
 
ph
ys
ic
ia
ns
; I
nc
re
as
ed
 c
ol
la
bo
ra
ti
on
 b
et
w
ee
n 
ho
sp
ic
e 
an
d 
ho
sp
it
al
. M
or
ph
in
e 
in
fu
si
on
 a
nd
 D
N
R 
or
de
rs
 
w
er
e 
m
or
e 
lik
el
y 
in
 s
tu
dy
 u
ni
ts
. A
lt
ho
ug
h 
m
ea
n 
kn
ow
le
dg
e 
sc
or
es
 im
pr
ov
ed
, n
o 
si
gn
ifi
ca
nt
 c
ha
ng
es
 
w
er
e 
fo
un
d.
 N
um
be
r 
of
 p
at
ie
nt
s 
pl
ac
ed
 o
n 
ca
re
 
pa
th
w
ay
: 9
 o
f 2
7 
in
 O
nc
ol
og
y/
G
er
ia
tr
ic
 u
ni
ts
, a
ll 
50
 
in
 P
C 
un
it
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 p
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ra
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at
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, c
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 c
ar
e 
te
am
, 
us
e 
of
 p
re
pr
in
te
d 
or
de
rs
 fo
r 
th
e 
w
it
hd
ra
w
al
 
of
 li
fe
-s
us
ta
in
in
g 
tr
ea
tm
en
t,
 h
ir
in
g 
of
 a
 m
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at
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 p
os
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, p
at
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op
m
en
t 
of
 
la
st
 o
ff
ic
es
 p
ol
ic
y,
 in
te
rd
is
ci
pl
in
ar
y 
w
or
k-
sh
op
s 
an
d 
te
ac
hi
ng
 s
es
si
on
s 
(in
cl
ud
in
g 
a 
D
V
D
 
on
 t
he
 p
ri
nc
ip
le
s 
an
d 
st
an
da
rd
s 
of
 a
ft
er
ca
re
).
Pr
e 
(n
=4
3)
 a
nd
 p
os
t-
te
st
 (n
=4
2)
 a
ud
it
s 
sh
ow
ed
 
im
pr
ov
em
en
ts
 in
 c
ar
e 
an
d 
ra
is
ed
 t
he
 p
ro
fil
e 
of
 a
f-
te
rc
ar
e.
 Im
pr
ov
em
en
ts
 a
ch
ie
ve
d 
fo
llo
w
in
g 
th
e 
au
di
t 
w
er
e 
m
od
es
t.
H
oc
kl
ey
, 
20
10
Q
ua
si
-e
x-
pe
rim
en
-
ta
l s
tu
dy
N
ur
si
ng
 
ho
m
e 
/ 
U
K
N
ur
se
s 
an
d 
ca
rin
g 
st
af
f 
(n
=u
nk
no
w
n)
1-
3 
ke
y 
ch
am
pi
on
s 
in
 e
ac
h 
se
rv
ic
e 
(w
ho
 
re
ce
iv
ed
 4
 w
or
ks
ho
ps
 a
nd
 a
 4
-d
ay
 t
ra
in
in
g 
co
ur
se
) i
m
pl
em
en
te
d 
a 
lis
t 
of
 a
ll 
pe
rm
an
en
t 
re
si
de
nt
s 
w
it
h 
pr
om
pt
s 
fo
r 
m
on
th
ly
 d
is
cu
s-
si
on
s 
ar
ou
nd
 a
dv
an
ce
d 
ca
re
 p
la
nn
in
g,
 D
N
A
R 
st
at
us
, f
am
ily
 a
nd
 r
es
id
en
t 
co
m
m
un
ic
at
io
n,
 
an
d 
sy
m
pt
om
 a
ss
es
sm
en
t 
co
nt
ro
l. 
St
af
f 
re
ce
iv
ed
 a
 2
-h
ou
r 
sc
en
ar
io
-b
as
ed
 t
ra
in
in
g.
 
Ea
ch
 s
er
vi
ce
 a
ls
o 
ha
d 
an
 o
ut
re
ac
h 
vi
si
t 
fr
om
 
th
e 
pr
oj
ec
t 
fa
ci
lit
at
or
 e
ve
ry
 1
0-
14
 d
ay
s.
Re
tr
os
pe
ct
iv
e 
re
vi
ew
 o
f c
lin
ic
al
 n
ot
es
 b
ef
or
e 
(n
=9
5)
 a
nd
 d
ur
in
g 
th
e 
in
te
rv
en
ti
on
 (n
=1
33
) a
nd
 
po
st
-in
te
rv
en
ti
on
 s
ta
ff
 a
ud
it
 (n
=6
8)
 s
ho
w
ed
 t
ha
t 
do
cu
m
en
ta
ti
on
 o
f D
N
A
R 
in
st
ru
ct
io
ns
 r
os
e 
fr
om
 1
5%
 
to
 7
2%
. E
vi
de
nc
e 
of
 c
on
ve
rs
at
io
ns
 a
bo
ut
 a
dv
an
ce
d 
ca
re
 p
la
nn
in
g 
ro
se
 fr
om
 4
%
 t
o 
53
%
. T
he
 u
se
 o
f 
th
e 
ad
ap
te
d 
Li
ve
rp
oo
l C
ar
e 
Pa
th
w
ay
 r
os
e 
fr
om
 3
%
 
to
 3
0%
. H
os
pi
ta
l d
ea
th
s 
re
du
ce
d 
fr
om
 1
5%
 t
o 
8%
 
an
d 
nu
m
be
r 
of
 h
os
pi
ta
l b
ed
-d
ay
s 
re
du
ce
d 
by
 3
8 
%
. I
m
pr
ov
em
en
t 
in
 s
ta
ff
 c
on
fid
en
ce
 in
 a
dd
re
ss
in
g 
ps
yc
ho
-s
oc
ia
l a
nd
 e
m
ot
io
na
l n
ee
ds
 a
nd
 t
al
ki
ng
 w
it
h 
pa
ti
en
ts
 a
nd
 r
el
at
iv
es
 a
bo
ut
 d
yi
ng
.
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So
ur
ce
St
ud
y 
m
et
ho
d-
ol
og
y
Se
tt
in
g 
/ 
co
un
tr
y
Pa
rt
ici
pa
nt
s i
n 
in
te
rv
en
tio
n 
(n
)
De
sc
rip
tio
n 
of
 st
ra
te
gy
Re
su
lts
Ja
co
bs
, 
20
02
Q
ua
si
-e
x-
pe
rim
en
-
ta
l s
tu
dy
H
os
pi
ta
l /
 
U
SA
Ph
ys
ic
ia
ns
 a
nd
 
nu
rs
es
 (n
=u
n-
kn
ow
n)
To
 im
pr
ov
e 
en
d-
of
-li
fe
 c
ar
e 
ph
ys
ic
ia
ns
 
an
d 
nu
rs
es
 w
er
e 
gi
ve
n 
bi
an
nu
al
 fe
ed
ba
ck
 
th
ro
ug
h 
a 
pa
lli
at
iv
e 
ca
re
 r
ep
or
t 
ca
rd
. T
he
se
 
re
po
rt
s 
w
er
e 
al
so
 p
re
se
nt
ed
 t
o 
th
e 
m
ed
ic
al
 
di
re
ct
or
. O
th
er
 in
te
rv
en
ti
on
s 
in
cl
ud
ed
 
pa
lli
at
iv
e 
ca
re
 s
oc
ia
l w
or
k 
co
ns
ul
ta
ti
on
s 
an
d 
ed
uc
at
io
na
l s
es
si
on
s 
ab
ou
t 
sy
m
pt
om
 
m
an
ag
em
en
t,
 p
sy
ch
ol
og
ic
al
/s
oc
ia
l c
on
ce
rn
s,
 
bi
oe
th
ic
al
 a
nd
 le
ga
l i
ss
ue
s.
M
ed
ic
al
 r
ec
or
d 
re
vi
ew
 (n
=1
94
),
 fa
m
ily
 in
te
rv
ie
w
s 
(n
=1
33
),
 a
nd
 a
 p
hy
si
ci
an
 s
ur
ve
y 
(n
=8
) s
ho
w
ed
 s
ig
ni
fi-
ca
nt
 im
pr
ov
em
en
t i
n 
th
e 
m
an
ag
em
en
t o
f r
es
pi
ra
to
ry
 
sy
m
pt
om
s,
 b
ut
 n
o 
ch
an
ge
s 
in
 o
th
er
 in
di
ca
to
rs
. H
ow
-
ev
er
, t
he
 p
ro
je
ct
 le
d 
to
 s
om
e 
ch
an
ge
s 
be
in
g 
in
it
ia
te
d 
in
 in
st
it
ut
io
na
l p
ol
ic
ie
s 
an
d 
cl
in
ic
al
 m
an
ag
em
en
t.
Ki
nl
ey
, 
20
04
Q
ua
si
-e
x-
pe
rim
en
-
ta
l s
tu
dy
Pa
lli
at
iv
e 
ca
re
 u
ni
t 
/ 
U
K
N
ur
se
s 
an
d 
m
ed
ic
al
 s
ta
ff
 
(n
=3
3)
O
ra
l c
ar
e 
do
cu
m
en
ta
ti
on
, i
nc
lu
di
ng
 a
n 
as
se
ss
m
en
t 
to
ol
, o
ra
l c
ar
e 
pl
an
, a
nd
 p
ro
to
co
l 
of
 c
ar
e 
w
er
e 
im
pl
em
en
te
d.
 S
ta
ff
 r
ec
ei
ve
d 
a 
re
fr
es
he
r 
tr
ai
ni
ng
 o
n 
or
al
 c
ar
e,
 in
cl
ud
in
g 
fe
ed
ba
ck
 fr
om
 b
as
el
in
e 
au
di
t,
 t
ea
ch
in
g 
ab
ou
t 
or
al
 c
ar
e,
 d
is
cu
ss
io
n 
ab
ou
t 
pr
od
uc
ts
, 
de
m
on
st
ra
ti
on
 o
f o
ra
l c
ar
e,
 d
is
cu
ss
io
n 
an
d 
a 
vi
de
o.
 A
n 
in
fo
rm
at
io
n 
le
af
le
t 
(in
 t
he
 fo
rm
 o
f 
a 
bo
ok
m
ar
k)
 w
as
 a
ls
o 
de
ve
lo
pe
d.
Pr
e 
(n
=5
0)
 a
nd
 p
os
t-
te
st
 (n
=4
7)
 r
et
ro
sp
ec
ti
ve
 r
ev
ie
w
 
of
 p
at
ie
nt
 r
ec
or
ds
 a
nd
 p
re
te
st
-p
os
tt
es
t 
st
af
f k
no
w
l-
ed
ge
 q
ue
st
io
nn
ai
re
 (n
=2
3)
 s
ho
w
ed
 im
pr
ov
em
en
ts
 in
 
aw
ar
en
es
s 
an
d 
kn
ow
le
dg
e.
 
Ke
ay
, 
20
03
Q
ua
si
-e
x-
pe
rim
en
-
ta
l s
tu
dy
N
ur
si
ng
 
ho
m
e 
/ 
U
SA
Ph
ys
ic
ia
ns
 
(n
=1
2)
A
 h
al
f-
da
y,
 e
du
ca
ti
on
al
 o
ut
re
ac
h 
pr
og
ra
m
m
e 
ba
se
d 
on
 a
 c
ur
ri
cu
lu
m
 fo
r 
ed
uc
at
in
g 
nu
rs
in
g 
ho
m
e 
ph
ys
ic
ia
ns
 in
 p
al
lia
ti
ve
 a
nd
 h
os
pi
ce
 
ca
re
. P
ro
gr
am
m
e 
in
cl
ud
ed
 a
ud
it
 &
 fe
ed
ba
ck
, 
us
e 
of
 o
pi
ni
on
 le
ad
er
s 
an
d 
re
vi
ew
 o
f g
ui
de
-
lin
es
.
Pr
e 
an
d 
po
st
 t
es
t 
qu
es
ti
on
na
ir
es
 a
nd
 t
er
m
in
al
 c
ar
e 
au
di
t f
or
m
s s
ho
w
ed
 th
at
 th
e 
in
te
rv
en
tio
n 
w
as
 
as
so
ci
at
ed
 w
it
h 
si
gn
ifi
ca
nt
 im
pr
ov
em
en
ts
 in
 t
er
m
in
al
 
ca
re
 o
ut
co
m
es
: i
m
pr
ov
ed
 p
ai
n 
co
nt
ro
l, 
be
tt
er
 
co
nt
ro
l o
f s
ho
rt
ne
ss
 o
f b
re
at
h,
 b
et
te
r 
co
nt
ro
l o
f u
n-
co
m
fo
rt
ab
le
 s
ym
pt
om
s,
 m
or
e 
at
te
nt
io
n 
to
 h
yg
ie
ne
 
an
d 
be
re
av
em
en
t.
 In
cr
ea
se
d 
us
e 
of
 W
H
O
 c
la
ss
 3
 
m
ed
ic
at
io
ns
. D
ec
re
as
e 
in
 W
H
O
 c
la
ss
 1
 m
ed
ic
at
io
n.
 
N
um
be
r 
of
 u
ne
xp
ec
te
d 
de
at
hs
 d
ro
pp
ed
 fr
om
 3
6%
 t
o 
5%
. M
or
e 
do
cu
m
en
ta
ti
on
 o
f c
om
fo
rt
 m
ea
su
re
s.
 B
et
-
te
r d
oc
um
en
ta
tio
n 
of
 re
sid
en
ts
’ a
dv
an
ce
 d
ire
ct
iv
es
.
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ho
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og
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tt
in
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/ 
co
un
tr
y
Pa
rt
ici
pa
nt
s i
n 
in
te
rv
en
tio
n 
(n
)
De
sc
rip
tio
n 
of
 st
ra
te
gy
Re
su
lts
La
nk
-
sh
ea
r, 
20
10
Q
ua
si
-e
x-
pe
rim
en
-
ta
l s
tu
dy
H
os
pi
ta
l /
 
Ca
na
da
Ph
ys
ic
ia
ns
 
(n
=9
6)
Fu
ll-
da
y 
or
ie
nt
at
io
n 
fo
r 
cl
in
ic
ia
n 
m
en
to
rs
, 
re
gi
on
al
 e
du
ca
ti
on
 s
es
si
on
 fo
r 
cl
in
ic
ia
ns
 
an
d 
ad
m
in
ist
ra
to
rs
, p
re
se
nt
at
io
ns
 a
t r
ou
nd
s 
an
d 
de
pa
rt
m
en
t m
ee
tin
gs
 w
er
e 
us
ed
 to
 
la
un
ch
 t
he
 p
ro
je
ct
. C
lin
ic
ia
n 
m
en
to
rs
 h
el
d 
ed
uc
at
io
na
l i
nf
or
m
at
io
n 
se
m
in
ar
s 
fo
r 
sm
al
l 
gr
ou
ps
 a
nd
 in
di
vi
du
al
 p
hy
si
ci
an
s.
 U
pd
at
e 
on
 p
ro
je
ct
 w
as
 a
 s
ta
nd
in
g 
ag
en
da
 it
em
 a
t 
re
gu
la
r 
m
ee
ti
ng
s 
in
 t
he
 c
en
te
rs
. M
on
it
or
in
g 
an
d 
fe
ed
ba
ck
, i
nc
lu
di
ng
 m
on
th
ly
 c
on
fe
re
nc
e 
ca
lls
 a
nd
 m
on
th
ly
 q
ua
lit
y 
as
su
ra
nc
e 
re
po
rt
s 
on
 b
ot
h 
ce
nt
er
 a
nd
 in
di
vi
du
al
 p
hy
si
ci
an
 le
ve
l, 
w
er
e 
us
ed
 t
o 
fa
ci
lit
at
e 
on
go
in
g 
di
al
og
ue
 a
nd
 
m
ot
iv
at
e 
ph
ys
ici
an
s t
o 
im
pr
ov
e 
do
cu
m
en
ta
-
tio
n 
of
 ca
nc
er
 st
ag
e.
Pr
e 
(n
=5
2)
 a
nd
 p
os
t-
te
st
 (n
=4
2)
 q
ue
st
io
nn
ai
re
 in
di
-
ca
te
d 
th
at
 d
oc
um
en
ta
tio
n 
of
 ca
nc
er
 st
ag
e 
im
pr
ov
ed
 
on
 b
ot
h 
or
ga
ni
sa
ti
on
al
 a
nd
 p
ro
vi
nc
ia
l l
ev
el
s.
Ly
on
, 
20
07
Q
ua
si
-e
x-
pe
rim
en
-
ta
l s
tu
dy
Ca
re
 
ho
m
es
 /
 
A
us
tr
al
ia
N
ur
se
s 
an
d 
m
ed
ic
al
 s
ta
ff
 
(n
=u
nk
no
w
n)
A
n 
au
di
t-
fe
ed
ba
ck
 a
pp
ro
ac
h 
w
as
 u
se
d 
to
 
im
pl
em
en
t 
1)
 M
on
th
ly
 m
ee
ti
ng
s,
 2
) E
xt
er
na
l 
as
si
st
an
ce
: 2
.1
) a
ss
is
ta
nc
e 
w
it
h 
th
e 
de
ve
l-
op
m
en
t 
of
 a
n 
im
pl
em
en
ta
ti
on
 s
tr
at
eg
y 
an
d 
as
si
st
an
ce
 w
it
h 
sy
st
em
 c
ha
ng
es
, 2
.2
) t
w
o-
da
y 
tr
ai
ni
ng
 a
nd
 a
dd
it
io
na
l o
ne
-t
o-
on
e 
as
si
st
an
ce
 
w
it
h 
an
 e
xp
er
ie
nc
ed
 m
en
to
r, 
3)
 In
fo
rm
at
io
n 
se
ss
io
ns
 o
n 
ad
va
nc
ed
 c
ar
e 
pl
an
ni
ng
 in
cl
ud
in
g 
in
tr
od
uc
to
ry
 d
isc
us
sio
n 
an
d 
in
fo
rm
at
io
n 
ki
ts
 
fo
r 
do
ct
or
s 
w
ho
 w
er
e 
no
t 
ab
le
 t
o 
at
te
nd
 t
he
 
se
ss
io
ns
, a
nd
 4
) D
oc
um
en
ti
ng
 a
nd
 im
pl
e-
m
en
ti
ng
 g
ui
de
lin
es
. D
ur
in
g 
th
e 
co
ur
se
 o
f 
th
e 
pr
oj
ec
t,
 r
eg
ul
ar
 b
ut
 o
pt
io
na
l s
up
po
rt
 
m
ee
ti
ng
s 
w
er
e 
us
ed
 t
o 
di
sc
us
s 
pe
rs
on
al
 
en
co
un
te
rs
. A
t 
th
e 
en
d 
of
 t
he
 p
ro
je
ct
, a
 s
ho
rt
 
se
ss
io
n 
ab
ou
t 
ad
va
nc
ed
 c
ar
e 
pl
an
ni
ng
 w
as
 
ad
de
d 
to
 a
 m
an
da
to
ry
 st
ud
y 
da
y.
Pr
e 
an
d 
po
st
-im
pl
em
en
ta
ti
on
 a
ud
it
 o
f r
es
id
en
ts
’ 
fil
es
 (n
=4
6)
 in
di
ca
te
d 
im
pr
ov
em
en
ts
 in
 d
oc
um
en
t-
ed
 e
vi
de
nc
e 
th
at
 t
he
 r
es
id
en
t 
ha
s 
be
en
 in
vo
lv
ed
 
in
 a
dv
an
ce
d 
ca
re
 p
la
nn
in
g,
 s
ig
ni
fic
an
t 
ot
he
rs
 h
av
e 
ha
d 
th
e 
op
po
rt
un
it
y 
to
 b
e 
in
vo
lv
ed
 in
 a
dv
an
ce
d 
ca
re
 p
la
nn
in
g 
an
d 
th
er
e 
is
 e
vi
de
nc
e 
of
 o
ng
oi
ng
 
as
se
ss
m
en
ts
. P
re
- a
nd
 p
os
t-
im
pl
em
en
ta
ti
on
 a
ud
it
 o
f 
st
af
f (
n=
6)
  i
nd
ic
at
ed
 t
ha
t 
ad
va
nc
ed
 c
ar
e 
pl
an
s 
ar
e 
m
or
e 
re
gu
la
rl
y 
co
m
pl
et
ed
 a
nd
 im
pl
em
en
te
d 
af
te
r 
re
ce
iv
in
g 
tra
in
in
g.
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Re
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M
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U
SA
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or
ke
rs
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ci
al
 w
or
ke
rs
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ci
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te
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 c
lin
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n 
ed
uc
at
io
n,
 lo
ca
l c
ha
m
pi
on
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ev
el
op
m
en
t 
an
d 
fe
ed
ba
ck
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f f
am
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 s
at
is
fa
ct
io
n 
da
ta
.
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e 
(n
=6
6)
 a
nd
 p
os
t-
te
st
 (n
=6
0)
 fa
m
ily
 s
at
is
fa
c-
ti
on
 q
ue
st
io
nn
ai
re
 a
nd
 p
re
 a
nd
 p
os
t-
te
st
 (n
=1
5)
 
qu
es
ti
on
na
ir
e 
fo
r 
so
ci
al
 w
or
ke
rs
 in
di
ca
te
d 
de
cr
ea
se
d 
fa
m
ily
 s
at
is
fa
ct
io
n 
(n
ot
 s
ig
ni
fic
an
t)
. I
nc
re
as
ed
 y
ea
rs
 
as
 a
 s
oc
ia
l w
or
ke
r 
ha
d 
a 
si
gn
ifi
ca
nt
 a
nd
 p
os
it
iv
e 
ef
fe
ct
 o
n 
fa
m
ily
 s
at
is
fa
ct
io
n 
an
d 
in
cr
ea
se
d 
ca
se
lo
ad
 
ha
d 
a 
si
gn
ifi
ca
nt
 a
nd
 n
eg
at
iv
e 
ef
fe
ct
 o
n 
fa
m
ily
 s
at
is
-
fa
ct
io
n 
w
it
h 
so
ci
al
 w
or
ke
rs
. S
ig
ni
fic
an
t 
in
cr
ea
se
 in
 4
 
of
 t
he
 1
4 
re
po
rt
ed
 a
ct
iv
it
ie
s:
 d
is
cu
ss
in
g 
sp
ir
it
ua
l/
re
-
lig
io
us
 n
ee
ds
 w
it
h 
th
e 
fa
m
ily
, t
al
k 
w
it
h 
fa
m
ily
 a
bo
ut
 
to
uc
hi
ng
 t
he
ir
 lo
ve
d 
on
e,
 ta
lk
 w
it
h 
fa
m
ily
 a
bo
ut
 
di
sa
gr
ee
m
en
ts
 in
 t
he
 p
la
n 
of
 c
ar
e,
 a
nd
 a
ss
ur
in
g 
th
e 
fa
m
ily
 t
ha
t 
th
e 
pa
ti
en
t 
w
ou
ld
 b
e 
ke
pt
 c
om
fo
rt
ab
le
. 
N
o 
im
pr
ov
em
en
t 
in
 s
oc
ia
l w
or
ke
rs
’ s
at
is
fa
ct
io
n 
w
it
h 
m
ee
ti
ng
 fa
m
ili
es
’ n
ee
ds
 o
r 
fa
m
ily
 r
at
in
gs
 o
f s
oc
ia
l 
w
or
ke
rs
.
M
ir
an
do
, 
20
05
Q
ua
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l s
tu
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H
os
pi
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U
K
N
ur
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ys
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an
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af
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er
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m
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ist
ra
tiv
e 
an
d 
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ic
al
 
st
af
f (
n=
un
-
kn
ow
n)
A
 c
ar
e 
pa
th
w
ay
 w
as
 in
tr
od
uc
ed
 t
o 
12
 c
lin
ic
al
 
ar
ea
s 
of
 a
 h
os
pi
ta
l v
ia
 m
ul
ti
di
sc
ip
lin
ar
y 
tr
ai
n-
in
g,
 a
ud
it 
an
d 
fe
ed
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m
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 p
ro
je
ct
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 m
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ra
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fie
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 d
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 re
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 m
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di
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 d
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se
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ia
l o
ra
l d
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 c
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-
m
un
ic
at
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n 
w
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e 
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m
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w
in
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 t
ra
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ue
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en
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f c
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 m
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ra
m
m
es
 in
vo
lv
ed
: r
ot
at
io
n 
of
 1
2 
se
ss
io
ns
 o
n 
pa
in
 m
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 c
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 d
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 p
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r s
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 p
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 m
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 c
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 d
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in
te
rv
en
ti
on
 a
ud
it
 (n
=2
0)
 s
ho
w
ed
 t
ha
t 
th
e 
pa
th
w
ay
 is
 b
ei
ng
 u
se
d 
du
ri
ng
 d
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 d
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 p
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 p
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pe
ri-
m
en
ta
l 
st
ud
y
N
ur
si
ng
 
ho
m
e 
/ 
U
SA
Un
kn
ow
n
Cl
in
ic
al
 le
ad
er
sh
ip
 t
ea
m
 v
is
it
ed
 t
w
o 
co
n-
fe
re
nc
es
: o
ne
 p
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 m
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 m
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at
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 o
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’ c
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 c
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ig
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re
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 c
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 p
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at
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 c
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 d
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 p
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) p
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 re
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c p
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at
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 d
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 p
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 c
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, d
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, b
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 c
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 d
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 d
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f d
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at
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 p
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, p
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ra
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 c
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at
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w
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 s
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 d
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 c
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 p
at
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 re
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, f
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 p
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Abstract
Background: Interventions to improve palliative care encounter challenges 
beyond the usual implementation problems because of palliative care’s complex 
and changing characters. In this study, we explored barriers and facilitators faced 
by healthcare professionals in five European countries (England, Germany, Italy, 
Norway, and the Netherlands) with regard to improving the organisation of their 
palliative care service. 
Methods: Semi-structured individual and focus group interviews were conducted 
with purposefully selected health-care professionals. The constant comparative 
method was used to analyse the data. 
Results: Professionals working in hospitals, hospices, nursing homes and primary 
care facilities who provide palliative care to adult patients, were interviewed 
(n=40) or participated in ten focus group interviews (n=59). Barriers and 
facilitators were inductively grouped into 16 categories and arranged into five 
themes: innovation, individual professional level, group dynamics, organisational 
context and local political-economic context. Although the barriers and facilitators 
identified differed in scope, context, strength and provenance, they were shared 
by professionals from different European countries.
Conclusion: This study identified barriers and facilitators to organisational change 
in palliative care. Some of these barriers and facilitators were experienced 
by professionals in almost all countries and are therefore prerequisites to 
change. Understanding the barriers to and facilitators of change will help tailor 
organisational improvements to the needs of individuals and organisations.
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Background
Palliative care aims to preserve the best possible quality of life of the patient whose 
disease is not responsive to curative treatment1. Improvements in palliative care 
usually focus on pain and symptom control, use of standardised assessment tools, 
care in the last days of life and the quality of dying2,3. To date, improving specific 
organisational aspects of palliative care has received less attention3. 
Interventions to improve the organisation of palliative care encounter challenges 
beyond the usual problems of implementation of change in healthcare. Patients 
in need of palliative care often move between services, have changing (and 
often increasing) needs for treatment and support, have multiple problems and 
symptoms4 and receive care from a variety of professionals5. This requires optimal 
collaboration between patients, informal carers and a range of professionals and 
healthcare organisations1,6. In order to overcome these challenges and improve 
the organisation of palliative care, systematic implementation to translate the 
results of clinical research into everyday clinical routines is necessary7. A first 
step in a systematic implementation process is the identification of barriers and 
facilitators7. Recent studies have provided some insights in possible barriers and 
facilitators related to changing the organisation of other fields in healthcare, for 
example in the handover of care8, case management9 and the introduction of 
nursing guidelines10. However, studies on improving the organisation of palliative 
care are still lacking.
For this reason, the objective of this study was to identify barriers to and 
facilitators of improvements in the organisation of palliative care in Europe. The 
results from this study will be used in the European Seventh Framework IMPACT 
project (IMplementation of quality indicators for PAlliative Care sTudy) to develop 
and tailor national and setting-specific strategies to improve the organisation of 
palliative care in England, Germany, Italy, Norway and the Netherlands11. 
Methods
A qualitative design, with semi-structured individual and focus group interviews, 
was used. Individual interviews were conducted in order to gain professionals’ 
understanding of barriers and facilitators to improve the organisation of palliative 
care12. Focus group interviews were used to reflect the social and cultural contexts 
of barriers and facilitators to improve the organisation of palliative care13. 
Participants and settings
The study took part in England, Germany, Italy, Norway and the Netherlands. 
Participants of the individual and focus group interviews were purposefully 
selected healthcare professionals working in services providing palliative care. 
Besides professionals working in hospitals, hospices and primary care settings, 
also nursing home professionals were included because of the growing population 
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in such settings in need of palliative care. Services which have been providing 
palliative care for adult patients for at least 2 years were eligible for this study. 
In each country a snowballing method was used to select professionals for the 
individual and focus group interviews: all professionals approached were asked 
to nominate other professionals14. Professionals were included if they were either 
clinically involved in palliative care (e.g. nurses and physicians) or in the organisation 
of palliative care (e.g. managers of a specific palliative care service) and if they had 
at least 1-year professional experience in palliative care. Recruitment continued 
until no new themes or information was coming out of the interviews.
Data collection
A semi-structured interview guide, based on the literature and previous 
experiences of the research team, was developed and used to guide both 
individual interviews and focus groups7. Questions of the interview guide were 
refined during an international research meeting with researchers of the IMPACT 
project (appendix 1). To test the interview guide, at least two pilot interviews were 
conducted per country. Interview and focus groups were recorded with either 
written or verbal consent of the participants, and transcribed verbatim using an 
agreed transcription format. All focus group interviews were led by experienced 
moderators. 
Data analysis
Analysis started after the first interview. In each country, researchers (see appendix 
2) condensed data and suggested codes closely related to the text fragments 
by using a constant comparative method15. To control for subjectivity, two 
researchers per country independently coded the data. Software for the analysis 
of qualitative data (such as Atlas.ti and MAXQDA) was used to facilitate the coding 
process. Codes and associated text fragments were translated into English and 
shared between the researchers. At an international IMPACT research meeting, 
the interview guide was evaluated and adapted where necessary and a consensus 
codebook was made. Next, this codebook was used by the researchers for the 
analysis of the remaining interview and focus group data: two researchers in each 
country discussed the codes until consensus was reached. When no consensus 
could be reached, a third researcher was consulted. Categories were derived from 
the codes and discussed between the researchers in the five countries via email 
and Skype meetings. Per country, a report was produced, summarising the barriers 
and facilitators to improve the organisation of palliative care in the respective 
countries. Two researchers (JvRP and FB) compared all these reports of the 
individual countries, applying an adapted version of the Grol and Wensing model16 
for understanding change at different levels of healthcare in order to organise 
the barriers and facilitators into categories. The adapted model consisted of five 
themes instead of six: innovation, individual professional level, group dynamics, 
organisational context and local political - economic context. Categories were fed 
back and checked with researchers from each country. 
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Ethical considerations
The Medical Ethics Committee of the district Arnhem-Nijmegen has declared that 
this study does not fall within the remit of the Medical Research Involving Human 
Subjects Act (WMO) (registration number 2012/075). This means that this study 
can be carried out without an approval by an accredited medical ethics committee.
Results
In total, 40 professionals were interviewed and another 59 participated in 10 
focus group interviews (table 1). They were spread evenly in all major services 
providing palliative care, including hospitals, hospices, nursing homes and primary 
care facilities.
Barriers and facilitators were inductively categorised into 16 categories and 
organised into themes, using the adapted model for understanding change at 
different levels of healthcare16. Table 2 provides an overview of the framework 
with categories, barriers and facilitators, and associated quotes in each theme. 
Table 3 provides an overview of the categorised barriers and facilitators per 
country. The themes and categories are summarised below.
Table 1: Interviewee characteristics
EN DE IT NO NL
# Interviews 4 2 11 10* 9*
   Male - - 4 1 5
   Female 4 2 7 11 6
   Physicians 3 - 8 3 5
   Nurses 1 1 2 3 5
   Social worker - 1 - - -
   Psychologist - - 1 - -
   Managers - - - 6 1
# Focus groups 1 3 2 2 2
   Male - 6 6 1 4
   Female 2 9 8 8 15
   Physician - 5 6 - 6
   Nurses 2 6 3 9 4
   Social worker - 1 - - -
   Psychologist - - 1 - 1
   Manager - - - - 1
   Other - 3 4 - 7
EN: England; DE: Germany; IT: Italy; NO: Norway; NL: The Netherlands
* In both Norway and the Netherlands, two interviews were conducted with two inter-
viewees. The number of interviews (n=36) is therefore lower than the actual number of 
interviewees (n=40).
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Table 2: Themes, categories, codes, and associated quotes
Themes Categories Codes Associated quotations
Innovation Accessi-
bility
Time of train-
ing, Availability 
of education, 
Frequency of 
contact
[…] we are trying to organise different moments 
during the year when all our professionals come 
here […] to update all together their training 
program (psychologist, primary care, Italy).
Attractive-
ness
Method of 
presentation, 
(lack of) tailor-
ing, Extrinsic 
motivation, 
Extrinsic incen-
tives
Cases were presented, cases from our own 
organisation, cases which really increased 
motivation of the staff (manager, hospice, The 
Netherlands).
Usefulness 
of change
Usefulness, 
Impact of 
research, Use 
of new knowl-
edge
[…] it is important that you will also see the 
results of what you are doing (nurse, hospice, 
The Netherlands).
Individual 
profession-
al level
Attitude Intrinsic inter-
est, Intrinsic 
motivation, 
Decision mak-
ing process
[…] I say ‘interest’, I don’t know - but maybe it 
is more interest in end of life care or dementia 
or whatever and that obviously makes life a lot 
easier when new initiatives and services are 
available (nurse, hospice, England).
Not all professionals have the proper motiva-
tion, time, availability or willingness to involve 
themselves in something that goes beyond their 
daily work (psychologist, primary care service, 
Italy).
Profes-
sional 
skills
Practitioner 
autonomy, 
Placing 
responsibility,  
Stepwise intro-
duction of new 
responsibilities
We [physicians] used to administer the 
chemotherapy. This has now been completely 
delegated to the nurses. […] the doctor became 
more an observer. […] the number of patients 
has increased, so you could not sit there and 
watch the treatment proceed for 3 hours, so 
things had to change. The nurses’ competence 
is much, much more extensive than before (phy-
sician, hospital, Norway). 
Knowl-
edge
Level of 
knowledge, 
Knowledge of 
palliative care 
services, (lack 
of) skills, (lack 
of) experience
If you only experience 20-25 deaths per year 
within the entire organisations, it is difficult for 
the individual nurse to maintain the necessary 
skills to care for these patients (physician, nurs-
ing home, The Netherlands).
Nurses need to know what they can improve 
before they can improve [...] (physician, nursing 
home, The Netherlands). 
Aware-
ness
(lack of) 
awareness of 
palliative care
We should make professionals understand that 
palliative care doesn’t represent the last step 
[…] (physician, hospice, Italy).
Despite all our efforts and education provided, 
there isn’t a culture about palliative care in 
everyone yet. For example, it is frustrating when 
GPs don’t refer their patients to us because they 
are still conscious (nurse, hospice, Italy).
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Group 
dynamics
Team 
climate
(lack of) group 
support, 
Culture of 
change, Fear 
and avoidance, 
Participation
The team doesn’t support each other, [...] those 
who are motivated to change are so few that 
it is too difficult for them to stand up against 
those who are against changes (manager, hos-
pice, The Netherlands).
We were trained so traditionally that most of 
the time, the doctors led the meetings. The 
others who were present just sat there and an-
swered the questions they were asked, instead 
of considering themselves as equal members 
of the team with an active role in the meeting 
(manager/nurse, palliative care unit, Norway).
Network Forced 
network, 
Knowing other 
professionals 
/ services, 
Competition 
between 
services
[…] there is an increasing number of services 
and offers, meaning it is becoming much more 
complicated […] (social worker, palliative care 
unit, Germany).
[…] within such a network, people interact who 
cannot stand each other, but we ask them to do 
so (physician, nursing home, The Netherlands).
Profes-
sional 
guidance
Role modeling, 
Mentoring, 
Feedback
We have a retired GP who is really good, […] 
who goes out to see the GPs in […] that worked 
really well, he was well regarded in his role. So, 
of course, him going back to the GPs, they think 
that’s marvelous, you know, they respect him 
(nurse, hospice, England).
With that colleague I took the time to discuss  
what the possibilities were and showed him 
what he could improve. This practical contact 
really made a difference (physician, hospital, 
The Netherlands)
Organi-
sational 
context
Organi-
sational 
processes
Physical struc-
tures, Manag-
ing complex-
ity, Extrinsic 
interest, Use 
of technology
[…] we need to work a lot with temporary 
personnel, which brings along the problem that 
they cannot take part in meetings of quality 
circles. This means that it is extremely difficult 
to implement agreed standards (head nurse, 
primary care, Germany). 
Organi-
sational 
structures
Structure of 
organisation, 
Place of care
[…] the hospital itself has changed from being 
one big building to several big buildings. We 
used to meet colleagues in the cantina. But now 
we’re too busy, so we never go to the cantina 
and if you do, you go to different cantinas, so 
you don’t meet colleagues like you used to. The 
lobbying you could do earlier, you can’t do that 
anymore (physician, hospital, Norway).
Staff Staff size, 
Staff turnover, 
Availability of 
staff, Hiring 
new staff, 
Depletion of 
other service, 
[...] sometimes you have to deal with a culture 
that is very much dependent on the persons 
working there. If some of these persons leave, it 
becomes very difficult to maintain innovations 
(physician, nursing home, The Netherlands).
[…] there are only few people interested in 
qualifying, choosing this profession is becoming 
increasingly unattractive […] (physician, pallia-
tive care unit, Germany).
Time Time 
constraints, 
Burden of 
information
[…] so busy with caseload stuff that you haven’t 
got the time or as much time as you’d like to do 
that education bit and training (nurse, hospice, 
England).
[…] you are so busy every day that you don’t 
find the time to meet people (physician, pallia-
tive care unit, Norway).
Table 2: Continued
104
Chapter 5
Innovation
Three categories emerged: (1) accessibility of improvement strategies, (2) 
attractiveness of improvement strategies and (3) usefulness of change. 
Accessibility of improvement strategies
Interviewees in Italy, Norway and the Netherlands stated that it is important that 
improvement strategies (such as education) are arranged in a way that as many 
professionals of the same team as possible can participate. Professionals in the 
Netherlands also stated that they perceived restricted access to the improvement 
strategies as a barrier, for example when the training frequency was low.
Attractiveness of improvement strategies
Professionals in Italy, Norway and the Netherlands considered the attractiveness of 
improvement strategies important. They stated that the perceived attractiveness 
of an improvement strategy increases when it is tailored to the needs of the service 
in question. Interactive educational methods and enthusiasm and motivation of 
those responsible were considered important contributors to the attractiveness 
of an improvement strategy. The attractiveness of quality improvement projects 
was also facilitated by certifying participants for their participation, e.g. for having 
received education. 
Usefulness of change
Perceived usefulness of quality improvement projects was mentioned as an 
important facilitator by professionals in all countries except England. Professionals 
Economic 
and politi-
cal context
Financial 
arrange-
ment
(lack of) re-
sources, Finan-
cial aspects, 
Financial 
incentives
If you […] need an additional employee […], 
this will cost money. If I don’t have the money, 
I won’t have the employee, if I don’t have the 
manpower for this task, I may put less effort 
in documentation work. And if then someone 
comes and says: The documentation is not 
appropriate ... Well, what would be the reason? 
Lack of resources. I think, this is where one 
shoots oneself in the foot (physician, hospital, 
Germany).
Other medical areas […] receive funding from 
large (pharmaceutical) industries. Palliative 
care doesn’t have that kind of support (general 
practitioner, The Netherlands).
Regula-
tions
Availability 
of (existing) 
guidelines/ 
rules, For-
malisation of 
change
Everything, […] yes, it needs to be in concord-
ance with the principles of the whole organisa-
tion (director, nursing home, Germany).
When palliative care was introduced, the 
national organisation was primarily focused to 
improve cure within the hospital and not care 
within primary care (general practitioner, The 
Netherlands).
Each citation is supplemented with the type of profession, setting and country of the 
professional involved.
Table 2: Continued
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were, for example, more motivated to collect data to measure the quality 
improvement or use specific tools when these activities benefitted their own 
clinical practice.
Individual professional level
Four categories were related to this theme: (1) professional skills, (2) attitude of 
professionals, (3) knowledge and (4) awareness of palliative care.
Professional skills
The introduction of new professional skills, which are expected to become part of 
behavioural routines, was mentioned as an important facilitator for the success of 
quality improvement projects by professionals in all countries but the Netherlands. 
A Norwegian professional, for example, clarified that the education nurses receive 
now is much more extensive than it used to be, enabling task delegation from 
physician to nurse.
Attitude of professionals
A positive attitude of professionals regarding improvements was considered an 
important factor for the success of quality improvement projects by professionals 
in all countries. Participation in staff training is, for example, facilitated when staff 
members are motivated and have an interest in the topic. Professionals in England, 
Germany, Italy and the Netherlands also stated that reluctance of professionals, 
as well as of organisations, to participate contributes to erroneous beliefs about 
palliative care, adherence to obsolete routines and may be due to the pressure on 
the organisation to participate in many improvement projects. 
Knowledge and awareness of palliative care
Knowledge and awareness of palliative care were mentioned by professionals in 
Germany, Italy, Norway and the Netherlands. Professionals in Italy, for example, 
described that there is a general lack of awareness about palliative care, and 
professionals in the Netherlands stated that their managers considered palliative 
care unimportant, because they were not aware of what palliative care actually 
is. However, they also stated that by improving their knowledge, their motivation 
and interest to change increased.
Group dynamics
Three categories emerged: (1) professional guidance, (2) team climate and (3) 
participation in a network.
Professional guidance
Professionals in England, Norway and the Netherlands mentioned that 
professionally guiding people in their practice and performance, such as role-
modelling and mentoring, has a positive effect on their performance, and was 
therefore perceived as facilitator for many change strategies. 
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Team climate
The importance of a positive team climate was mentioned by professionals in 
Germany, Italy, Norway and the Netherlands. Top-down implementation, for 
example, was not considered to be effective. A well-balanced team with the 
involvement of staff in decision making regarding implementation of changes 
was in general considered more effective. Also, several interviewees reported 
that some of their colleagues were reluctant to change, which decreased the 
motivation of the team to change. Existing norms and values which were difficult 
to change, were the underlying reasons for this reluctance. In the Netherlands, 
being involved in too many improvement projects at the same time was perceived 
as an exhausting factor for the team.
Participation in a network
Being part of a palliative care network was an important facilitator in Italy, Norway 
and the Netherlands. Professionals involved in a network mentioned that it 
helped them to know other professionals in their organisation, making it easier 
to initiate quality improvement projects. However, participation in networks was 
also perceived as a barrier since issues of collaboration and communication took 
up too much time at the expense of other improvement strategies (in Norway), 
involved cooperation with people that sometimes was perceived as difficult (in 
the Netherlands) and resulted in competition between services to get funded 
(also in the Netherlands).
Organisational context 
There are four categories in this theme: (1) organisation of care processes, (2) 
organisational structure, (3) availability of staff and (4) availability of time to 
implement improvement strategies.
Organisation of care processes
Professionals in England, Germany, Italy and the Netherlands stated that it is easier 
to implement changes when they are in harmony with the general principles of 
care of their institution. It was also mentioned that having access ‘to the right 
people’ (e.g. management) made it easier to initiate quality improvement projects. 
Organisational structure
The infrastructure of a service (e.g. physical and spatial structure of the building 
where it is located but also the hierarchical structure of the organisation) was 
mentioned as a barrier by German, Norwegian and Dutch professionals. For 
example, spending too much time travelling within or between buildings and a 
shortage of facilities such as rooms for educational activities, were perceived as 
barriers.
Availability of staff
Staff shortages were especially experienced in England, Norway and the 
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Netherlands. Not having enough staff to allow training without disruption of 
clinical care created difficulties in improving the organisation of palliative care. 
High staff turnover results in a never-ending need for training while the services 
do not have the resources to supply this demand, resulting in professionals having 
little time to update themselves professionally. However, in services with extra 
financial resources, hiring extra staff to work shifts for the permanent employees, 
facilitated their participation in educational sessions. Norwegian professionals 
commented that recruiting experienced personnel is a rather quick way of 
increasing palliative care expertise amongst staff. However, they also stipulated 
that this is not always a good solution since it will deplete other services.
Availability of time
Lack of available time to participate in improvement projects was perceived 
as an important barrier in all countries, but mentioned from two perspectives. 
Firstly, professionals are faced with extreme time constraints in their clinical work, 
which limits their availability for training, participation in improvement projects 
and keeping up to date with new knowledge. Secondly, quality improvement 
projects may require strategies that take a considerable amount of time to 
implement, which consequently puts an additional burden on the professionals 
and organisation. In Germany, lack of time was also considered a facilitator if the 
innovation would result in saved time, as it helped to focus on the benefits of 
change.
Local political-economic context
Two categories emerged: (1) financial arrangements and (2) effective organisational 
regulations.
Financial arrangements
In all countries, interviewees mentioned that extrinsic financial incentives are 
crucial for the effectiveness of implementation strategies designed to promote 
service improvement. For example, there has been a lack of recruitment in 
services in England and Norway due to financial barriers, because specialist staff 
were considered too expensive. Financial constraints also resulted in truncation of 
quality improvement projects, limiting their effect.
Organisational regulations
Interviewees in all countries except for Germany reported that they experienced 
existing regulations on a national, regional and local level both as a facilitator as 
well as a barrier to changing practice. Professionals considered them a facilitator 
because clear organisational regulations facilitated participation in quality 
improvement projects and ensured the quality of care. However, interviewees 
in the Netherlands perceived them as a barrier because new regulations caused 
them a lot of extra work. In Italy, some professionals mentioned that the fixed 
number of certain staff in nursing homes (e.g. not enough staff in relation to the 
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number of patients) negatively affected their work and consequently the success 
of improvement projects. Professionals in England and Norway also mentioned 
that policies and guidelines in place to protect patient information can, for 
example, also limit the use of innovative quality improvement strategies, such as 
the use of an electronic patient file.
Discussion
This study identified barriers and facilitators to improve the organisation of 
palliative care. They could be arranged in five themes as described by Grol, 
being the innovation itself, the individual professional level, group dynamics, 
the organisational context and the local political-economic context16. All themes 
appeared to be related to structures and processes of care, as described in 
the Donabedian Model17. Although the barriers and facilitators differ in scope, 
context, strength and provenance, most of them were shared by professionals 
from different European countries. However, when comparing barriers and 
facilitators cross-nationally, differences in the provision of palliative care should 
be considered. For example, the national health-care system and organisation of 
palliative care differs in the five participating countries. As shown elsewhere, all 
five countries have legislation about palliative care18,19. Despite broadly similar 
legal frameworks, access to palliative care services differs between countries20. 
There are, for example, cultural barriers in Italian society that refrain patients from 
receiving adequate and timely palliative care18,21. Although such barriers were not 
reported by professionals in the other countries, some of them experienced a lack 
of awareness, but then primarily caused by a lack of knowledge about palliative 
care of their superiors. Furthermore, the availability of palliative care services also 
differed between countries. However, even though, hospices are not available in 
Norway and Italy does not have palliative care units in hospitals18, patients receive 
palliative care in other types of services, whereby most services provide palliative 
care in agreement with the World Health Organisation’s definition of palliative 
care18,22. 
Differences were found not only between countries but also within countries, such 
as regional or setting-specific regulations. Sometimes, the same aspect appeared 
to be a facilitator in one service and a barrier in another. In the Netherlands, for 
example, networking was considered a facilitator in one service as it resulted 
in knowing other professionals, but a barrier in another service, as economic 
regulation caused competition between services. 
Despite these national differences, it appeared that similar barriers and facilitators 
regarding the organisation of palliative care existed in different countries. For 
example, team climate was mentioned as an influential factor by professionals 
in all countries but England, and organisational processes were mentioned by 
professionals in Germany as well as in the Netherlands. Financial resources and 
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a positive attitude to change were mentioned by professionals in all countries, 
suggesting that, for example, sufficient funding and the motivation of staff are a 
prerequisite to change. Facilitators that were mentioned as a barrier when absent 
(e.g. attractiveness of improvement strategies) could also be considered as an 
essential requirement to change.
Several facilitators identified in this study are comparable to those found in other 
studies in healthcare, like flexibility of timing educational sessions23, enthusiastic 
and active initiators24 and intrinsic motivation of the team members25. Comparable 
barriers are lack of awareness25, lack of training and guidance26, fear of change26, 
time constraints21, staff shortages21,27, lack of funding21,27 and lack of adherence 
to guidelines28. The factors identified in our study are therefore not unique to 
palliative care, but it appears that there are similarities between the organisation 
of care in different services and countries. Even though the factors may not be 
unique, the combination of them is relevant because of the complexity of palliative 
care21. Patients in need of palliative care, for example, have multiple problems 
and symptoms resulting in changing (and often increasing) needs for treatment 
and support4. Consequently, they receive care from a variety of professionals in 
different types of services1,6. This requires multidisciplinary teamwork and a good 
division of tasks and responsibilities1,6. However, the multidisciplinary approach in 
palliative care is also what makes it more difficult to change the organisation of 
palliative care5. In our study, a Norwegian interviewee, for example, pointed out 
that because staff were trained so traditionally, physicians led the team meetings, 
while the other staff present did not participate. West et al. described ‘participation 
safety’ as defined by the extent to which a team participates in making decisions 
and whether team members feel psychologically safe in proposing new ideas, 
as a factor that can influence teamwork29. In this case, ‘participation safety’ was 
not possible because of the attitude of the nurses and the social pressure of the 
physicians. Together with self-efficacy, attitude and social-influence are the main 
determinants of the ASE-Model (Attitude, Social-influence and self-Efficacy)30, 
which in itself is derived from the theory of planned behaviour31. Knowing these 
determinants can facilitate adaptation of improvement strategies in order to 
achieve the planned behaviour of the nurses. However, only few implementation 
models translating the results of research into clinical routines recommend 
to perform a detailed analysis of barriers and facilitators before starting the 
intervention7,32. For example, the widely used framework for the development 
and evaluation of complex interventions to improve health of the UK Medical 
Research Council, does not consider such uncertainties until the pilot testing of 
the intervention33. The PDSA-cycle (Plan-Do-Study-Act) does not even explicitly 
mention a barriers and facilitators analysis34. Although most implementation 
studies refer to one of these models, only few studies actually perform a barrier 
and facilitator analysis before starting to implement an intervention35. The barriers 
and facilitators identified in this study will be used in the IMPACT project to tailor 
country and setting-specific intervention strategies to improve the organisation of 
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palliative care in 40 services across Europe. 
Strengths and limitations
A strength of this study is that it is a large study, conducted with individual and focus 
group interviews in five European countries. Professionals working in the field of 
palliative care in hospitals, hospices, primary care settings and nursing homes were 
included. The results of our study can therefore be used in a variety of services, 
addressing not only patients with cancer, but also patients with dementia in need 
of palliative care. A limitation of this study is that the interviews were conducted 
in five different languages. Although a common format was used for transcription 
and translation and meanings were reviewed in consensus meetings, different 
native languages may have caused differences in interpretation. Second, the aim 
of this study was to identify barriers and facilitators to improve the organisation 
of palliative care in different European countries. A second limitation is therefore 
that factors shaping strategies for service changes may be system-specific and not 
identified in our sample. 
 
Conclusion
This study identified barriers and facilitators to organisational change in palliative 
care. Some of these barriers and facilitators were experienced by professionals in 
almost all countries and are therefore prerequisites to change. In order to promote 
successful implementation of change, it is important to tailor an organisational 
improvement to the needs of individuals and organisations. Understanding the 
barriers to and facilitators of change is essential for such tailoring.
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Appendix 1
Interview guide
Theme Aim Questions / probes
1. Identify-
ing known 
improvement 
strategies
To identify strate-
gies that have been 
recently used to 
improve (the organ-
isation of) palliative 
care in the particular 
setting.
Tell me about the organisation you are in.
Probes:
• How does the organisation differ from the 
organisation in the past?
• Can you give an example...
• What was changed
• How was it changed
2. Identifying 
barriers and 
facilitators
To identify factors 
(barriers and facilita-
tors) that influence 
strategies to improve 
palliative care in the 
setting.
What are barriers/is helpful to improvement 
strategies used in your setting to improve 
palliative care?
Probes:
• Can you tell more about...
• How does that influence daily work?
• Can you give examples...
• What is your experience with...
• Are there any other influencing factors you 
can think of?
3. Identifying 
potential strat-
egies
To identify potential 
(future) strategies to 
improve the organisa-
tion of palliative care 
in the setting, taking 
the factors that in-
fluence the provision 
of palliative care into 
account.
So what are you going/do you like to do next 
in your service?
Probes:
• Why this strategy?
• Can you think of the consequences of such 
a strategy being used?
• What do you need to improve palliative 
care?
• Would [example strategies] work in your 
setting? If so why?; If not why?
4. Supplement To identify important 
aspects in the provi-
sion of palliative care 
that have not  been 
discussed yet.
What do you think is really good?
If you can recommend to other settings or 
countries a strategy to improve palliative care 
that works well in your setting, what would 
that be? 
If you can think of existing strategies to 
improve palliative care that you wouldn’t 
recommend to other settings or countries, 
what would that be?
Is there anything else you would like to 
discuss?
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Appendix 2
Researcher information
Country Researcher Professional Background
England ND Researcher (PhD student) at University College London, with 
a professional background in psychology. Responsible for the 
interviews and analysis in England.
Germany BJ Senior researcher at the Universities of Bonn and Göttingen, 
with a professional background in philosophy. Responsible for 
the interviews and analysis in Germany.
Italy EM Researcher at the University of Bologna, with a professional 
background in psychology. Responsible for the interviews and 
analysis in Italy.
Norway RS Researcher (PhD student) at the Norwegian University of 
Science and Technology, with a professional background in so-
ciology. Responsible for the interviews and analysis in Norway.
The 
Netherlands
JvRP Researcher (PhD student) at the Radboud university medical 
center, with a professional background in health sciences 
and nursing. Responsible for the interviews and analysis in 
the Netherlands, and for the comparison of data between 
countries.
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Abstract
Background: In the past decades, many new insights and best practices in 
palliative care, a relatively new field in healthcare, have been published. However, 
this knowledge is often not implemented. The aim of this study therefore was to 
identify strategies to implement improvement activities identified in a research 
project within daily palliative care practice.
Methods: A nominal group technique was used with members of the IMPACT 
consortium, being international researchers and clinicians in cancer care, dementia 
care and palliative care. Participants identified and prioritised implementation 
strategies. Data was analysed qualitatively using inductive coding.
Results: Twenty international clinicians and researchers participated in one of 
two parallel nominal group sessions. The recommended strategies to implement 
results from a research project were grouped in five common themes: 1. 
Dissemination of results e.g. by  publishing results tailored to relevant audiences, 
2. Identification and dissemination of unique selling points, 3. Education e.g. 
by developing e-learning tools and integrating scientific evidence into core 
curricula, 4. Stimulation of participation of stakeholders, and 5. Consideration of 
consequences e.g. rewarding services for their implementation successes but not 
services that fail to implement quality improvement activities.
Discussion: The added value of this nominal group study lies in the prioritisation by 
the experts of strategies to influence the implementation of quality improvement 
activities in palliative care. Efforts to ensure future use of scientific findings should 
be built into research projects in order to prevent waste of resources. 
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Background
Palliative care is an approach that aims to improve the quality of life of patients 
facing problems associated with life-limiting illnesses, and their relatives1. A 
growing numbers of new insights and best practices in palliative care are being 
disseminated via scientific publications and presentations, yet they are often not 
implemented in daily practice2. Failure to implement research findings  leads to 
bias, unnecessary duplication of studies and suboptimal patient outcomes3,4. In 
the USA, for example, only about 55% of the patients received recommended 
care5.
Chalmers et al. state that about 85% of the global annual investment in biomedical 
research is currently wasted6, even though effective strategies and models for 
stepwise implementation of new evidence exist. Examples of such strategies and 
models include the UK Medical Research Council’s framework for the development 
and evaluation of complex interventions to improve health7, the Plan-Do-Study-
Act cycle8, or the stepwise implementation model of Grol et al.2. Yet the use of 
such implementation models is often restricted to the time frame after a research 
project closes. It is a challenge to continue implementation of new evidence 
and best practices in daily clinical practice after the research or implementation 
project has been completed, and it is not always seen as the role of researchers4.
An example of such a project is IMPACT (IMplementation of quality indicators in 
PAlliative Care sTudy). In this EU funded 7th Framework project, quality indicators 
(QIs) for the organisation of palliative care were developed, and used to assess 
and improve the organisation of 40 palliative care services across Europe9. The 
results and tools of this project, even though it is built around implementation 
may not be further disseminated, adopted and implemented as soon as IMPACT 
finishes, without further action. 
The aim of this study was to identify strategies that can facilitate the implementation 
of scientific output to improve the organisation of palliative care after a large 
research project like IMPACT has ended.
Method
A nominal group technique was used. This technique follows a structured and 
evaluative methodology, developed to facilitate group or team decision making10. 
As such, they can be used to analyse healthcare problems11, and bridge the gap 
between researchers and healthcare professionals12,13. A nominal group differs 
from focus group interviews as these are often used to explore what individuals 
believe or feel as well as why they behave in the way they do14.
Participants
Participants were members of the IMPACT consortium, all internationally 
(European) recognised researchers and clinicians (including physicians, nurses, 
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social workers and psychologists) in cancer care, dementia care and palliative 
care, including (former) board members of the European Association of Palliative 
Care (EAPC - http://www.eapcnet.eu/) and of Interdem (http://www.interdem.
org), an international research group on early detection and timely intervention in 
dementia. Participants were divided by profession and field of interest to create 
two groups of similar size and with an equal balance of clinicians and researchers. 
All participants were aware of the results of the IMPACT project prior to the 
nominal group sessions, which were: a generic model of palliative care13, a set 
of quality indicators to evaluate the organisation of palliative care15, strategies 
to improve the organisation of palliative care, and an overview of barriers and 
facilitators of such improvement strategies16. At the start of the nominal group 
sessions, all participants were asked for their consent to participate.
Conduct of the groups
Both nominal groups were conducted during the annual consortium meeting of 
the IMPACT project, one day before the EAPC research congress in Lleida (Spain) 
in June 2014. 
Both nominal groups were led by an experienced moderator (YE and MVD, 
coordinators of the IMPACT project), and an observer was present in each group 
to take notes. To ensure comparability of the two nominal groups, the moderators 
discussed the protocol of the nominal group approach prior to commencing the 
nominal group sessions. As a first step, the moderators invited group members 
to individually write down strategies for implementing the results of a research 
project (such as IMPACT) in daily practice, with no limit to the number of strategies. 
Secondly, the moderators asked each group member to list the strategies in order 
of importance. These strategies were documented on a flipchart (or laptop and 
projector) in full view of all participants. Subsequently, the moderators invited 
the other group members to react to these strategies in order to initiate a 
discussion. During these discussions, common themes were identified, which 
allowed the moderators to combine overlapping strategies. When all participants 
had mentioned their strategies and no further discussion was necessary, the 
moderators invited each participant to rank their five most important themes 
(1 being the most important and 5 the least important) and subsequently the 
feasibility of each theme (1 being most feasible and 5 least feasible). Feasibility 
was defined as the likelihood that the theme can be operationalised as concrete 
actions. The ratings provided by the participants were again documented in full 
view of all participants. 
Analysis
Data resulting from the nominal group technique was analysed using a qualitative 
approach. In order to merge the recommendations mentioned by participants in 
the two nominal group sessions, all items mentioned by the participants were 
independently coded and subsequently compared by two researchers (JRP and 
YE). They discussed the codes until consensus was reached. When no consensus
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could be reached, a third researcher was consulted. When all items were coded, 
categories and themes were derived from the codes. As participants ranked their 
five most important strategies, this helped in identifying top themes.
Ethical considerations
The Medical Ethics Committee of the district Arnhem-Nijmegen has declared that 
this study does not fall within the remit of the Medical Research Involving Human 
Subjects Act (registration number 2012/075). This means that this study could be 
carried out without an approval by an accredited medical ethics committee.
Results
Twenty participants took part in the nominal group (table 1).
In one nominal group, 21 potential strategies were mentioned and in the second 
nominal group 31. These strategies could be ranked and combined into the 
following themes (table 2):
Dissemination of the results
Participants considered conferences, and in particular publications tailored to 
specific audiences, to be important. For example, results should also be published 
in ‘policy language’ for policy makers, ‘professional language’ in newsletters of 
Table 1: Participant characteristics
Group 1 Group 2
Male / Female 6 / 4 3 / 7
Age 52.5 (25-64) 56.5 (30-60)
Researcher 5 6
Clinician 5 4
Years in practice (st.dev.) 19 (13.1) 20.7 (12.4)
Type of settings
Primary care 1 -
Nursing home - 1
Hospital 4 3
Academic setting 5 6
Country
Australia 1 -
Belgium - 1
Finland - 1
Germany 1 1
Italy 1 1
Netherlands 2 2
Norway 1 3
Spain 1 -
United Kingdom 3 1
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professional scientific organisations and in ‘laymen language’ for the general 
public (e.g. by using social media). 
Unique selling points
Participants considered a unique selling point or sales pitch a prerequisite to 
promote quality improvement activities to services. They argued that quality 
improvement activities should highlight those aspects that are unique, known to 
be attractive or solve a problem or barrier. Secondly, participants also considered 
the collaboration between researchers and clinicians an important unique selling 
point, as this already shows that clinicians have been involved from the start.
Educational activities
In both nominal groups, participants mentioned using specific e-learning tools 
as well as mass-learning (e.g. YouTube) for dissemination. They also suggested 
integration of training activities with daily routines and inclusion of  quality 
improvement activities with the core curricula used by teaching staff. 
Participation of stakeholders 
Participants mentioned that it is important to involve different types of stakeholders 
(patients, professionals, policy makers, insurers and funders). Professionals of a 
(scientific) organisation can, for example, acknowledge quality improvement 
Table 2: Strategies mentioned by the participants of both nominal group 
sessions (themes and categories)
Dissemination of the results
• Presentations at conferences
• Publications (e.g. in scientific peer-reviewed journals, in professional journals, via policy 
channels but also (international) professional organisations, newspapers)
• Social media (e.g. websites, YouTube, Twitter) 
Unique selling points
• Sales pitch (focus on facilitating factors / preconditions/ user friendliness/ visibility)
• The impact of using unique selling point/strategy/sales pitch
Educational activities
• Integration of training activities into daily scheme
• User friendly format (e.g. e-learning modules, mass learning via YouTube, downloadable 
slides)
• Train the trainer
Participation of stakeholders
• Expert organisations (e.g. those responsible for implementation)
• Patients, relatives, professionals and policy makers
• Healthcare insurers and funders
• Early adopters: staff in pilot services
Consideration of consequences
• Rewards (e.g. financial, certificates)
• Negative consequences (e.g. no accreditation)
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activities and include them in their protocols. Therefore, it is important to identify 
those stakeholders who can and will contribute to quality improvement activities. 
Participants suggested using local expert organisations, but also ‘early adopters’ 
derived from the network of the services itself. 
Consequences
Participants mentioned that services can be stimulated to implement quality 
improvements when they are rewarded for their activities, for example with 
certificates of best practice. However, they also stated that quality improvement 
activities require commitment from the service. Services can therefore also be held 
responsible for failure to implement quality improvement activities. For example, 
participants suggested threats to the accreditation of services as a sanction for not 
implementing quality improvement activities.
The strategies mentioned by the participants of both nominal groups led to the 
following recommendations about implementation strategies to improve the 
organisation of palliative care (table 3).
Discussion
This study identified specific strategies to implement the results of research 
projects in the field of palliative care. The nominal group technique allowed 
international clinicians and researchers to prioritise five common themes: 
dissemination of the results, unique selling points, educational activities, 
involvement of stakeholders and the consideration of consequences. These 
strategies are in line with those found in literature4,17-21. For example, in an 
overview by Grol and Grimshaw18, in which they included 54 reviews about the 
effectiveness of different interventions to change clinical practice, they described 
dissemination activities, educational activities and financial interventions. In 
another overview, Grimshaw et al. described educational activities as well as 
Table 3: Recommendations based on the strategies to facilitate imple-
mentation 
• Publish results regarding the implementation of quality improvement activities tailored 
to its audience (e.g. patients, professionals caregivers, policy makers and researchers)
• Identify and disseminate unique selling points to implement quality improvement 
activities
• Develop e-learning tools (e.g. via YouTube)
• Integrate scientific evidence into the core curricula (of practitioner disciplines)
• Stimulate the active participation of important stakeholders to engage and initiate  
quality improvement activities (e.g. professional (scientific) organisations)
• Reward services that successfully implemented quality improvement activities (e.g. 
financial incentive)
• Restrict services that provide suboptimal palliative care and do not implement quality 
improvement activities (e.g. no accreditation) 
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disincentives4. In a review, Giguere et al. described the effect of different strategies 
using printed educational materials20. In a report for the Danish Institute for Health 
Services Research and Development, Thorsen et al. described dissemination 
strategies, educational activities and incentives and sanctions19. And in his 
‘Diffusion of Innovations’, Rogers described the involvement of stakeholders21. 
However, several of the strategies identified have yet to be applied to improve 
daily clinical practice. For instance, identifying the unique selling points of studies, 
and using negative consequences for services are methods that are not frequently 
used. As for negative consequences, in the USA the Centers for Medicare & 
Medicaid Services applied financial penalties to hospitals that did not improve 
their hospital acquired infection rate, and as a result infection rates declined in 
many hospitals22. Regarding the participation of stakeholders, it is known that 
‘early adopters’ are important21: Rogers described that they show a high degree of 
innovativeness, are a role model for others and help trigger the critical mass when 
adopting an innovation21. But ‘early adopters’ hardly appear to be used when 
introducing changes into daily clinical practice.
Participants also considered the social media as agents of change that could be 
used more often. However, various healthcare organisations, scientific journals, 
researchers and healthcare professionals use different kind of social media to 
communicate about palliative care and disseminate new evidence into daily clinical 
practice23,24. Examples are the EAPC blog (https://eapcnet.wordpress.com/) and 
reviews of palliative care services (such as available for the Netherlands: https://
palliatief.tevreden.nl/). Furthermore, palliative care knowledge networks (such as 
CareSearch in Australia: http://www.caresearch.com.au/) can contribute to the 
dissemination and implementation of new evidence in daily clinical practice. 
The added value of our study is that all these strategies have been considered 
together and prioritised by experts.
Surprisingly, de-implementation and mandating quality improvement projects 
were not mentioned. De-implementation, meaning stopping ineffective or harmful 
interventions is particularly important as there are many suboptimal forms of care 
in use. In palliative care, for example, the use of artificial hydration was recently 
discussed in a paper by Nakajima et al.25. They showed that artificial hydration 
did not improve dehydration symptoms, quality of life, or survival in terminally 
ill cancer patients25. The continuation of such ineffective and sometimes even 
harmful medical practices is undesirable and may result in rising healthcare costs 
in addition to the increased burden on patients and care givers26. Mandating 
quality improvement projects is important because without the full support 
of the scientific and professional organisations, the implementation of quality 
improvement projects will not progress2. 
However, as the participants in our study emphasised, using only one strategy 
to implement quality improvement activities in daily clinical practice is not 
sufficient. Participants recommended, in line with Grol and Grimshaw18, the use 
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of a combination of strategies. It appears to be important that, for each quality 
improvement activity a theoretically grounded structured procedure, like the 
framework for the development and evaluation of complex interventions of the 
UK Medical Research Council7, the Plan-Do-Study-Act cycle8, or the Stepwise 
Implementation Model of Grol et al.2, is used. These implementation models 
facilitate both researchers and professionals in a step-by-step guide to implement 
evidence based best practices into daily clinical routine. Such models also may 
provide users with a detailed description of the current situation, preferred 
situation, reasons why the preferred situation has not been reached, factors that 
could be used to reach the preferred situation, etc. This information facilitates 
the development of specific actions necessary to initiate change. For example by 
following the steps described in the theory of planned behaviour or behaviour 
change wheel27,28. The recommendations stipulated in this paper can be used to 
tailor quality improvement activities specifically for palliative care. For example 
one of the recommendations has already been carried out by organising the 
Palliative Care 2020 conference at which stakeholders were invited to discuss the 
future of palliative care in Europe and which resulted in the European Declaration 
on Palliative Care29.
Strengths and limitations
Strengths of this study were that the IMPACT consortium consisted of an 
international, multiprofessional group of professionals (including nurses, 
physicians, social workers and researchers). The mix of researchers with a 
background in implementation science, professionals active in daily clinical practice 
and members involved in national policy making, facilitated the identification 
of optimal implementation strategies. This study allowed the members of the 
IMPACT consortium to think about future implementation strategies while the 
study was still ongoing. However, this also shows a limitation of this study; as no 
patients or informal caregivers were involved.
Conclusion
Research projects generate a growing amount of new knowledge. Often this new 
knowledge is not implemented in daily practice, particularly in an environment 
as complex as palliative care. Timely efforts should be made to ensure that the 
future application of scientific findings is integrated into the research itself, to 
prevent wasting resources and as an endpoint for better healthcare for patients. 
The recommendations reported here may be of particular use in promoting 
quality improvement activities in palliative care. Important stakeholders, such as 
scientific and professional organisations and leaders on the level where the actual 
implementation takes place, can perform a key role in the wider implementation 
of new evidence.
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Abstract 
Background: People with dementia can benefit from a palliative care approach. 
Recommendations, such as those of the EAPC have been proposed to strengthen 
the provision of palliative care for this group of patients. Yet, it remains challenging 
for professionals to identify when a person with dementia is in need of palliative 
care. The objective of this study therefore was to explore when professionals in 
long-term care settings consider a person with dementia in need of palliative care.
Methods: Teams with in total 84 professionals working in 13 long-term care settings 
from 6 countries (France, Germany, Italy, Norway, Poland and the Netherlands) 
received a case-vignette concerning a person with dementia recently admitted to 
a nursing home. Teams were asked to discuss when they considered people with 
dementia eligible for palliative care. The constant comparative method was used 
to analyse their answers. 
Results: Three different time points in the disease trajectory when people with 
dementia were considered to be eligible for palliative care were extracted: 
(1) early in the disease trajectory; (2) when signs and symptoms of advanced 
dementia are present; and (3) from the time point that curative treatment of co-
morbidities is futile. Yet, none of these time points was uniformly considered by 
the professional teams across Europe. In some cases, professionals working in the 
same nursing home didn’t even reach consensus when considering persons with 
dementia eligible for palliative care. 
Conclusion: The results of the study identified that professionals across Europe 
have different opinions regarding the time point when to consider a person with 
dementia in need of palliative care.
131
Identification of the palliative phase in people with dementia
Background
Worldwide, about 36 million persons have dementia1. People with advanced 
stages of dementia have complex physical and psychological needs2,3. Many suffer 
from symptoms such as pain, agitation, dyspnea, neuropsychiatric symptoms 
and depression4, which threatens the quality of their lives as well as that of their 
relatives. Appropriate palliative care can deal with the needs and preferences 
of people with dementia and their families2. However, access to palliative care 
services for people with dementia is less defined than for patients with cancer5. 
Professionals in dementia care often lack the necessary skills to anticipate the 
changing palliative care needs of a person with dementia5-7. Therefore, people with 
dementia are more frequently hospitalised and too often receive burdensome 
interventions8. Moreover, compared to patients with other life-threatening 
diseases, they are less likely to receive advance care planning6, are less frequently 
referred to palliative care teams or hospice care6 and more often experience 
symptoms for a longer period of time9. 
Dementia is more and more acknowledged as a life-threatening disease5. Time 
from diagnosis until death varies from two to 20 years2,10. This protracted course 
of dementia makes it difficult for persons with dementia and their families, as 
well as for professionals to discuss end-of-life issues, such as advance treatment 
decisions, preferred place of care and death or lasting power of attorney2,4,5. 
Consequently, people with dementia are often not involved in discussions about 
preferences and needs early in the disease11, when their cognitive impairment 
does not yet impede their participation in the decision-making process.
Recently, the European Association for Palliative Care published a white paper on 
defining palliative care in dementia12. One of the recommendations is to consider 
the time point of the diagnosis of dementia as the starting point of palliative 
care12. However, there is still an ongoing discussion on the identification of the 
palliative phase in dementia. Besides, people with dementia have unequal access 
to palliative care services compared to patients with cancer13. Therefore, the aim 
of this study was to explore when professionals in long-term care (LTC) facilities 
across Europe consider a person with dementia in need of palliative care.
Methods
The EU-funded Seventh Framework IMPACT project (IMplementation of quality 
indicators in PAlliative Care sTudy) aims to develop and tailor national and setting-
specific strategies to improve the organisation of palliative care in several European 
countries. As part of this study, a pre-post test was conducted in 40 services across 
Europe to assess the organisation of palliative care of long-term care settings, in 
which also a case-vignette was used. Case-vignettes have been used in a variety 
of settings14-18, and they offer a promising alternative for the assessment of the 
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performance of healthcare professionals. Case-vignettes consist of ‘text, images 
or other stimuli to which research participants are asked to respond’16. In this 
study, the case-vignette was created in a way that it explicitly excluded clinical 
details of the depicted subject (e.g. about the prognosis, symptoms, etc.) in 
order to stimulate discussion. The present paper presents the results of the case-
vignette about identifying the palliative phase in people with dementia.  
Case-vignette
Specific characteristics of a person with dementia were drafted by a general 
practitioner (Professor of Primary Care for Older People, SI), and used to develop 
a case-vignette in English. The case-vignette was presented to the IMPACT project 
team (consisting of 14 clinicians and researchers). After having fine-tuned the 
concept case-vignette with their feedback (table 1), the English case-vignette was 
translated into the local languages of the participating countries involved in the 
project, using a forward-backwards translation. Subsequently, researchers were 
asked to pilot test the translated case-vignette with at least two professionals in 
their country. These professionals were asked to evaluate the comprehensiveness 
and clarity of the vignettes.
Table 1: Case-vignette of a person with dementia.
Mrs. White is 83 years old. She has been married for 56 years to Charles. They have one 
child, Lucy, who is 47, and who keeps in regular contact with them.  
Mrs. White was diagnosed with dementia about 9 years ago. Until recently, she lived with 
her husband in a house in the country. Because Mrs. White can get quite aggressive when 
she does not understand what is going on, her husband can no longer deal with her at 
home. Therefore Mrs. White recently moved to a nursing home.
Question: Please explain if and when you would consider Mrs. White as a person in need 
of palliative care?
Setting and participants 
At least two LTC settings for people with dementia were purposefully selected 
per country. These LTC settings had to have at least one year of experience in the 
provision of palliative care. Each of the selected LTC settings recruited members 
from their multidisciplinary team (table 1). Selection criteria for these team 
members were being involved in direct patient care or, at least, having knowledge 
of direct patient care. In each setting, one professional was appointed by the 
researchers as contact person.
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Data collection
The multidisciplinary teams participated in a meeting in which the case vignette 
was presented. In each setting, the contact person chaired this meeting. This 
person was instructed about the purpose of the meeting. The participants did 
not receive a definition of palliative care as this would have biased the results. 
In this study, participants were stimulated to share their own definitions and 
clinical perceptions about palliative care. Participants were also instructed to 
consider the depicted person as one of their own residents and were asked: 
‘Please, could you explain if and when you would consider Mrs. White as a person 
in need of palliative care?’. Instructions also stated that consensus within the 
multidisciplinary team was not important; different opinions could exist. Within 
each multidisciplinary group, the chair person summarised and documented the 
answer(s) according to a predefined template divided into three main sections: 
job titles of participants; outcomes of the discussion; observational analysis of 
the discussion process. The chair person was asked to translate the answers into 
English and to provide detailed information about the process how they came to 
their answers (e.g. specifying if there was immediate consensus, whether there 
was a long discussion, if requests of clarifications occurred and reactions of the 
participants ). Subsequently, the chair persons submitted their answer(s) as open 
text into an online data-registration tool (a web-based data registration tool 
based on LimeSurvey). If any of the information was unclear, the chair person was 
contacted to provide further explanations.
Analysis
In each non-English country, the researcher translated the answers of the vignette 
into English. Two researchers (JvRP and EM) independently coded the data by 
using a constant comparative method19. First, each researcher conducted the 
comparison within single interviews, developing and labeling categories with 
appropriate codes in order to outline the core concepts of the interviews. Second, 
a comparison between interviews was conducted, combining the codes in clusters, 
in order to define the concepts and identify similarities and differences between 
interviews20. The two researchers discussed their codings until consensus was 
reached. Regular contact (face-to-face, by Skype and by email) was used during 
the analysis to refine codes and to group the codes into unique categories. When 
no consensus could be reached, a third researcher was consulted (YE). Themes 
and categories were regularly fed back and discussed with two other authors 
(MVD and YE).
Ethical considerations
The Medical Ethics Committee of the district Arnhem-Nijmegen has declared that 
this study doesn’t fall within the remit of the Medical Research Involving Human 
Subjects Act (WMO) (registration number 2012/075). This means that this study 
can be carried out without an approval by an accredited medical ethics committee.
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Results
Thirteen nursing homes in six European countries (France, Germany, Italy, Norway, 
Poland and the Netherlands) participated in the vignette study. In all nursing 
homes, the staff were responsible for the provision of palliative care. In Germany, 
Poland and one Dutch nursing home, staff had 24/7 accessibility to specialist 
services, whereas in the other nursing homes this fluctuated between working 
hours only to none at all. In one German, the Italian and Dutch nursing homes, 
an end-of-life care pathway was commonly used for the last three days of life of a 
person in need of palliative care.
In total, 84 professionals took part in the multidisciplinary team discussions (Table 
2). Professionals in nine nursing homes considered Mrs. White in need of palliative 
care (Table 3). In four nursing homes, professionals stated that Mrs. White was not 
in need of palliative care. The multidisciplinary team reached consensus on their 
view when to consider Mrs. White in need of palliative care in ten nursing homes. 
The opinions of the multidisciplinary teams varied so much in the remaining three 
nursing homes, that they were not able to reach consensus during the discussion 
of the vignette. 
The reasons why the multidisciplinary teams did or did not consider Mrs. White 
in need of palliative care varied and could be grouped into three categories 
representing different attitudes of staff members on the entry point for palliative 
care: (1) palliative care starts early in the disease trajectory, (2) palliative care starts 
when signs and symptoms of advanced dementia are present, and (3) palliative 
care starts when curative treatment for co-morbidities is no longer possible. 
Table 2: Participating professionals per nursing home 
DE-
1
DE-
2
FR-
1
FR-
2
IT-
1
IT-
2
IT-
3
NO-
1
NO-
2
NL-
1
NL-
2
PL-
1
PL-
2
Physician - - 1 1 1 1 1 - - - - 1 1
Nurse 3 2 1 1 1 1 1 2 6 3 5 2 3
Healthcare assistant 4 2 1 3 1 1 - 3 1 3 - - -
Psychologist - - - 1 1 2 - - - - - 1 1
Social worker - - - - - - - - - - - 1 -
Other - - 2 5 3 2 4 - - 1 - 1 3
Total 7 4 5 11 7 7 6 5 7 6 5 6 8
DE: Germany, FR: France, IT: Italy, NO: Norway, PL: Poland, NL: the Netherlands
Palliative care should start early in the disease trajectory
Professionals in a German nursing home (DE-2) unambiguously agreed that Mrs. 
White was a person in need of palliative care from the day she moved in. A similar 
answer came from an Italian nursing home (IT-2), whereby some professionals 
stated that dementia is a terminal disease and consequently all their residents, 
including Mrs. White, should be treated as people in need of palliative care. In 
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the Netherlands, the vignette generated a debate between professionals in a 
nursing home (NL-1): participating healthcare assistants first had the impression 
that palliative care only involved the last three days of life. Two nurses, however, 
persuaded the healthcare assistants that they should consider people like Mrs. 
White, with a diagnosis of dementia, as in need of palliative care. In the end, 
the multidisciplinary team agreed that Mrs. White was in need of palliative care. 
Similarly, some professionals of a Norwegian (NO-2) and of a Polish (PL-2) nursing 
home argued that people with early-stage dementia should be considered in need 
of palliative care.
Palliative care should start when clinical symptoms of advanced 
dementia are present
A German nursing home (DE-1) used a self-developed assessment tool to identify 
palliative care needs and symptoms of their own residents. For that reason, the 
members of this team agreed that if Mrs. White would meet the criteria of this 
assessment tool, they would consider her in need of palliative care. Similarly, 
staff in an Italian nursing home (IT-1) unanimously considered Mrs. White in need 
of palliative care if she suffered from serious communication deficits, physical 
disorders, pain and severe agitation. Yet, in a second Italian nursing home (IT-2), 
staff were not able to reach consensus whether to consider Mrs. White in need of 
palliative care. Some professionals did mention that palliative care is exclusively 
applicable for people with advanced dementia. In a third Italian nursing home 
(IT-3), team members agreed that a person with advanced dementia would be 
considered in need of palliative care. However, they considered that Mrs. White, 
as depicted in the vignette, did not show symptoms of advanced dementia. An 
analogous concept was expressed by professionals in two French nursing homes 
(FR-1 and FR-2). They unanimously agreed that Mrs. White was not in an advanced 
stage of dementia and therefore not in need of palliative care. Professionals in a 
Norwegian nursing home (NO-1) also shared this opinion. However, in another 
Norwegian nursing home (NO-2), staff were not able to reach consensus. Some 
stated that palliative care is applicable for people with dementia with a short life 
expectancy. Lastly, Polish professionals (PL-1 and PL-2) referred to the time point 
in the disease trajectory in which dementia symptoms seriously hamper a person’s 
autonomy and demand intensive medical and nursing care. 
Palliative care should start when curative treatment for co-
morbidities has no longer a beneficial effect 
Professionals from a Dutch nursing home (NL-2) agreed that at the time Mrs. 
White is experiencing physical diseases and the doctors decide not to treat these 
anymore, she should be considered in need of palliative care. In a Norwegian 
nursing home (NO-2) professionals did not reach consensus, and only some of 
them considered Mrs. White in need of palliative care when she would no longer 
benefit from medical or surgical treatment. 
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Discussion 
This study highlights the challenges faced by professionals working in long-term 
care settings with people with advanced dementia in defining the time point when 
palliative care should start. With the help of a case-vignette, we identified three 
time points in the disease trajectory of a person with dementia that teams of 
nursing home professionals considered as the moment to start palliative care: (1) 
from the early stages of dementia, (2) when signs and symptoms of advanced 
dementia are present, and (3) from the time point that curative treatment for 
co-morbidities is futile. Discrepancies were found not only between European 
countries, but also between staff members working in the same LTC setting. In 
some nursing homes, for example, professionals disagreed about the time point 
a person with dementia is in need of palliative care. Also between countries, 
different time points when a person becomes eligible for palliative care were 
mentioned. 
However, most professionals described that palliative care should be provided 
when a person with dementia shows symptoms indicating the advanced stage of 
dementia is approaching the end-of-life phase, such as swallowing disorders, pain, 
or when the body does not respond to food or liquids anymore.
Birch et al. described that professionals often find it difficult to recognise unmet 
palliative care needs of people with dementia because the progression of 
dementia differs in each person2. The progression towards the advanced stages of 
dementia, for example, remains unpredictable2,10. Prognostic indicators to identify 
end-stage dementia may increase the availability of palliative care options for 
people with dementia and their families8, but they are often used too late and 
seem unreliable to predict a person’s death21. Some of the professional teams in 
our study responded that the early stages of dementia can be considered as the 
time point palliative care starts. Black et al.22 described that recognising the needs 
and preferences of people with dementia early in the disease trajectory facilitates 
the involvement in the decision-making process and advance care planning.
Professionals in two nursing homes considered the time point that curative 
treatment for co-morbidities is futile and does not improve the person’s quality of 
life as the starting point for palliative care. However, similarly to using prognostic 
indicators, considering the time point when co-morbidities cannot be treated 
might be too late in the disease trajectory to provide proactive palliative care as 
the cognitive abilities of a person with dementia have declined too much so that 
the person is no longer able to participate in the decision making process and 
advance care planning.
Before group discussion, some professionals even considered the last days of life 
as the starting point for palliative care, meaning when the patient is about to die. 
Although we only reported about the final considerations of the professionals, it is 
important to note that this could potentially be a fourth time-point. 
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Differences between countries in identifying the time point of the palliative phase 
were expected, because of different cultures and national regulations for palliative 
care23. However, even within countries, different opinions about the time point of 
the palliative phase were identified. Thereby, there appeared to be differences in 
definition about palliative care between services. Although important consensus 
statement reports such as the EAPC’s White Paper, defining optimal palliative care 
in older people with dementia12, have been developed and dissiminated, they 
are not sufficient to overcome these barriers. Access to palliative care therefore 
depends on the perceptions of palliative care professionals about when palliative 
care becomes appropriate for people with dementia. There is a need for further 
research into the differences palliative care makes to quality of life and end of life 
care for people with dementia, and the perceptions of palliative care professionals 
about the value of engaging in the care of people with dementia. Knowledge 
about and experience in palliative care of professionals working in dementia care 
therefore need to be improved24. Teaching professionals to lead their caregiving 
by needs probably might be the most important step in providing timely palliative 
care in each phase of the disease. Reaching consensus about the definition of 
palliative care and subsequently about the time point of the palliative phase is 
therefore necessary25. 
This study can contribute to the ongoing discussion on this topic by showing that 
there are three time points when nursing home professionals consider a person 
with dementia in need of palliative care: early in the disease trajectory, advanced 
dementia or when curative treatment for co-morbidities has no more beneficial 
effect. Even within services, it appeared that sometimes there were different 
opinions regarding the starting point of the palliative phase. Future attempts 
to define the optimal time point of the palliative phase in dementia should 
acknowledge these differences.
 
Strengths and limitations
This study contributes to our knowledge about the challenges that professionals 
working in LTC settings experience during their daily work with people suffering 
from dementia, particularly regarding their palliative care needs. Besides, it is the 
first study in which we get insights in how professionals that work with people 
with dementia on a daily basis define the starting point of palliative care. This is 
an important addition to the theoretical studies on this topic12,26. However, some 
limitations have to be taken into account. Participants did not receive a definition 
of palliative care prior to their discussion about the starting point of palliative care 
as it was the aim of this study to allow them to share their own definitions and 
clinical perceptions about palliative care. Their opinions may have therefore been 
influenced by the type of palliative care intervention available in their service. If 
we would have provided the WHO definition of palliative care, their own meaning 
would probably have been influenced by this.
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Second, as answers provided by the participants were anonymised, it was not 
possible to identify differences in the personal perspectives of the healthcare 
professionals. If these would have been reported, the anonymity of the participants 
would have been at stake because of the few services and professionals involved.
Third, although data was collected in nursing homes in six European countries, 
the data may not be representative for all services at the regional or national 
healthcare system in the respective countries. This study was too small to grasp 
such differences. Further multicenter and multinational studies have to be 
conducted to analyse regional or national differences regarding the starting point 
of the palliative phase.
Fourth, it was the aim of this study to explore when professionals in long-term 
care settings consider a person with dementia in need of palliative care and not 
to reach consensus about the time point that the palliative phase starts in people 
with dementia. Future research can therefore use the three time points identified 
in this paper, to further explore the possibilities of reaching consensus about the 
time point of the palliative phase in people with dementia within and between 
services.
Conclusion
The findings from this study show that professionals across Europe have different 
opinions regarding the time point when to consider a person with dementia in 
need of palliative care. The range of opinions described in this study lead to the 
recommendation that multiple methods for information and education of staff 
members should be pursued to improve palliative care policy and service delivery 
for people with dementia.
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General discussion
In the previous chapters, I presented the results of the EU funded 7th Framework 
IMPACT (IMplementation of quality indicators for PAlliative Care sTudy) project, 
which aimed to develop and introduce quality indicators in order to assess and 
improve the organisation of palliative care for patients with cancer or dementia. 
In the first chapter, a description of the problem and subsequently the research 
questions were presented. Chapter 2 provided a more detailed description of the 
entire IMPACT project. In this final chapter, the main findings of the studies carried 
out in chapter 3 to 7 are presented and discussed in the light of relevant and 
recent literature. Subsequently, the most relevant methodological issues and the 
implications of the results are discussed. Finally, a number of recommendations 
for practice, policy and future research are given. 
Summary and interpretation of main findings
Quality indicators to assess and improve the organisation of 
palliative care were developed 
Getting insights in the quality of care provided is an essential first step of improving 
the organisation of palliative care. However, there are few science-based quality 
criteria regarding the organisation of palliative care.
In chapter 3, I described how we developed a set of quality indicators resulting 
from a five-round modified RAND Delphi-procedure with an international panel of 
professionals and researchers active in the fields of palliative cancer and dementia 
care. The final set consists of 23 quality indicators that described the accessibility 
of the palliative care service, its infrastructure, the use of symptom assessment 
tools, management of personnel, documentation of clinical data, quality of care 
and education. These identified domains are in line with the recommendations 
how to improve the organisation of palliative care as stipulated by the Council 
of Europe1. In contrast to quality indicators for palliative care developed in the 
past2,3, these quality indicators have been developed within an international 
context. Moreover, compared to other quality indicators on the organisation of 
palliative care4,5, our quality indicators focus on both cancer and dementia care, 
thereby making the step to broaden palliative care to other diseases than cancer. 
In our Delphi-procedure, we explicitly included healthcare professionals working 
in dementia care to rate the usefulness of the quality indicators. But panellists 
in our study agreed not to formulate disease-specific quality indicators as it was 
the aim of our set to focus on the organisation of services and not on the care 
provision itself. I believe that our set of quality indicators therefore is unique: it 
can be used in different countries, and in services for patients with cancer and in 
those for patients with dementia. However, because our set of quality indicators is 
generically applicable in different services and for different diseases, it is possible 
that country or setting-specific quality indicators are missing in this international 
set. If appropriate, each country can add them. 
The quality indicators we developed can identify potential areas for improvement. 
They can be used by healthcare professionals as mirror information to improve 
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the organisation of palliative care in their service. As such, our quality indicators 
can be called ‘internal quality indicators’6. Because they were developed for 
this specific purpose, they are not meant to be used for external purposes, 
such as accreditation or certification7. Further validation, reliability of repeated 
measurement, inter-rater reliability, case mix adjustment and discriminatory 
capacity should be further defined. Within the IMPACT project, our quality 
indicators have been tested in a pre-post test intervention study. These results 
have yet to be published and are beyond the scope of this thesis. 
Strategies to improve the organisation of palliative care were 
identified
Different strategies to change the organisation of care exist. Yet, few studies 
investigated the use of such strategies specifically for the organisation of palliative 
care.
In chapter 4, I described the results of an integrative review in which we found 68 
studies that met our inclusion criteria: they described specific strategies to improve 
the organisation of palliative care. These studies included educational strategies, 
process mapping, feedback, multidisciplinary meetings and multi-faceted 
interventions. Most studies reported positive results regarding the implementation 
of quality improvement activities for the organisation of palliative care using 
any of the identified strategies. Even interventions like audit and feedback, 
that was found to be hardly effective in a Cochrane review, showed positive 
results in our review8,9. The same accounts for continuing education meetings10, 
printed educational methods11,12, educational outreach13, reminders14,15, and for 
example inter-professional collaboration16,17. These positive results are also not 
in line with an overview of Grol and Grimshaw, in which they included 54 reviews 
about the effectiveness of different interventions to change clinical practice18. 
Most interventions they studied, including educational activities, feedback and 
multiprofessional collaboration had mixed effects18. They also found that combined 
interventions were more effective than single interventions18. The positive results 
identified in our review might be caused by the fact that participants in a quality 
improvement project perform better as a result of knowing that they are a study 
object (Hawthorne effect)19, because effects were often measured directly after 
the intervention or because only a few studies were randomised controlled (RCT) 
or blinded studies. Aoun et al. described that RCTs comprise only about 6% of all 
studies conducted in palliative care20. RCTs require significant time and funding, 
expert research guidance, and particularly in palliative care populations they are 
scarce because of recruitment restrictions, high attrition, (selection) bias, lack of 
blinding, confounding, and small sample sizes20. Nonetheless, there is a need for 
high-quality evidence in palliative care.
By reviewing existing literature on this topic, a description of the existing strategies 
both revealed the weakness of the evidence as well as the potential of several 
strategies. Moreover, although we identified a wide range of strategies, it is 
possible that we have missed potentially interesting publications, as there are no 
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uniform search strategies to identify improvement strategies for the organisation of 
care, even though there are initiatives such as the Cochrane Effective Practice and 
Organisation of Care (EPOC)21, or the Expert Recommendations for Implementing 
Change (EIRC)22. 
An overview of barriers and facilitators of strategies to improve the 
organisation of palliative care was developed
To implement changes in the organisation of palliative care, it is important to know 
which potential factors facilitate or hinder the intervention. However, an overview 
of such barriers and facilitators for the organisation of palliative care was lacking.
In chapter 5, I described barriers and facilitators of strategies to improve the 
organisation of palliative care, as mentioned in 40 individual and 10 focus group 
interviews with professionals involved in palliative care in five European countries 
(England, Germany, Italy, Norway and the Netherlands). These barriers and 
facilitators were categorised into five themes: the innovation itself, the individual 
professional level, group dynamics, the organisational context, and the local 
political-economic context. These themes are in line with those described in other 
studies, in other areas of healthcare like the organisational culture, structural 
characteristics, implementation climate and readiness23. Lennox et al. studied 
challenges of implementing a COPD care bundle. The barriers they identified were: 
lack of time, shortage of staff and lack of staff engagement and their facilitators 
were related to improve engagement of staff, education and financial incentives24. 
Our barriers and facilitators are also comparable to those identified regarding the 
provision of palliative care itself, such as time constraints25, lack of funding25,26, and 
lack of professional awareness26. 
In our study in five European countries, we found similarities between the 
organisation of care in different services and countries, despite national and 
international differences in culture, healthcare system and organisation of 
palliative care. For example, in all type of settings and in all countries professionals 
indicated that financial resources and a positive attitude to change are of the 
highest importance. This suggests that sufficient funding and the motivation of 
staff are a prerequisite to change. Thereby, facilitators that were mentioned as a 
barrier when absent (e.g. attractiveness of improvement strategies) can also be 
considered as an essential requirement to change. Our barriers and facilitators 
should therefore be considered when implementing quality improvement 
initiatives into the organisation of palliative care. However, an additional 
assessment of national barriers and facilitators remains a necessity, irrespective 
of the findings from our international study, as was also stipulated by Grol27.
Strategies to implement the results of research into daily clinical 
palliative care were defined
When a research project has been finished, it is important to implement its results 
into daily clinical practice. However, this step is often insufficiently explored, 
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leaving many research results unused.
In chapter 6, I presented recommendations on how to implement the results of 
research projects into daily clinical practice. Key opinion leaders participating in 
two parallel nominal group sessions identified and prioritised a set of potential 
strategies, which could be categorised into five common themes: dissemination 
of the results, unique selling points, educational activities, involvement of 
stakeholders and consequences of implementation. Our findings are in line with 
previous studies11,18,28-30, but add the prioritising by the participants of strategies 
to influence the implementation of quality improvement activities in palliative 
care. Thereby, these strategies are still not used in a structured way. But when 
applied in other projects, they often resulted in promising effects. In the USA, 
for example, the use of financial consequences has resulted in a reduction of the 
hospital acquired infection rate31.
Although the panellists in our study made a congruent description of strategies 
similar to what is known from the literature, they did not consider de-
implementation and mandating of quality improvement activities. Yet, these 
aspects are considered essential to improve daily clinical practice32,33. The 
recommendations that resulted from the nominal group sessions should therefore 
not be considered as standalone and ready-to-use strategies; they need to be 
tailored to the specific situation. Implementation of our recommendations should 
therefore always be guided by a stepwise implementation approach.
The identification of the starting point of palliative care in people 
with dementia remains unclear
Palliative care was originally developed as care for patients with cancer. During the 
last decade, palliative care is increasingly provided to patients with other types of 
diseases, such as dementia. The question is, however, when these patients are 
eligible for palliative care.
In chapter 7, we found that healthcare professionals caring for people with 
dementia in long-term care facilities described three time-points when they 
consider a person with dementia in need of palliative care: 1) at an early stage of 
dementia, 2) when signs and symptoms of advanced dementia are present, or 3) 
as soon as curative treatment for co-morbidities is futile.
The first time-point (considering the early stage of dementia as the starting point 
for palliative care) is comparable with the recommendation of the European 
Association on Palliative Care (EAPC) to consider the diagnosis of dementia as the 
starting point for palliative care34. Healthcare professionals often find it difficult 
to recognise unmet palliative care needs of people with dementia35, and late 
identification of the palliative phase may results in problematic communication 
with the person with dementia36. Identifying needs and preferences early in the 
disease trajectory should therefore facilitate the involvement in the decision-
making process and advance care planning37.
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However, in our study, most professionals considered the second time-point 
(when a person with dementia shows symptoms indicating the advanced stage 
of dementia) as the starting point for palliative care. This is in contrast with 
the recommendation of the EAPC to consider the diagnosis of dementia as the 
starting point of palliative care34. Birch, for example, explains that because of the 
unpredictability of the disease trajectory of dementia, the length of the remaining 
life of a person with dementia is not clear35. Raymond et al. described that family 
members felt frustrated when they had to discuss end-of-life care as it was difficult 
to accurately anticipate the end of life for a person with dementia38. The person 
with dementia and his or her family first have to learn how to live with the disease 
and its consequences, once a diagnosis of dementia has been made. Palliative 
care should therefore not ‘take over’ usual care for persons with dementia, but 
should remain an additional service. Pacala described this by comparing palliative 
and geriatric care and stated that these two fields “spend far too much time 
highlighting the marginal differences between the two disciplines in an effort to 
justify their own existence”39. But palliative care does not usurp geriatric care, nor 
does palliative care usurp dementia care. Instead, palliative care should identify 
mutual strengths and recognise the differences with other types of care in order 
to bring the provision of palliative care to a higher quality level, irrespective of 
setting or disease.
The third time-point mentioned (when curative treatment for co-morbidity 
becomes futile), might be too late in the disease trajectory to provide proactive 
palliative care as the cognitive abilities of a person with dementia have declined 
too much so that the person is no longer able to participate in the decision making 
process and advance care planning. Raymond et al. described that professionals 
have a lack of knowledge about palliative care, especially those providing dementia 
care40. Education and training in palliative care for patients with dementia needs 
to be developed and implemented.
Because we collected our data using a case-vignette in a limited number of settings 
and countries, (France, Germany, Italy, Norway, Poland and the Netherlands), 
generalizability to other countries or settings is restricted; further research is 
therefore necessary. Yet, our study showed that professionals have varying 
opinions when to consider a person with dementia in need of palliative care, not 
only between countries, but also within countries and between staff members of 
the same long-term care facility. Secondly, it showed that professionals often have 
a lack of understanding what palliative care actually is about. Our findings can 
therefore contribute to the changing paradigm on this topic. 
Main discussion and conclusions
This thesis has resulted in 1) a set of quality indicators to assess and improve 
the organisation of palliative care, 2) an overview of strategies to improve the 
organisation of palliative care, 3) a description of barriers and facilitators regarding 
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improvement strategies, 4) an overview of strategies to implement changes into 
daily clinical practice and 5) a critical assessment whether the above described 
strategies can also be used in palliative dementia care by identifying the time-
points when professionals working in long-term care facilities consider a person 
with dementia in need of palliative care. 
All these findings are related to the first four steps described in Grol’s stepwise 
Implementation of Change Model27. When a thorough analysis of the actual 
performance, identification of barriers and facilitators and specific improvement 
strategies are not considered when improving the quality of care, failure of the 
implementation is imminent. Despite this potential risk for failure, there is still a 
lack of attention regarding implementation science, resulting in a lot of scientific 
efforts being wasted41. Also in palliative care, a lot of newly found evidence is 
not implemented. Hanchanale and Jordan42, for example, reported that only 
43% of abstracts presented at an international palliative care conference in 2005 
eventually made it to peer-reviewed publication. But even when research is 
published, the impact of the scientific evidence that is presented remains limited. 
Greenhalgh et al.43, documented five downsides for evidence based medicine: 
statistically significant benefits may be marginal in clinical practice; inflexible rules 
and technology driven prompts produce care that is management driven rather 
than patient-centered; evidence-based guidelines often map poorly to complex 
multimorbidity; the evidence base is biased by organisations, like pharmaceutical 
companies, that have a special interest in specific results; and the volume of 
evidence has become unmanageable. Adequate use of a stepwise implementation 
model is therefore important to ensure that optimal and tailored strategies are 
being introduced into daily clinical practice. 
The results presented in this thesis can be used to assess and hence change the 
organisation of palliative cancer and dementia care. We thereby recommend 
to apply Grol’s Implementation of Change Model to improve the organisation 
of palliative cancer and dementia. However, where Grol only mentions the 
“integration of changes into routine care”, we propose to explicitly add to Grol’s 
Implementation of Change Model, the identification of specific strategies to ensure 
implementation of new scientific evidence into clinical practice. This facilitates 
researchers to think about how to ensure wider implementation of their results 
more early in a research project and allows the translation of research results to 
other areas of healthcare.
Implications for practice, policy and research
The findings described in this thesis allowed to make the following 
recommendations (table 1):
Recommendations for practice
We developed a set of quality indicators that can be used to assess and subsequently 
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identify areas for improving the organisation of services providing palliative care. 
While explicit measurement constitutes an important first step for improving the 
quality of the organisation of palliative care, measurement alone is not enough27. 
Other critical steps are also necessary, such as feeding back the results; identifying 
and specifying improvement objectives; identification of potential barriers and 
facilitators; identifying and implementing effective strategies; and measuring the 
impact of the implemented strategies27,44. For which this study provided the tools 
for. Besides using our set of quality indicators, services should understand that 
specific tools must be used that can guide quality improvement objectives. For 
example, the online application developed by the IMPACT project 
(http://impactpalliativecare-assessment.eu), that assesses and hence guides 
services in their quality improvement process.
Secondly, this thesis showed that sub-optimal palliative care is provided 
across Europe. Although there are different initiatives that aim to improve the 
identification of those patients that may profit of palliative care (e.g. the surprise 
question)45, there is a need to further improve the knowledge and provision of 
palliative care. I encourage the model presented by Quill and Abernetly, in which 
they distinguish two levels of palliative care: “primary palliative care (skills that 
all clinicians should have) and specialist palliative care (skills for managing more 
complex and difficult cases)”46. In the Netherlands, the use of palliative care 
consultation teams is a good example of how generalist and specialist services 
can work together in the provision of palliative care47. A potential solution in 
the Netherlands may be the recently published ‘Care pathway for palliative care 
1.0’, which provides recommendations about the provision of palliative care for 
all healthcare professionals48. But without the inclusion of palliative care in the 
curricula of nursing and medical training, improving (the organisation of) palliative 
care will remain difficult. I therefore recommend that palliative care becomes an 
integral part of the core curricula of the medical education for at least physicians 
and nurses.
Recommendations for policy
The studies conducted in this thesis have shown that there is a vast amount of 
literature available on quality indicators specifically for palliative care. Few quality 
indicators, however, are actually being used in daily practice. Therefore, we call 
upon national and international policy makers to enforce the use of our set of 
quality indicators. In the Netherlands, for example, the Netherlands Organisation 
for Health Research and Development obliged the use of quality indicators 
developed by Pasman et al. in all new palliative care research projects. Our set of 
quality indicators could be adopted by the scientific organisations, like Palliactief 
in the Netherlands, as a tool to stimulate internal quality improvement projects of 
settings that provide palliative care. This also stipulates my second point, as I would 
like to highlight the importance of mandating quality improvement activities: 
without full support of scientific professional organisations, implementation of 
quality improvement activities into daily clinical practice will be hampered. 
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Thirdly, national and international policies should be developed that stimulate the 
implementation of high quality palliative care. The recommendations stipulated in 
the ‘2014 European Declaration on Palliative Care’, which resulted from a joined 
conference of the IMPACT and EURO-IMPACT consortia, may be of particular use 
for decision makers at regional, national and international level (appendix 1)49.
Recommendations for future research
The findings reported in this thesis evoke several new questions. First of all, the 
quality indicators presented in this thesis are meant for internal purposes: as a 
tool for professionals in order to assess whether their service meets a basic quality 
level and hence initiate improvement projects. Although the results can be used 
to compare services, they cannot be used for a quality rating. Additional research 
is necessary to identify whether and how the current set of quality indicators can 
also be used for external purposes. 
Second, we showed that a large variety of strategies are being used to implement 
quality improvements to the organisation of palliative care. However, only few 
studies used a randomised controlled design. In order to prevent further sub-
optimal research designs and unnecessary duplication of studies and facilitate 
comparison of studies, I recommend that more randomised controlled trials 
should be started, or that high quality alternative designs will be developed.
Third, I recommend that researchers identify strategies to translate their results 
into daily practice more early in their research project in order to prevent wasting 
of all their efforts. 
Fourth, improving palliative care for persons with dementia is only possible when 
all professionals caring for them have a basic knowledge about palliative care. 
Therefore, it is important to further explore what palliative care adds to the care 
of persons with dementia and subsequently when the palliative phase starts in 
persons with dementia.
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Table 1: Recommendations following the results 
presented in this thesis
Recommendation Field
1.1 Use a stepwise implementation model to assess, initiate and guide quali-
ty improvements in daily clinical practice
Practice
1.2 Encourage the distinction between primary palliative care and specialist 
palliative care
Practice
1.3 Promote the knowledge and experience of healthcare professionals by 
ensuring that palliative care becomes an integral part of the core curricu-
la of the medical education for at least physicians and nurses
Practice
2.1 Enforce the use of our quality indicators to assess the level of quality of 
the organisation of palliative care provided by services
Policy
2.2 Mandate quality improvements by scientific professional organisations Policy
2.3 Develop national and international policies that stimulate the implemen-
tation of high quality palliative care 
Policy
3.1 Explore the possibility to use our quality indicators for external purposes 
(e.g. as a quality rating)
Research
3.2 Facilitate the comparison of studies regarding strategies to improve the 
organisation of palliative care by conducting more randomised controlled 
trials or other high quality alternatives
Research
3.3 Identify strategies to translate new evidence into daily clinical practice 
more early in research projects 
Research
3.4 Explore what palliative care adds to the care of people with dementia and 
subsequently when the palliative phase starts in people with dementia
Research
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Appendix 1
2014 European Declaration on Palliative Care
“Palliative care is an approach that improves the quality of life of patients and their 
families facing the problems associated with life-threatening illness, through the 
prevention and relief of suffering by means of early identification and treatment of 
other problems, physical, psychosocial and spiritual” [World Health Organisation, 
2002].
Palliative care is required from early in the disease course, can be delivered 
alongside potentially curative treatment, and continues to include end-of-life or 
terminal care.
Calling upon policy and decision makers at regional, national and international 
level to:
1. Recognise that the delivery of and access to high quality palliative care is a 
public health priority which requires a public health approach. 
2. Develop or redraft national and international healthcare policies, such as 
policies on healthy ageing, long-term care and dementia, to include palliative 
care as an essential component. 
3. Develop or redraft palliative care-specific policies to include referral criteria 
that allow patients and their family timely access to palliative care consistent 
with their level of need, regardless of diagnosis, age, prognosis, estimated life 
expectancy or care setting. 
4. Develop or redraft policies to include mechanisms to ensure access to specialist 
multidisciplinary palliative care services or teams in all healthcare settings. 
5. Promote a paradigm shift in health and social care towards basic palliative 
care skills for all healthcare professionals, to empower them to deliver patient-
centred family-focused care for all people with a life-limiting illness, based on 
personalised or tailored care plans, with attention to all needs of the patient 
and his or her family. 
6. Support inter-professional and multi-disciplinary collaboration as a cornerstone 
of high-quality care and education in palliative care. 
7. Invest in curriculum development and education in palliative care across all 
disciplines of health and social care at undergraduate and post-graduate level, 
and establish palliative care as a specialty. 
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8. Promote public awareness through community level approaches: education of 
the public and training of family carers and volunteers. 
9. Increase funding opportunities for national and international research in 
palliative care. 
10. Establish continuous mechanisms to monitor and improve the quality of and 
access to palliative care. 
Launched in Brussels, October 2014
Summary
Samenvatting
Dankwoord
Publication list
Curriculum vitae
9

161
Summary
Summary
In this thesis, a step-by-step approach to find methodologies to improve the 
organisation of palliative care was taken. Firstly, we identified a set of quality 
indicators for the evaluation of the organisation of palliative care. Secondly, we 
identified strategies that can improve palliative care. Thirdly, we identified barriers 
and facilitators regarding these improvement strategies. Fourthly, we identified 
strategies to improve the implementation of research results into daily clinical 
practice. And finally, to explore potential areas for improvement regarding 
palliative care for people with dementia, we also identified the various time 
points when healthcare professionals consider people with dementia in need of 
palliative care. 
Chapter 1 and chapter 2 describe the context in which this thesis was written. In 
chapter 1, I describe that due to the ageing of the population and higher survival 
rates of people with chronic diseases, there will be an increasing number of 
patients in need of palliative care. I illustrated what the advantage of palliative 
care is for patients with cancer and those with dementia. Yet, many patients 
receive sub-optimal palliative care, despite the large advances in palliative care 
that have been made over the last decade. To further improve the provision of 
palliative care, the organisation of palliative care needs to be improved as a base 
for the provision of optimal palliative care. Chapter 1 concludes with the research 
objectives and an outline of this thesis. 
In chapter 2, a detailed description of the larger EU funded 7th Framework IMPACT 
(IMplementation of quality indicators for PAlliative Care sTudy) project, of which 
this thesis was part of, is provided by describing the protocol of the entire project.
Chapter 3 presents the results of a study identifying a set of quality indicators 
for the evaluation of the organisation of palliative care. An international panel of 
healthcare professionals and researchers active in the field of palliative cancer 
and dementia care participated in a five-round modified RAND Delphi-procedure. 
The Delphi-procedure resulted in 23 useful quality indicators, representing the 
accessibility of the service, its infrastructure, the use of symptom assessment tools, 
management of personnel, documentation of clinical data, quality of care and 
education. This set of quality indicators should be considered for the evaluation 
of the organisation of palliative care and to subsequently identify potential areas 
for improvement.
Chapter 4 describes the results of a literature review regarding strategies that 
were used to improve the organisation of palliative care. An integrative review 
methodology was used as this allows to summarise empirical and theoretical 
literature that use diverse methodologies and study designs. After having applied 
our inclusion criteria to the 2379 initially identified publications, 68 experimental 
or quasi-experimental studies were included. These studies included educational 
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strategies (n=14), process mapping (n=1), feedback (n=1), multidisciplinary 
meetings (n=1) and multi-faceted implementation strategies (n=51). Fifty-three 
studies reported positive outcomes, 11 studies reported mixed effects and four 
studies had a limited effect. However, these results should be interpreted carefully 
as studies might have been subject to the Hawthorne effect, publication bias, and 
only few of them used prospective, controlled designs. More controlled designs 
or large prospective studies with improved designs for specific improvement 
strategies are necessary to compare and identify the most effective strategy to 
change the organisation of palliative care.
Chapter 5 presents the results of a study on barriers and facilitators regarding 
strategies to improve the organisation of palliative care. Forty individual and ten 
focus group interviews were conducted with healthcare professionals involved in 
the provision of palliative care in five European countries. Barriers and facilitators 
were inductively grouped into 16 categories and arranged into five themes: 
innovation, individual professional level, group dynamics, organisational context 
and local political-economic context. This study demonstrates that although 
the barriers and facilitators identified differed in scope, context, strength and 
provenance, they were shared by professionals from different European countries. 
Taking these barriers and facilitators into account can therefore be seen as a 
prerequisite to change.
Chapter 6 describes the results of a study identifying strategies to implement 
improvement activities into daily palliative care practice, when new evidence 
has been generated. A nominal group technique was used with members of the 
IMPACT consortium, being international researchers and clinicians in cancer care, 
dementia care and palliative care. Twenty experts participated in one of two parallel 
nominal group sessions. The nominal group approach allowed the panellists to 
prioritise strategies towards the implementation of quality improvement activities 
specifically for the field of palliative care. The process resulted in a list of strategies 
that were combined into five common themes: dissemination of the results, 
unique selling points, educational activities, involvement of stakeholders and 
incentives and sanctions. Although these themes are in line with those previously 
described, they are not used in a structural way in daily practice yet. The added 
value of this nominal group study therefore is the prioritising by the experts of 
strategies to influence the implementation of quality improvement activities in 
palliative care. It also showed that efforts to ensure future use of scientific findings 
should be built into research projects in order to prevent waste of resources.
Chapter 7 presents the results of a study on the starting point of the palliative phase 
of persons with dementia. Thirteen teams of in total 84 professionals working in 
long-term care facilities in six countries (France, Germany, Italy, Norway, Poland 
and the Netherlands) received a case-vignette concerning a person with dementia 
recently admitted to a nursing home. Part of the professionals considered a 
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person with dementia already in need of palliative care (1) early in the disease 
trajectory; some (2) when signs and symptoms of advanced dementia are present; 
and others (3) from the time point that curative treatment of co-morbidities is 
futile. This study shows that professionals across Europe, but also within a country 
or even within a service have varying opinions when to consider a person with 
dementia in need of palliative care and can therefore contribute to the changing 
paradigm on this topic.
In chapter 8, the final chapter of this thesis, the most important findings described 
in chapter 3 to 7 are discussed. The results are placed within a theoretical 
background and compared with other studies. Besides, methodological issues as 
well as recommendations for practice, policy and future research are described. 
It can be concluded that a good organisation of palliative care is a prerequisite for 
good outcomes. The results presented in this thesis can contribute to improving the 
organisation of palliative care by (1) using the quality indicators to assess whether 
the service meets a basic quality level and subsequently identify potential areas 
for improvement; (2) using the described strategies to improve the organisation 
of palliative care; (3) using the barriers and facilitators to tailor the improvement 
strategies to the needs of the service; and (4) using the implementation strategies 
to ensure dissemination of the evidence based and best practices into daily clinical 
practice. Regarding the time-points when to consider a person with dementia in 
need of palliative care, the variety of opinions of professionals across Europe 
show that further research is necessary to define the provision of palliative care 
for persons with dementia.
As such, this thesis adds knowledge about implementation science specifically 
related to the organisation of palliative care by exploring methods to improve the 
translation of evidence to areas of healthcare where suboptimal palliative care is 
still being provided.

165
Samenvatting
Samenvatting
In dit proefschrift is een stap-voor-stap benadering toegepast om methoden te 
identificeren die de organisatie van de palliatieve zorg kunnen verbeteren. Ten 
eerste hebben we een set van kwaliteitsindicatoren ontwikkeld om de organisatie 
van de palliatieve zorg te evalueren. Ten tweede hebben we strategieën bestudeerd 
die de palliatieve zorg kunnen helpen verbeteren. Ten derde zijn belemmerende 
en bevorderende factoren van deze strategieën geïnventariseerd. Ten vierde 
hebben we strategieën geïdentificeerd waarmee onderzoeksresultaten in de 
dagelijkse praktijk kunnen worden geïmplementeerd. Tot slot hebben we gekeken 
naar mogelijke verbeterpunten wat betreft de palliatieve zorg voor mensen met 
dementie. Daarbij hebben we de verschillende momenten dat zorgverleners 
mensen met dementie als palliatief patiënt beschouwen in kaart gebracht.
Hoofdstuk 1 en hoofdstuk 2 beschrijven de context waarin dit proefschrift is 
geschreven. In hoofdstuk 1 heb ik beschreven dat door de toenemende vergrijzing 
en een groeiend aantal mensen met chronische ziektes, het aantal mensen dat in 
aanmerking komt voor palliatieve zorg zal toenemen. Ik heb daarbij weergegeven 
wat de voordelen van palliatieve zorg zijn voor patiënten met kanker en voor 
mensen met dementie. Echter, er zijn veel patiënten die sub-optimale palliatieve 
zorg ontvangen. Dit ondanks de vele ontwikkelingen die de palliatieve zorg de 
laatste jaren heeft doorgemaakt. Om het aanbod van palliatieve zorg verder te 
kunnen verbeteren, zal ook de organisatie van palliatieve zorg verbeterd moeten 
worden zodat deze als basis kan fungeren voor het verlenen van optimale 
palliatieve zorg. Hoofdstuk 1 wordt afgesloten met de doelstellingen en een korte 
beschrijving van dit proefschrift. 
In hoofdstuk 2 wordt een meer uitgebreide beschrijving van het door de Europese 
Unie gefinancierde 7th Framework IMPACT (IMplementation of quality indicators 
for PAlliative Care sTudy) project gegeven, waarvan dit proefschrift onderdeel is.
Hoofdstuk 3 presenteert de resultaten van een studie waarin een set van 
kwaliteitsindicatoren ten behoeve van de evaluatie van de organisatie van de 
pallaitieve zorg is beschreven. Een internationaal panel bestaande uit zorgverleners 
en onderzoekers die actief zijn in de palliatieve zorg, oncologie of dementie heeft 
geparticipeerd in vijf rondes van een gemodificeerde RAND Delphi-procedure. 
Deze Delphi-procedure heeft geresulteerd in 23 kwaliteitsindicatoren die de 
toegankelijkheid van zorg, de infrastructuur, gebruik van meetinstrumenten, 
personeelsmanagement, documentatie van klinische data, kwaliteit van zorg 
en het opleidingsaanbod representeren. Deze set van kwaliteitsindicatoren is 
ontwikkeld ten behoeve van de evaluatie van de organisatie van palliatieve zorg 
en kan gebruikt te worden om mogelijkheden voor verbetering te identificeren.
Hoofdstuk 4 beschrijft de resultaten van een literatuurstudie naar strategieën 
die zijn gebruikt om de organisatie van palliatieve zorg te verbeteren. Een 
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‘integrative review’ is gebruikt omdat deze methode het toestaat om empirische 
en theoretische literatuur die verschillende methodieken en studiedesigns 
gebruiken, te includeren. Na het toepassen van de in- en exclusiecriteria op 
de 2379 initïeel geïdentificeerde publicaties, konden we 68 experimentele en 
quasi-experimentele studies includeren. Deze studies beschreven strategieën 
op het gebied van educatie (n=14), het in kaart brengen van processen (n=1), 
feedback (n=1), multidisciplinaire overleggen (n=1) en studies met twee of meer 
implementatiestrategieën (n=51). Drieënvijftig studies rapporteerden positieve 
effecten, 11 studies rapporteerden zowel positieve als negatieve effecten en in 
vier studies werd een minimaal effect beschreven. Deze uitkomsten dienen echter 
met enige voorzichtigheid geïnterpreteerd te worden, aangezien er een kans 
bestaat dat deze studies zijn beïnvloed door het Hawthorne effect, publicatiebias 
alsmede doordat slechts weinig studies gebruik maakten van een prospectief, 
gecontroleerd ontwerp. Om verbeterstrategieën te kunnen vergelijken en de 
meest effectieve strategieën voor de organisatie van de palliatieve zorg te kunnen 
identificeren, is het aan te bevelen dat er meer prospectieve studies met een 
betere studieopzet komen die zijn gericht op specifieke verbeterstrategieën om 
de organisatie van palliatieve zorg te veranderen.
Hoofdstuk 5 presenteert de resultaten van een studie naar belemmerende 
en bevorderende factoren ten aanzien van strategieën ter verbetering van 
de organisatie van palliatieve zorg. Hiervoor zijn 40 individuele en tien 
focusgroepinterviews uitgevoerd met zorgverleners in vijf Europese landen, die 
betrokken zijn bij de palliatieve zorgverlening. Belemmerende en bevorderende 
factoren zijn inductief gegroepeerd in 16 categorieën en gerangschikt in vijf 
thema’s: innovatie, individuele zorgverlener, groepsdynamiek, organisatie en 
lokaal politiek-economische context. Hoewel de belemmerende en bevorderende 
factoren verschilden in omvang, context, sterkte en herkomst, demonstreert deze 
studie dat ze wel degelijk gedeeld worden door zorgverleners in verschillende 
Europese landen. Het in acht nemen van deze bevorderende en belemmerende 
factoren is daarom een voorwaarde om te kunnen veranderen.
Hoofdstuk 6 beschrijft de resultaten van een studie waarin strategieën zijn 
geïdentificeerd om verbeteractiviteiten te implementeren in de dagelijkse 
praktijk op het moment dat nieuwe onderzoeksresultaten zijn gegenereerd. 
Een nominale groepstechniek is gebruikt bij leden van het IMPACT consortium, 
bestaande uit internationale onderzoekers en zorgverleners op het gebied van de 
palliatieve zorg, oncologie en dementie. Twintig experts hebben deelgenomen 
aan één van twee parallelle groepssessies. De nominale groepstechniek stelde 
de panelleden in staat om strategieën te prioriteren die specifiek bedoeld zijn 
voor het implementeren van kwaliteitsverbeterprojecten op het gebied van 
palliatieve zorg. Deze procedure heeft geresulteerd in een lijst van strategieën 
die werden gecombineerd in vijf thema’s: disseminatie van de resultaten, unique 
selling point, activiteiten op het gebied van educatie, betrekken van stakeholders 
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en stimulerende factoren en sancties. Hoewel ze overeenkomen met thema’s die 
eerder zijn beschreven, worden ze nog niet op een structurele manier toegepast 
in de dagelijkse praktijk. De toegevoegde waarde van deze studie is daarom de 
prioritering die de experts hebben gegeven aan de strategieën om de implementatie 
van kwaliteitsverbeteringen in de palliatieve zorg te beïnvloeden. Tevens toont het 
aan dat inspanningen om toekomstig gebruik van wetenschappelijke output te 
faciliteren ingebed moet worden in wetenschappelijke projecten om te voorkomen 
dat onderzoeksgelden worden verspild.
Hoofdstuk 7 presenteert de resultaten van een studie naar het startpunt van 
de palliatieve fase bij mensen met dementie. Dertien teams met in totaal 84 
zorgverleners werkzaam in instellingen in de langdurige zorg in zes landen 
(Duitsland, Frankrijk, Italië, Nederland, Noorwegen en Polen) ontvingen een 
casus over een persoon met dementie die recentelijk was opgenomen in een 
verpleeghuis. Na het bediscussiëren van deze casus, vond een deel van de 
zorgverleners dat deze persoon in aanmerking kwam voor palliatieve zorg (1) vroeg 
in het ziektetraject; sommigen (2) bij symptomen van gevorderde dementie; en 
anderen (3) wanneer het behandelen van co-morbiditeiten niet langer toereikend 
is. Deze studie toont aan dat zorgverleners in Europa, maar ook binnen één land 
en zelfs binnen een instelling een grote variatie aan meningen hebben wanneer 
mensen met dementie in aanmerking komen voor palliatieve zorg. Hierdoor kan 
deze studie bijdragen aan het veranderende paradigma over dit onderwerp.
In hoofdstuk 8, het laatste hoofdstuk van dit proefschrift, worden de belangrijkste 
bevindingen, beschreven in de hoofdstukken 3 tot en met 7 bediscussieerd. De 
resultaten zijn geplaatst binnen een theoretisch kader en vergeleken met andere 
studies. Hierbij zijn ook methodologische beperkingen alsmede aanbevelingen 
voor de praktijk, beleid en toekomstig onderzoek geformuleerd.
Er kan worden geconcludeerd dat een goede organisatie van palliatieve zorg een 
voorwaarde is voor goede uitkomsten. De resultaten die in dit proefschrift worden 
gepresenteerd kunnen bijdragen aan het verbeteren van de organisatie van de 
palliatieve zorg door (1) de kwaliteitsindicatoren te gebruiken om te beoordelen 
of zorginstellingen voldoen aan een bepaald basisniveau en daaraan gerelateerd 
kunnen ze gebruikt worden om mogelijkheden voor verbetering te identificeren; 
(2) de beschreven strategieën te gebruiken om de organisatie van palliatieve zorg 
te verbeteren; (3) de belemmerende en bevorderende factoren te gebruiken om 
de verbeterstrategieën aan te passen aan de behoeften van de instelling; en (4) de 
verbeterstrategieën te gebruiken om verspreiding van wetenschappelijke bewijs 
en best practices in de dagelijkse praktijk te waarborgen. 
Ten aanzien van het moment waarop mensen met dementie in aanmerking 
komen voor palliatieve zorg, laten de verschillende opvattingen van zorgverleners 
in Europea zien dat verder onderzoek nodig is om palliatieve zorg voor mensen 
met dementie verder te definiëren.
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Als zodanig draagt dit proefschrift bij aan de kennis over 
implementatiewetenschappen, specifiek gerelateerd aan de organisatie van 
palliatieve zorg door het bestuderen van methoden ten aanzien van de vertaling 
van wetenschappelijk bewijs naar de praktijk, waar sub-optimale palliatieve zorg 
wordt gegeven, te verbeteren.
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Een promotietraject doe je niet alleen. Door de jaren heen krijg je heel wat 
hulp en advies, bedoeld en onbedoeld. Het dankwoord van een proefschrift is 
de uitgelezen plaats om iedereen te bedanken die heeft bijgedragen aan mijn 
ontwikkeling tot onderzoeker. Ik beperk me daarbij tot hen die een belangrijke 
bijdrage aan dit proefschrift hebben geleverd. Velen zullen daardoor niet in 
persoon worden genoemd, maar kunnen zich bij dezen toch vertegenwoordigd 
voelen. 
Allereerst dank ik mijn promotoren, professor Vernooij-Dassen en professor 
Vissers. Beste Myrra, ik weet dat je een beetje opziet tegen dit dankwoord, want 
wat hebben wij in de afgelopen vier jaar veel meegemaakt. Maar wees gerust, ik 
zal niets schrijven over de vele keren dat we de kledingkeuze van jou en Yvonne 
hebben besproken, of de bekeuring voor het reizen zonder geldig vervoersbewijs 
in de metro van Praag. Myrra, wat ik wel wil schrijven is mijn enorme dank die ik 
je verschuldigd ben. Altijd had jij een uiterst kritische doch correcte houding. Deze 
feedback heeft gemaakt dat mijn werk goed terecht is gekomen en ik mij heb 
kunnen ontwikkelen tot een zelfstandig onderzoeker. Ik ben ervan overtuigd dat 
ik jou inspirerende rol als begeleider nog lang bij mij zal dragen in de rest van mijn 
loopbaan. Dank daarvoor. 
Beste Kris, als tweede promotor keek jij vaak vanaf de zijlijn mee, maar je was 
toch altijd betrokken. Telkens weer kwam je bij onze promotieoverleggen met 
zeer inspirerende inbreng, die meer dan eens een volledig nieuwe kijk op de zaak 
gaf. Jouw ervaring als arts was daarbij onmisbaar voor het slagen van het project. 
Dank voor alles.
Mijn copromotor, doctor Engels. Beste Yvonne, jij hebt misschien wel de 
belangrijkste rol vervuld in de totstandkoming van dit proefschrift. Ik had me geen 
betere copromotor kunnen wensen (understatement). Zelfs op het moment dat 
je gezondheid het even liet afweten, bleef jij voor me klaarstaan. Altijd was je 
enthousiast en problemen komen in jouw woordenboek niet voor: alles is een 
uitdaging en geen berg is je te hoog. Ik heb ongelooflijk veel respect voor hoe 
jij je als mens, collega en begeleider in dit promotietraject hebt opgesteld. Ik 
heb al heel veel van je mogen leren, maar hoop nog heel veel langer van jou te 
mogen blijven leren. Yvonne, zoals Myrra wel eens heeft gesproken: ‘Jij bent een 
ongelooflijk sterke vrouw!’ Dank voor alles.
Dear IMPACT consortium members, a European project of this kind, can’t be a 
success without the input of its partners. I would like to thank all of you for your 
generous support, advice, and feedback you gave me. In particular, I would like to 
thank:
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Professor Iliffe, dear Steve, I think Nathan is very lucky that he had you as his 
supervisor. Your expertise, generosity and kindness makes you a great researcher. 
Thank you for all your support throughout the project.
Professor Radbruch, dear Lukas, I envy you: despite your busy schedule, you were 
always able to find the time to respond to my emails, provide feedback to my 
papers, and support me where necessary. Thank you very much for that.
Professor Hjermstad, dear Marianne, despite your busy personal life, you 
consistently managed to find the time to respond to my papers. I know Ragni is in 
good hands with you. Thank you for everything.
Professor Chattat, dear Rabih, I enjoyed talking to you, in particular during some of 
the walks we had. Elena can be very luck that she has you as her direct supervisor. 
Thank you for very much for all your support.
Birgit, Elena, Ragni, and Nathan, we were responsible for the majority of the 
IMPACT work. I enjoyed working with all of you, and I think we were a great team. 
We really did it! I feel confident that each and every one of you will become a 
great researcher (if not already)! 
Elena, a special word to you, because I still don’t know how you managed to do 
it, but doing your work for the IMPACT project, following your psychology classes, 
and managing your own PhD trajectory, respect! We have worked together on 
several papers (both for your and my thesis), which I have enjoyed very much. 
It was great to experience some of the Italian lifestyle and I look forward to your 
defence here in Nijmegen. 
Het gaat te ver om alle medewerkers van IQ healthcare en de afdeling 
Anesthesiologie, Pijn en Palliatieve Geneeskunde persoonlijk te bedanken. Daarom 
een greep uit de selectie: Frederike, Angelique en Anita als onderzoekmedewerkers 
voor het IMPACT project hebben jullie geweldig werk verricht. Ik had nooit zonder 
jullie gekund! Zowel qua werk als sociaal was het prettig om met jullie te mogen 
samenwerken. Dank! 
Anna, hoewel jouw werk voor het IMPACT project geen deel uitmaakt van dit 
proefschrift, wil ik je ontzettend danken voor je geweldige inzet voor het IMPACT 
project. 
Alice, Monique en Jolanda, heel veel dank voor alle ondersteuning tijdens het 
project: van het plannen van vergaderingen tot de hulp bij de laatste loodjes. 
Dank, dank, dank. 
Myrna, het was mij een genoegen om ruim twee jaar samen met jou Schil (het 
forum voor alle junioronderzoekers van IQ healthcare) te mogen voorzitten. 
Hoewel niet direct gerelateerd aan mijn proefschrift, heeft het voorzitterschap mij 
persoonlijk heel veel opgeleverd. 
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In vier jaar tijd heb ik verschillende kamergenoten zien komen en gaan: Carola, 
Kalinka, Nancy, Marleen het was prettig om met jullie de kamer te mogen delen 
en informeel adviezen te kunnen uitwisselen. Jozette, jij verdient in dit rijtje een 
bijzondere vermelding. Onze promotietrajecten liepen nagenoeg gelijk op. Mede 
daardoor hebben wij vier jaar lang de kamer mogen delen. In deze vier jaar heb 
jij, mede door het vele hardop nadenken, voor de nodige gezelligheid gezorgd, mij 
gevraagd en ongevraagd feedback en advies gegeven en stond je altijd voor me 
klaar. Van een lach tot een traan, we konden op elkaar steunen. Jozette, ik had mij 
geen betere kamergenoot kunnen wensen. Dank voor alles en ik ben vereerd dat 
je ook het laatste stukje van mijn promotietraject met mij wil afsluiten als mijn 
paranimf.
Annick, je was al bang dat ik je zou overslaan, maar ik wil het rijtje van collega’s 
graag met jou afsluiten. Als projectmanager van het IMPACT project had jij de 
afgelopen vier jaar een buitengewoon lastige functie, maar IMPACT had zich geen 
betere projectmanager kunnen wensen. Annick, jij bent één van de meest warme 
personen die ik ken. Ik wil je bedanken voor alle informatie, adviezen, steun en 
ook het luisterende oor wat jij mij in de loop der jaren hebt gegeven.
Bas en Wouter, het stond al lang van tevoren vast dat één van jullie mijn tweede 
paranimf zou zijn. Tot op het laatste moment heb ik de keuze niet kunnen maken. 
Ik hoop dat jij Wouter, het me vergeeft dat ik uiteindelijk voor Bas heb gekozen 
als mijn paranimf. Maar Wouter, jij hebt ook een mooie bijdrage gehad in dit 
proefschrift: dank voor het ontwerp van de omslag.
Pap, mam, ik weet dat jullie het niet altijd makkelijk hebben gehad met mij. Eerst 
al die jaren het heen en weer gereis voor de sport, daarna ruim 13 maanden een 
zoon moeten missen omdat deze zonodig stage moest lopen in het buitenland. 
Maar zie hier, jullie opvoeding heeft ertoe geleid dat er nu een doctor in de familie 
zit. Dank voor jullie onophoudelijke steun en interesse in mijn werk.
Lieve Marjon, niemand weet beter wat ik de afgelopen vier jaar heb meegemaakt 
dan jij. Elke avond konden we elkaars promotietrajecten bespreken en elkaar op 
die manier verder helpen en er doorheen slepen. In alles wat jij doet ben je een 
ware steun en toeverlaat. Dank, heel veel dank Marjon!
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